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ABSTRACT 
 
Six species of Malaysian medicinal plants were selected on the basis of their known 
medicinal values. The plants chosen were Aloe vera - leaf and pulp, Azadirachta indica - 
leaf, Carica papaya - leaf, Centella asiatica - whole plant, Hymenocallis speciosa - leaf, 
tuber and root, Vernonia amygdalina - leaf and stem. Aqueous and ethanolic extract of the 
plant tissues were tested for their antimicrobial properties against five test microorganisms.  
Of the six plants tested, the aqueous and ethanolic extract of C. asiatica (whole 
plant) exhibited highly significant antimicrobial activity against the bacterial strains while 
the ethanolic extract of Vernonia amygdalina (leaf) showed distinct inhibition only towards 
B. cereus. C. asiatica and V. amygdalina were selected as candidates for further evaluation 
of their medicinal properties.  
Ammonium sulphate precipitation was conducted to determine if antimicrobial 
activity was due to peptides present in the plant. The antimicrobial activity for ethanolic 
plant extracts was observed in the supernatant with their pellet showing insignificant 
antimicrobial activity. The highest antimicrobial activity was observed in the ammonium 
sulphate supernatant of C. asiatica against S. aureus and B. cereus. Since phenolic 
compounds are responsible for their antimicrobial and antioxidant properties, they were 
investigated in C. asiatica and V. amygdalina.  
Total phenolic content (TPC) of plant extracts were determined with Folin-
Coicalteu assay. In C. asiatica, the TPC of the ethanolic extract was the highest 4.006 ± 
0.032 mg GAE/g d.w followed by methanolic extracts 3.346 ± 0.029 mg GAE/g d.w and 
aqueous extracts 1.120 ± 0.063 mg GAE/g d.w. In V. amygdalina, the TPC was highest in 
methanolic extract 1.168 ± 0.101 mg GAE/g d.w, followed by aqueous extract and 
ethanolic extract had the lowest TPC. 
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The antioxidant properties of the extracts were determined by DPPH radical 
scavenging assay and FRAP. Using the DPPH assay, ethanolic extract of C. asiatica 
showed high radical scavenging activity whereas the lowest activity was observed in the 
aqueous extracts. All three extracts of V. amygdalina showed weak radical scavenging 
activity. Using the FRAP assay, reducing capability of C. asiatica and was observed as 
methanol > ethanol > aqueous > ascorbic acid and the reducing capability of V. 
amygdalina extracts was observed as methanol > aqueous > ethanol > ascorbic acid. 
Protective effect of the plant extracts were tested against hydrogen peroxide induced 
haemolysis in vitro. The ethanolic and methanolic extracts of C. asiatica and V. 
amygdalina showed strong protective effect against hydrogen peroxide.  
Biologically active phenolic compounds present were elucidated with reverse-
phase high performance liquid chromatography (RP-HPLC), liquid chromatography 
mass spectroscopy (LC-MS) and fourier transform infrared spectroscopy (FT-IR). RP-
HPLC of C. asiatica methanolic extract presented two major compounds: 
chloramphenicol and benzoic acid. The identification of these compounds was 
confirmed by FT-IR analysis.  
The phenolic compounds in V. amygdalina were not well separated hence LC-
MS was done. Analysis by LC-MS identified thirty eight phenolic compounds in C. 
asiatica and forty in V. amygdalina including gallic acid derivatives, hydroxybenzoic 
acid, hydroxycinnamic acid, flavonoids, purine alkaloids and phenolic terpenes and 
lignins. Amongst them, the presence of phloridzin which is known for its antidiabetic 
properties was detected in the methanolic extract of V. amygdalina. 
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ABSTRAK 
 
Enam spesies tumbuhan perubatan Malaysia telah dipilih berdasarkan nilai-nilai 
perubatan mereka yang diketahui. Tumbuh-tumbuhan yang dipilih adalah Aloe vera - 
daun dan pulpa, Azadirachta indica - daun, Carica papaya - daun, Centella asiatica – 
seluruh tumbuhan, Hymenocallis speciosa - daun, ubi dan akar, Vernonia amygdalina - 
daun dan batang. Ekstrak berair dan etanol tisu tumbuhan telah diuji untuk aktiviti 
antimikrobial mereka terhadap lima mikroorganisma ujian.  
Daripada enam tumbuhan yang diuji, ekstrak berair dan etanol C. asiatica 
(seluruh tumbuhan) menunjukkan aktiviti antimikrobial yang amat ketara terhadap 
semua mikroorganisma yang diuji manakala ekstrak etanol daripada V. amygdalina 
(daun) menunjukkan aktiviti yang ketara hanya terhadap B. cereus. C. asiatica dan V. 
amygdalina telah dipilih untuk membuat penyilidikan lanjut terhadap ciri-ciri perubatan 
mereka.  
Presipitasi ammonium sulfat telah dilakukan untuk menentukan samada aktiviti 
antimikrobial adalah berdasarkan peptida yang hadir dalam tumbuhan. Didapati bahawa 
aktiviti antimikrob adalah dalam supernatan dengan pelet menunjukkan aktiviti yang 
tidak jelas bagi kedua-dua ekstrak etanol tumbuhan yang dikaji. Diperhatikan bahawa 
aktiviti antimikrobial adalah tertinggi bagi supernatan C. asiatica terhadap S. aureus 
dan B. cereus. Tatkala sebatian fenol mempengaruhi kegiatan antimikrob serta 
antioksida, ia telah dikaji dalam C. asiatica dan V.amygdalina.  
Kandungan fenol keseluruhan dalam ekstrak tumbuhan telah ditentukan dengan 
ujian Folin-Coicalteu. Kandungan fenol keseluruhan dalam C. asiatica adalah tertinggi 
dalam ekstrak etanol iaitu sebanyak 4.006 ± 0.032 mg GAE/g d.w diikuti oleh ekstrak 
methanol sebanyak 3.346 ± 0.029 mg GAE/g d.w dan ekstrak berair 1.120 ± 0.063 mg 
GAE/g d.w. Kandungan fenol dalam V. amygdalina pula adalah tertinggi bagi ekstrak 
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methanol iaitu sebanyak 1.168 ± 0.101 mg GAE /g d.w, diikuti oleh ekstrak berair dan 
ekstrak etanol mempunyai kandungan fenol yang terendah.  
Ciri-ciri antioksida ektrak tumbuhan telah ditentukan dengan ujian DPPH serta 
FRAP. Ekstrak etanol C. asiatica menunjukkan aktiviti memerangkap radikal yang 
tinggi manakala aktiviti terendah telah diperhatikan dalam ekstrak berair. Ketiga-tiga 
ekstrak V. amygdalina menunjukkan aktiviti memerangkap radikal yang lemah. Dengan 
menggunakan ujian FRAP, aktiviti pengurangan bagi ekstrak C. asiatica adalah 
diperhatikan seperti berikut methanol > etanol > berair > asid askorbik. Manakala 
aktiviti pengurangan bagi ekstrak V. amygdalina adalah diperhatikan seperti berikut 
methanol >  berair  >  etanol > asid askorbik. Keupayaan antihemolisis ekstrak 
tumbuhan yang dikaji telah ditentukan dengan menggunakan ujian hemolisis in vitro 
dengan eritrosit arnab. Ekstrak methanol C. asiatica telah menunjukkan keupayaan 
melindungi tertinggi terhadap hidrogen peroksida, ini diikuti dengan ekstrak etanol, 
manakala ekstrak berair menunjukkan kesan yang tidak tetap. Bagi Vernonia 
amygdalina pula, ekstrak etanol serta methanol telah menunjukkan keupayaan 
melindungi yang tinggi terhadap hidrogen peroksida manakala ekstrak berairnya 
didapati mempunyai keupayaan melindungi yang terendah.  
Sebatian fenol yang hadir dalam ekstrak tumbuhan telah ditentukan dengan 
reverse-phase high performance liquid chromatography (RP-HPLC), liquid 
chromatography mass spectroscopy (LC-MS) serta fourier transform infrared 
spectroscopy (FT-IR). RP-HPLC ekstrak metanol C. asiatica telah membentangkan dua 
komponen penting iaitu kloramfenikol serta asid benzoik. mengenalpasti sebatian fenol 
yang hadir. Pengenalpastian dua kompoun fenolik ini telah disahkan oleh analisis FT-
IR. Komponen fenol tidak dapat ditentukan bagi V.  amygdalina, maka LCMS telah 
dijalankan.  
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Analisis dengan LC-MS pula telah mengenalpasti kehadiran tiga puluh lapan 
sebatian fenolik serta empat puluh dalam V. amygdalina termasuk derivatif gallic, asid 
hydroksibenzoic, asid hydroksicinamik, flavonoid, alkaloid purin, terpen fenolik dan 
lignin. Phloridzin yang telah dikesan dalam ekstrak methanol V. amygdalina. memiliki 
ciri-ciri antidiabetik. 
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1.0 INTRODUCTION 
 
Currently, the emergence of bacterial resistance towards antibiotics has become 
a growing problem. Fleming (1929) discovered the first antibiotic, penicillin which was 
a mould that was able to lyse Staphylococcus aureus cells. Pharmacological industries 
have produced various new antibiotics ever since, but microorganisms have slowly 
developed resistance to these drugs because bacteria have the genetic ability to transmit 
and acquire resistance to drugs (Cohen, 1992). 
Plants have been used to maintain human health because they possess chemical 
compounds that are able to prevent and cure diseases (Nascimento et al., 2000). 
Furthermore, plant products are a better alternative compared to antibiotics and other 
synthetic drugs which display negative side effects such as sensitization reactions, and 
disruption of the metabolic processes in the body via interaction with the body system 
(Jamil et al., 2007). Hence antimicrobial agents from plants are a more reliable and 
effective source to fight these microorganisms without the development of resistance.  
 Novel antimicrobial agents obtained from traditional medicinal plants can be 
used to treat diseases and inhibit microbial infections (Hemaiswarya et al., 2008; Jain, 
1994). These natural products exhibit selective toxicity towards pathogenic bacteria and 
are generally harmless to host cells (Craig, 1998). The morphological parts of different 
medicinal plants such as the leaves, seeds, stem, roots, fruits, sap, or tuber are prepared 
as extracts, infusions, decoctions, powders and are utilized to treat various diseases in 
humans, plants and animals (Nostro et al., 2000). 
In various human cultures around the world, more than 35,000 plant species 
have been exploited for medicinal purposes (Lewington, 1993). However, this number 
could be inaccurate because knowledge on the indigenous uses of plants are usually not 
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well documented and are  passed on orally from one generation to another (Jantan, 
2004). 
Malaysia is covered by tropical rainforest which is home to more than 20,000 
species of angiosperms and 600 species of ferns whereby 15% of angiosperms and 13% 
of fern species were reported to possess medicinal properties (Puteh, 2005). Some of 
these have been commonly used as folk medicine for hundreds of years (Zaidan et al., 
2005). Various compounds are synthesized by biologically and chemically diverse 
plants in the tropical rain forest and these compounds act as defence agents against 
microorganisms and diseases. Furthermore, knowledge of the medicinal and chemical 
properties of these plants products could lead to the design and synthesis of new drugs 
(Jantan, 2004). 
Antimicrobial agents from plants target and destroy biochemical and 
morphological components of microorganisms not found in host cells (Samy & 
Gopalakrishnakone, 2010). Researchers are currently investigating natural sources such 
as plant extracts for antimicrobial agents including phenolic compounds. Antimicrobial 
agents in plants are plant secondary metabolites and are constantly present in active 
forms in all plants but in some plants they are activated by plant tissue damage or 
microbial infection (Osbourn, 1996). Major secondary metabolites in plants include 
alkaloids, flavones (flavonoids, flavonols, quinones), essential oils, lectins, 
polypeptides, phenolics, polyphenols, tannins and terpenoids (Samy & 
Gopalakrishnakone, 2010).  
Phenolic compounds are the largest group of secondary metabolites in plants 
ranging from simple structures with one aromatic ring to complex polymers such as 
tannins and lignins (Gurib-Fakim, 2006). These compounds serve as defence 
metabolites to prevent infection and provide oxidative stability in case of injuries 
(Šetkoviš et al., 2007; Croteau et al., 2000). Various studies have established that 
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simple phenolic acids are potent antimicrobial agents (Pereira et al., 2007; Kishimoto et 
al., 2005; Stoilova et al., 2005; Winkelhausen et al., 2005; Amiš et al., 2003).  
According to a study conducted by Amiš et al. (2003) phenolic compounds also 
possess antioxidant properties and act by scavenging free radicals due to the presence of 
conjugated ring structures or hydroxyl groups. Therefore it is important to closely study 
the antioxidant properties of the plant alongside with their antimicrobial properties. 
Antioxidants are substances that inhibit free radical-induced oxidative stress in 
biological systems by neutralizing free radicals, quenching singlet and triplet oxygen, 
and decomposing peroxides (Thirunavukkarasu et al., 2011; Anderson et al., 2001b). 
Antioxidants protect the body against oxidative damage initiated by reactive oxygen 
species. Oxidative damage is thought to be linked to diseases such as cancer, diabetes, 
shock, arthritis, acceleration of the ageing process and tissue injuries (Shahidi, 1997). 
Polyphenols found in medicinal plants are diverse compounds that possess 
significant antioxidant capacities (Anderson et al., 2001b). It was deduced that 
flavonoids (Pietta, Simonetti, & Mauri, 1998) phenolic acids, and phenolic diterpenes 
(Shahidi et al., 1992) are the main phenolic compounds that contribute to the 
antioxidant properties of plant extracts. 
In this study, six medicinal plants of Malaysia that are common and easily 
accessible: Aloe vera (aloe), Azadirachta indica (neem), Carica papaya (papaya), 
Centella asiatica (pegaga), Hymenocallis speciosa (green-tinged spiderlily), and 
Vernonia amygdalina (bitter leaf) were screened for antimicrobial activity. Plants that 
showed significant antimicrobial activity Centella asiatica (C. asiatica) and Vernonia 
amygdalina (V. amygdalina) were selected and further studies were conducted to 
identify the compound(s) present in the plant responsible for the antimicrobial activities. 
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C. asiatica is a member of the Umbelliferae family. This plant is a perennial 
creeper, flourishing in moist areas, growing naturally in India, Sri Lanka, Madagascar, 
Africa, Australia, China, Indonesia and Malaysia (James & Dubery, 2009). It has been 
used in ayurvedic medicine for centuries for the treatment of wound healing, asthma, 
ulcers, leprosy, lupus, vein diseases, and in memory enhancement (Orhan et al., 2013; 
Hashim et al., 2011; James & Dubery, 2009). Extracts of this plant were found to be 
antibacterial and antifungal in properties and also displaced  anticancer and antioxidant 
properties (Hashim et al., 2011). 
V. amygdalina is a perennial shrub of 2 to 5 metres in height. It grows 
throughout tropical Africa and is used to treat malaria, diabetes mellitus, gastrointestinal 
tract conditions and sexually transmitted diseases. Currently grown in Malaysia, the 
leaves are locally used for the treatment of hyperglycaemia in diabetes mellitus and 
hypertension (Atangwho et al., 2013). V. amygdalina is a member of the Asteraceae 
family. Based on recent studies conducted, extracts of this plant were found to be 
antimicrobial, antifungal, anticancer and antidiabetic (Oga et al., 2013; Ijeh & Ejike, 
2011). Antioxidant activity and phenolic content were reported in leaf extracts using 
different extraction techniques (Atangwho et al., 2013; Fasakin et al., 2011; Salawu et 
al., 2011; Anyasor et al., 2010; Owolabi et al., 2008) but bioactive phenolic compounds 
responsible for the antioxidant activity were not identified. 
The purpose of the research was to identify compound(s) from plant source that 
are antimicrobial and to provide further information on the bioactive phenolic 
compounds responsible for the antioxidant and antimicrobial activity in both C. asiatica 
and V. amygdalina.   
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1.2 Objectives of the research 
  
1. To screen six medicinal plants for antimicrobial activity.  
2. To evaluate the antioxidant capacity of selected plants that show strong 
antimicrobial activity. 
3. To identify the polyphenolic compounds present in the selected plants. 
4. To evaluate correlations of polyphenolic compounds with the bioactivities. 
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2.0 LITERATURE REVIEW 
 
2.1 Medicinal Plants as Antimicrobial Agents   
 
Microorganisms are evolving and are becoming resistant towards commercially 
available antibiotics. Bacteria that are resistant towards antibiotics, antiseptics and 
disinfectants cause major health problems. Currently, bacterial resistance has resulted in 
nosocomial infections causing serious health problems in the hospitals. Bacterial 
resistance may be due to mobile genetic elements such as plasmids, transposons, naked 
DNA or bacteriophages (Levy & Marshall, 2004; Marchese & Schito, 2000).  
Antibiotics were discovered in the nineteenth century, and administered to 
patients routinely. They have successfully solved public health hazards caused by 
bacterial infections, but certain antibiotics also cause delirious side effects. These side 
effects include adverse immune response, allergic reaction, hypersensitivity, nausea, 
depression of the bone marrow, thrombocytopenic purpura, agranulocytosis and other 
previously uncommon diseases (Busani et al., 2012; Ghosh et al., 2008; Ahmad et al., 
1998). Antibiotics react with the body system and disrupt important metabolic processes 
(Conlon et al., 2003; Hancock, 1997a; Lehrer et al., 1991). Apart from that, the 
indiscriminate use of antibiotics in the treatment of infectious disease and the design of 
antibiotics with limited chemical scaffolds and few advances since the 1980s, led to the 
development of multiple drug resistant bacteria (Talbot et al., 2006; Shah, 2005; 
Service, 1995; Davies, 1994). A potential solution to this problem is by using alternative 
antimicrobial agents discovered from nature. The extraction of bioactive components 
including antimicrobial peptides and phenolic compounds from natural sources like 
medicinal plants to treat bacterial infections seem attractive (Conlon et al., 2003; 
Hancock, 1997a; Lehrer et al., 1991).  
Literature review 
7 
 
The knowledge of using plants to naturally alleviate human health has been 
around for decades. Around 70,000 plants have the potential to treat various ailments 
(Busani et al., 2012; Jamil et al., 2007; Nascimento et al., 2000). With few exceptions, 
naturally occurring plant materials have little side effects on the human body when 
consumed at the right dosage and are more affordable compared to synthetic alternatives 
(Ciocan & Bara, 2007). In fact, 80% of the world population depend on plant based 
medicines (Azaizeh et al., 2003).  
Although synthetic drugs and antibiotics brought about a revolution in disease 
management, medicinal plants serve as a raw material for some important modern 
medicine and were used to cure deadly diseases even before synthetic drugs were 
discovered. The World Health Organization states that the best sources of a variety of 
drugs are from plants (Santos et al., 1995). Medicinal plants serve as a cure for diseases 
for millions of people inhabiting remote places in the world, who are unable to gain 
access to synthetic drugs and depend on traditional healers (Bhattacharjee, 2000). 
Plant drugs are placed in two categories (i) complex mixtures such as infusions, 
essential oils, tinctures or extracts and (ii) pure, active compounds from plant extracts. 
Pure compound from plant extracts with strong and specific activity and/or a small 
therapeutic index requires an accurate and reproducible dosage (Hamburger & 
Hostettmann, 1991). Plant extracts are selected as antimicrobial agent after thorough 
biological evaluation of the safety and efficacy of the extracts followed by the process 
of identifying active compounds, formulating dosage, efficacy and determining the 
pharmacokinetic profile of the new drug (Tanaka et al., 2006). 
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2.2  Medicinal Plants of Malaysia 
 
 The natural vegetation of Malaysia is made up of tropical rainforest which is 
home to an estimated 15000 plant species (Lattif et al., 1984). A study by Burkill 
(1966), recorded about 1300 plant species were used as traditional medicine in the 
Malaysian Peninsula. The tropical rainforest is rich with bioactive compounds which act 
as defence agent against pests, diseases and predators. Defensive compounds from the 
rainforest have greater diversity compared to those from temperate regions (Coley & 
Barone, 1996).  
Plant extracts from local plants have been used in the treatment of various health 
ailments in Malaysia (Ong et al., 2011; Siti et al., 2009; Ong & Norzalina, 1999). Elliott 
and Brimacombe (1986) found that about 25% of the drugs in modern medicine 
originated from tropical rainforest plant. Various plants such as tongkat ali (Eurycoma 
longifolia), hempedu bumi (Andrographidis paniculata), ginseng (Ginseng baloba), 
tumeric (Curcuma domestica) and misai kucing (Orthosiphon stamineus) were 
examples used in traditional medicine.  
 In Malaysia, plant samples are chosen for scientific research based on a random 
selection or ethno botanical knowledge of the indigenous usage of plants by traditional 
medicine practitioners (Jantan, 2004). Collection of plants in the earlier years of 
medicinal plant research in Malaysia was mainly for phytochemical screening. The 
beginning of medicinal plant research was started as early as 1954 by Arthur, on the 
phytochemical screening of 205 plants in Sabah followed by the screening of 200 
species in peninsular Malaysia for alkaloid by Douglas and Kiang (1957). Most 
phytochemical screenings were done to isolate bioactive alkaloids because most of the 
natural compounds are alkaloids.  
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2.3 Plant Derived Antibiotics 
 
Antibiotics function through bacteriostatic or bactericidal actions by accessing 
the intracellular targets of bacteria. Gram-positive bacteria do not possess an outer 
membrane and are relatively susceptible to antimicrobial agents. Gram-negative bacteria 
consist of an outer membrane which is a permeability barrier and is the main 
determining factor of antimicrobial resistance in bacteria together with additional 
resistance mechanism such as efflux and β-lactamases that work together to promote 
antimicrobial resistance (Hancock, 1997b; Nikaido, 1994).  
Plant derived antibiotics that overcome the outer membrane barrier are effective 
as antimicrobial agents. Plants have multiple methods of defence against pathogens 
where some defence mechanism are pre-formed while others are triggered after 
recognition of pathogen attack (Jones & Dangl, 2006). Two groups of plant antibiotics 
that are involved in plant defence mechanism are phytoalexins and phytoanticipins. It is 
important to note that the distinction between phytoalexins and phytoanticipins is not 
based on the chemical structure but how these compounds are produced in the plant 
(VanEtten et al., 1994). 
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2.3.1 Phytoalexins 
 
Phytoalexins (Figure 1-1) are plant antibiotics comprising of a variety of small 
molecules of 500 Da (Hemaiswarya et al., 2008) and are synthesized de novo after the 
exposure of plant towards microbial pathogens (Grayer & Kokubun, 2001). These plant 
antibiotics consist of a diverse structural space such as terpenoids, glycosteroids, 
flavonoids and polyphenols. Most of these structures have weak antimicrobial activity 
compared to bacterial and fungal origin. However plant derived antibiotics have adopted 
a different pathway to fight bacteria despite the fact that these antibacterial compounds 
have low potency (Hemaiswarya et al., 2008). Upon detection of pathogen in the plant, 
phytoalexin production requires transcriptional and/or translational activity. The 
mechanism triggered involves trafficking and secretion of antimicrobial compounds to 
the infected area (Bednarek & Osbourn, 2009). 
An example of phytoalexin in plants is scopoletin, a hydroxycoumarin found in 
tobacco plants. This compound displays antimicrobial activity in vitro (Matros & Mock, 
2004; Chong et al., 2002; Valle et al., 1997). It was shown that a decrease in scopoletin 
and scopolin (glucoside form of scopoletin) levels is linked with decreased resistance 
towards Tobacco Mosaic Virus (TMV) infections in tobacco plants (Chong et al., 
2002). 
 
 
   
 
Figure 1- 1: Examples of plant phytoalexin structures 
The chemical class of the compound is followed by species common 
name in parentheses followed by its scientific name. Scopoletin from 
(tobacco) Nicotiana tabacum (A) and camalexin from (thale cress) 
Arabidopsis thaliana (B). 
A B 
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2.3.2 Phytoanticipins 
 
 VanEtten et al. (1994) defined phytoanticipin (Figure 1-2) as a low molecular 
weight antimicrobial compounds present in the plants before pathogenic attack or are 
produced in the plants by pre-existing constituents after infection by pathogen. Some 
phytoanticipins are present on plant surfaces while others are sequestered as pre-
existing compounds in vacuoles or organelles and are released after attack by pathogen 
through a hydrolysing enzyme (González-Lamothe et al., 2009).    
 An example of a glycosylated phytoanticipin is saponin, found in many plant 
species. Saponin comprises of three major groups of compounds such as triterpenoid, 
steroid or steroidal glycoalkaloid (Osbourn, 1996). An example of a saponin is avenacin 
which was discovered in oat roots (Morrissey & Osbourn, 1999). Avenacin forms 
complexes with sterols in fungal membrane resulting in the loss in membrane integrity 
due to pore formation. Avenacin A-1, which is the major form of avenacin functions as 
a chemical barrier in the epidermal layer of oat root tip cells and in emerging lateral root 
(Osbourn et al., 1994), acting as a chemical defence towards pathogen attack 
(Papadopoulou et al., 1999).   
 
 
 
 
 
 
 
      
     Figure 1- 2: Examples of plant antibiotic phytoalexin structures 
The major oat root saponin avenacin A-1 (A) and the saponin α-tomatine from tomato (Solanum 
lycopersicum) (B). 
 
 
             
A 
B 
Literature review 
12 
 
2.4 Bioactive Components in Plants 
 
 There are about 100,000 bioactive compounds produced in plants also identified 
as the aromatic secondary metabolites. Secondary metabolites are mostly derived from 
isoprenoid, phenylpropanoid, alkaloid or fatty acid/polyketide pathways and differ from 
plant primary metabolites as they are not involved in intermediary metabolism of the 
plant. The numerous secondary metabolites present in plants are a result of plant 
evolution towards improved defence against microbes and predators giving plants their 
antimicrobial trait (Dixon, 2001). Most secondary metabolites are constitutive in healthy 
plants while others may exist as inactive precursors activated by tissue damage or 
pathogenic infections (Osbourn, 1996). 
Medicinal properties of plants are due to the combinations of secondary 
metabolites such as alkaloids, steroids, tannins, and phenolic compounds that are 
synthesized and deposited in specific or in all parts of the plant. These medicinal 
properties are specific in a plant family, genus and species proving the fact that 
combinations of secondary metabolites are distinct between plant taxa (Parekh et al., 
2005; Balandrin et al., 1985). Composition of secondary metabolites varies between (i) 
tissues such that the bark, heartwood, roots, branch basses and wound tissues have 
higher concentration, (ii) species and (iii) seasons (Gottlieb, 1990).  
Medicinal plant extracts and phytochemical constituents present in the plant 
tissues with well-known antimicrobial properties play an important role in promoting 
human health and are non-toxic to the human body (Sheeba, 2010). Plant extracts work 
in synergy with synthetic antibiotics against drug resistant bacteria (Ncube et al., 2008). 
The antimicrobial activity is due to the recognition of potential target sites in 
microorganisms by plant secondary metabolites which resembles endogenous 
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metabolites, ligands, hormones, signal transduction molecules or neurotransmitters 
(Parekh et al., 2005).  
Bioactive compounds also give plant their odour such as terpenoids whereas 
plant pigments are from quinones and tannins. In addition, these compound provide 
flavour, for example some herbs and spices used by humans to season their food 
(Cowan, 1999). Secondary metabolites are important as active compounds in medicinal 
preparation thus it is isolated and identified (Taylor et al., 2001). However, isolating 
specific active compounds identified in the plant extracts are tedious because extracts 
contain mixtures of structurally related compounds with different degree of bioactivity 
and cytotoxicity (Jaki et al., 2008).  
 
2.4.1 Phenolic compounds 
 
Phenolic compounds are compounds that possess at least one aromatic ring with 
a hydroxyl group or its substituent. This group of compounds was first discovered in 
lignin when it stimulated various physiological responses in plants and animals (Daniel, 
2006). Phenolics are synthesized from cinnamic acid that is formed from phenylanine. 
The number of constitutive carbon atoms based on the basic phenolic skeleton 
distinguishes each phenols such as simple phenols, benzoic acid, phenylpropanoids and 
flavonoids (Michalak, 2006). They are classified based on the carbon atom numbers and 
biosynthetic pathway each group is derived (Daniel, 2006).  
Most of the aromatic secondary metabolites synthesized in plants are phenolics 
and their oxygen substituted derivatives (Geissman, 1963). Subclasses in this group 
include phenols, phenolic acid, coumarins, flavones, flavonoids, flavonols, quinones 
and tannins. These compounds are important antimicrobial agents and serve as the plant 
defensive agent against pathogenic bacteria (Das et al., 2010).  
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Phenolics are toxic to microorganisms due to the sites and number of hydroxyl 
groups on the phenol groups. Past research have revealed that highly oxidized phenols 
possesses stronger inhibitory actions towards a microorganism (Urs & Dunleavy, 1975). 
The microorganisms are inhibited by phenolic compound via enzyme inhibition through 
reaction with sulfydryl group or non-specific protein interactions (Mason & 
Wasserman, 1987). 
 
2.4.1.1  Simple phenols and phenolic acids 
 
Simple phenols and phenolic acids consist of a single substituted phenolic ring. 
Simple phenols comprises of phenolic alcohols, aldehydes, ketones and their glycosides. 
These compounds are colourless (as solids) and are easily oxidised upon exposure to air 
and alkaline conditions. Woody plants contain free phenols whereas metabolically 
active plants contain glycosylated phenols (Hopkinson, 1969). The number of hydroxyl 
groups and their site(s) determine their toxicity towards microorganisms (Scalbert, 
1991; Urs & Dunleavy, 1975). 
 
 
 
 
 
 
 
 
 
 
Figure 1- 3: Examples of simple phenols and phenolic acids 
Figure displays the molecular structure of caffeic acid (A), rosmaric acid (B) chlorogenic (C), catechol 
(D) and pyrogallol (E). 
 
 
A 
C 
B 
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Phenolic acids comprises of benzoic and cinnamic acids. Common benzoic acid 
includes p-hydroxy benzoic, vanillic and syringic acid found in lignin in angiosperms. 
Some phenolic acids common in plants are gentisic and protocatechuic acid (Daniel, 
2006).  
Purified aloe emodin that contains the polyphenols caffeic acid (Figure 1-3A), 
rosmaric (Figure 1-3B) and chlorogenic (Figure 1-3C) derivatives inhibits Herpes 
simplex virus-1 (HSV-1), Varicella zoster virus (VZV), pseudorabies and influenza 
virus (Sydiskis et al., 1991). Analysis on the structure-activity of phenolic groups 
indicates that antimicrobial activity is related to the site(s) and number of hydroxyl 
groups (Li et al., 2004). This is evident in catechol (Figure 1-3D) which has two 
hydroxyl groups and pyrogallol (Figure 1-3E) which has three hydroxyl groups, 
whereby both are toxic towards microorganisms. However increase in hydroxylation 
results in increase in inhibitory activity of microorganisms (Geissman, 1963). Some 
authors also discovered that highly oxidized phenolic compounds are better inhibitors 
(Scalbert, 1991; Urs & Dunleavy, 1975). 
 
2.4.1.2  Coumarins 
 
Coumarin (Figure 1-4A) comprises of phenolic substances with fused benzene 
and α-pyrone rings (O'Kennedy & Thornes, 1997). They are responsible for the 
characteristic odour of hay and possess antithrombotic (Thastrup et al., 1985), anti-
inflammatory (Piller, 1975), and vasodilatory (Namba et al., 1988) properties. 
Coumarins were found to be toxic towards rodents, however based on recent studies, 
they were discovered to have ―species-dependent metabolism‖ such that in humans 
toxic coumarin derivatives are excreted via the urine (Weinmann, 1997). 
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Coumarins such as warfarin (Figure 1-4B) have antiviral properties (Berkarda, 
1993), and are used as an oral anticoagulant to inhibit HSV-1 that causes cold sores in 
humans (Eloff & McGaw, 2006). Based on a study conducted by O'Kennedy and 
Thornes (1997), it was discovered that coumarins inhibited Candida albicans in patients 
with vaginal candidiasis. Another important compound is calanoid (4-
propyldipyranocoumarins) isolated from Calophyllum lanigerum var. austrocoriaceum 
and C. inophyllum, from the tropical rainforest trees of Sarawak, Malaysia (Currens et 
al., 1996). Callophylum coumarins, classified as calonoids, inophyllums and 
cordatoloids, based on the C-4 substituent on the lactone ring, are natural reverse 
transcriptase inhibitors. Calanoid A has potential activity towards HIV-1 reverse 
transcriptase, hence it is a novel natural non-nucleotide reverse transcriptase inhibitor 
that may be useful when combined with other antiretroviral drugs (Cos et al., 2004).  
 
 
 
 
 
Figure 1- 4: Examples of coumarins 
Figure displays the molecular structure of coumarin (A) and warfarin (B). 
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2.4.1.3  Quinones 
 
 Quinones (Figure 1-5A) are highly reactive compounds comprising of aromatic 
rings with two ketone substitutions. Quinones are coloured compounds responsible for 
the browning of cut or injured fruits and vegetables, colour of henna used as dye and an 
intermediate in the melanin synthesis pathway of skin (Schmidt, 1988; Fessenden & 
Fessenden, 1982). Oxidation and reduction reactions occur easily leading to the switch 
between diphenol (hydroquinone) and diketone (quinone), rendering the redox potential 
important in biological systems. This is observed through the role of ubiquinone 
(coenzyme Q) in mammalian electron transport system. Apart from that, vitamin K, a 
naphthoquinone possess antihaemorrhagic activity causing oxidation in body tissues 
(Cowan, 1999). 
 
 
 
 
Figure 1- 5: Examples of quinone 
Figure displays the molecular structure of quinone (A) and hypericin (B). 
  
Quinones complex irreversibly with nucleophilic amino acids in proteins 
resulting in the loss of protein function (Stern et al., 1996). This makes it a potential 
antimicrobial compound targeting surface-exposed adhesions, cell wall polypeptides 
and membrane bound enzymes in microorganisms. An anthraquinone isolated from a 
tree in Pakistan, Cassia italica was discovered to possess bacteriostatic activity against 
Bacillus anthracis, Corynebacterium pseudodiphthericum, and Pseudomonas 
aeruginosa and bactericidal activity against Pseudomonas pseudomalliae  (Kazmi et al., 
1994). An antidepressant antharaquinone also known as hypericin (Figure 1-5B) 
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isolated from Hypericum perforatum (St. John‘s wort) was reported to possess 
antimicrobial activity (Duke, 1985).  
 
2.4.1.4  Flavones, flavanol and flavanoids  
 
Hydroxylated phenolics containing one carbonyl group form flavones (Figure 1-
6A). Flavonol is formed by addition of a 3-hydroxyl group (Fessenden & Fessenden, 
1982). Flavonoids are synthesized by plants in response to a microbial infection, and 
occur as a C6 - C3 unit linked to an aromatic ring (Dixon et al., 1983). Flavonoids have a 
broad spectrum of antimicrobial activity due to their ability to form complexes with 
extracellular and soluble proteins and to interfere with bacterial cell walls (De Clercq, 
2000). Lipophilic flavonoids disrupt microbial membranes (Tsuchiya et al., 1996) and 
flavonoids lacking hydroxyl groups on their β-rings are active antimicrobials (Chaurasia 
& Vyas, 1977).  
 The most reduced form of C3 in flavonoids are catechins (Figure 1-6B), 
commonly found in oolong green teas. Teas containing a mixture of catechin 
compounds have antimicrobial properties (Toda et al., 1989) that inhibit Vibrio 
cholerae O1 (Borris, 1996), Streptococcus mutans (Tsuchiya et al., 1996; Batista et al., 
1994; Sakanaka et al., 1992; Sakanaka et al., 1989), Shigella (Vijaya et al., 1995), and 
other bacteria and microorganisms (Sakanaka et al., 1992; Thomson & Schultes, 1978). 
 
 
 
 
Figure 1- 6: Examples flavones, flavonoids and flavonols 
Figure displays the molecular structure of flavone (A), catechin (B) and chrysin (C). 
B C A 
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The various antimicrobial activities are (i) galangin, a 3,5,7-trihydrocyflavone 
from Helichrysum aureonitens, which inhibits HSV-1 and coxsackie B virus, (ii) 
isoquercitrin from Waldstenia fragarioides with anti-HSV activity, and (iii) 
swertifrancheside, glycyrrhizin and chrysin (Figure 1-6C) which inhibit HIV (Cos et al., 
2004; Jassim & Naji, 2003). Wogonin is a natural mono flavonoid, with rapid tissue 
distribution and prolonged rate of plasma elimination possessing anti-inflammatory, 
anticancer, neuroprotective, and antiviral activities (Tai et al., 2005). This compound is 
advantageous in the development of antirabies and antiencephalitis therapies.     
 
2.4.1.5  Tannins 
 
Tannins (Figure 1-7A) are a group of polymeric phenolic substances of 500 to 
3000 Da, found in the bark, wood, leaves, fruits, and roots of plants (Scalbert, 1991). 
They possess astringent property and are responsible in tanning leather and precipitating 
gelatine from solutions (Basri & Fan, 2005; Nizet et al., 2001). Tannins are soluble in 
water, alcohol and acetone and form precipitates with proteins (Basri & Fan, 2005).  
 
 
 
 
 
 
 
Figure 1- 7: Examples of tannins 
Figure displays the molecular structure of tannin (A) and proanthocyanidins (B).   
 
        Tannins can be classified as hydrolysable or condensed forms. Hydrolyzable 
tannins exist as multiple esters with D-glucose conjugate on gallic acid subunit whereas 
condensed tannins (proanthocyanidins Figure 1-7B) are derived from flavonoid 
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monomers. Tannins are formed by condensation of flavan derivatives in woody tissues 
of plants or by polymerization of quinone units (Geissman, 1963). 
Tannins were widely studied when tannin-containing beverages such as red wines 
and green teas were found to prevent and cure various illness when consumed over a 
period of time (Serafini et al., 1994). Tannins can stimulate phagocytic cells and inhibit 
tumours and bacteria by forming complexes with microbial proteins via hydrogen 
bonding, hydrophobic effect or covalent bonding (Stern et al., 1996; Haslam, 1996). 
Tannins may displayed direct antimicrobial activity by inhibiting germ tubes of 
Crinipellis perniciosa at low concentrations (Brownlee et al., 1990). Scalbert (1991) 
studied the antimicrobial properties of tannins and found that they were toxic towards 
filamentous fungi, yeasts, and bacteria. Methanolic extracts from the bark of Terminalia 
alata in Nepal were antibiotic in nature (Taylor et al., 1996). In ripe fruits, antimicrobial 
properties of tannins are due to hydrolysis of the ester linkage between gallic acid and 
polyols and this serves as a natural defence mechanism (Samy & Gopalakrishnakone, 
2010). Traditional medicine practitioners commonly use tannins to treat mouth ulcers, 
catarrh, wounds, haemorrhoids and diarrhoea (Ogunleye & Ibitoye, 2003). 
 
2.4.2 Terpenoids and Essential oils 
 
Essential oil or quinta essentia are compounds responsible for the fragrance in 
plants. Essential oil comprises of phenolic compounds with a C3 side chain and has a 
low level of oxidation state in the absence of oxygen. Oils with enriched isoprene 
structure are identified as terpenes (Figure 1-8A), having a general chemical formula of 
C10H16. Terpenes exist as di (C20), tri (C30), tetra (C40), hemi (C5) or sesquiterpenes 
(C15). Compounds with additional elements, usually oxygen are termed as terpenoids.  
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Terpenoids share a common origin with fatty acids but differ from fatty acids 
due to extensive branching and they possess cyclic ring structure. They actively inhibit 
bacteria (Amaral et al., 1998; Ahmed et al., 1993; Habtemariam et al., 1993), fungi 
(Ayafor et al., 1994; Harrigan et al., 1993; Kubo et al., 1993), viruses (Sun et al., 1996; 
Xu et al., 1996; Pengsuparp et al., 1994), and protozoa (Ghoshal et al., 1996; 
Vishwakarma, 1990). Examples of terpenoids include menthol (Figure 1-8B), camphor 
(monoterpenes) and artemisin (sesquiterpenoids) (Cowan, 1999; Ahmed et al., 1993). 
 
 
 
 
 
Figure 1- 8: Examples terpenoids and essential oils 
Figure displays the molecular structure of limonene (monoterpene), a constituent 
of lemon and orange oil (A), menthol (B) and cinnamaldehyde (C). 
 
Artemisin and its derivative α-arteether, also known as quinghasu possess 
antimalarial properties (Vishwakarma, 1990). Chaurasia and Vyas (1977) reported that 
about 60% of essential oil derivatives inhibited fungi whereas about 30% inhibited 
bacteria. An example of bioactive component from essential oil with antimicrobial 
properties is cinnamaldehyde (Figure1-8C) from Cinnamomum osmophloeum. It 
actively inhibited Escherichia coli, Enterococcus faecalis, Staphylococcus aureus 
(including methicillin resistant S. aureus) and Vibrio parahaemolyticus. 
Cinnamaldehyde also inhibited oral bacteria and was used in antiseptic mouthwashes 
(Wallace, 2004). Other bioactive compounds isolated from essential oils includes 
thymol, carvacol, camphor and terpinene-4-ol (Acamovic & Brooker, 2005). 
An example of the terpenoid constituent is capsaicin, from Capsicum annuum 
used in many cuisines across the world (Vishwakarma, 1990). Capsaicin was found to 
inhibit Helicobacter pylori and was also reported to be analgesic (Cordell & Araujo, 
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1993) as it affects the nervous, cardiovascular and digestive systems in humans (Virus 
& Gebhart, 1979).   
 
2.4.3 Alkaloids 
 
Alkaloids are heterocyclic nitrogen compounds such as nicotine derived from 
amino acids (Figure 1-9A). Structures of the alkaloid ring includes pyridines, pyrroles, 
indoles, pyrrolidines, isoquinolines, and piperidines (Bennett & Wallsgrove, 1994) 
Morphine (Figure 1-9B) was the first medically useful alkaloid isolated from the flower 
of Papaver somniferum (opium poppy) in 1805 (Fessenden & Fessenden, 1982).  
 
 
 
 
 
Figure 1- 9: Examples of alkaloids 
Figure displays the molecular structure of nicotine (A) and morphine (B). 
 
 
Pharmacologically active compounds isolated in the early years were mostly 
identified as alkaloids (Das et al., 2010) such as (i) diterpenoid isolated from the 
Ranunculaceae (buttercup) family which displayed antimicrobial activities (Omulokoli 
et al., 1997; Atta & Choudhary, 1995; Jones Jr & Luchsinger, 1979); (ii) solamargine, a 
glycoalkaloid from Solanum khasianum berries which inhibits HIV and intestinal 
infections associated with AIDS (McDevitt et al., 1996; McMahon et al., 1995); and 
(iii) quinine which inhibits malarial parasites (Iwu et al., 1999).  
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2.4.4 Lectins and Polypeptides 
 
Antimicrobial peptides (AMPs) are a positively charged group of molecules that 
provides fast and effective means of defences against invading pathogens in the 
majority of living organisms. The characteristic properties of AMPs include small size 
(less than 10kDa), cationic, amphipathic and vary in length, sequence and structure. 
AMP provides defence against a wide range of microorganisms such as gram-positive 
and gram-negative bacteria, protozoa, yeast, fungi and viruses (Reddy et al., 2004). The 
first AMP discovered was from wheat flour in 1942 (Balls et al., 1942). 
 
 
 
 
 
 
 
Figure 1- 10: Example of peptide 
Figure displays the molecular structure of 
purothionin from Hordeum vulgare (barley). 
 
 
AMPs are classified into five main groups. The five groups comprises of peptides 
(i) that form α-helical structure; (ii) β-sheet; (iii) rich in cysteine residues; (iv) rich in 
regular amino acids (mostly histatin, arginine and proline); and (v) composed of rare 
and modified amino acids. Mode of action is by selective destruction of cell membranes 
and the amphipathic structural arrangement by the AMPs. Examples of the mode of 
action includes the Barrel stave and carpet model (Reddy et al., 2004). 
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Various plants have been discovered to possess low molecular mass peptides (Ye 
& Ng, 2002; Huynh et al., 1996; Osborn et al., 1995). These peptides are tissue specific 
(Price et al., 1987), located in the external layers of plant tissues and act as the first line 
of defence against microorganisms (Samy & Gopalakrishnakone, 2010).  
Purothionin is an example of peptide isolated from barley and wheat, comprising 
of 47 amino acids and is effective against yeast and bacteria (De Caleya et al., 1972). 
Another antimicrobial peptide isolated from fava beans, identified as fabatin was found 
to inhibit E. coli, P. aeruginosa, and Enterococcus hirae (Zhang & Lewis, 1997).  
 
2.5 Antioxidant Activity of Plant Phenols 
 
 The body generates free radicals through metabolic pathways and immune 
functions. Apart from that, the level of free radicals is also elevated in the body through 
environmental pollution, pesticides, radiation and ageing (Adedapo et al., 2009; Gulcin 
et al., 2007). Free radicals are categorized as reactive oxygen species (ROS) which 
includes radical super oxide anion (O2
-
), hydroxyl (OH·) and non-radicals such as 
hydrogen peroxide (H2O2). ROS target cellular and extracellular components such as 
lipids, proteins, enzymes, DNA, and RNA resulting in cell death by necrosis or 
apoptosis (Evans, 1993; Ames et al., 1993).  
 Imbalance between production of ROS in the cell and enzymatic (superoxide 
dismutase, glutathione peroxidase, and catalase) and non-enzymatic (ascorbic acid, 
vitamin E, glutathione, carotenoids, and flavonoids) antioxidants brings about oxidative 
stress (Peuchant et al., 2004; Gilgun-Sherki et al., 2002). Oxidative stress may lead to 
degenerative diseases including diabetes, cancer, cardiovascular diseases and 
inflammatory diseases (Calir et al., 2009; Que et al., 2007; Sharififar et al., 2007; 
Gerber et al., 2002; Anderson et al., 2001a; Shahidi et al., 1992; Cerutti, 1991). 
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 Antioxidants present in food are able to scavenge ROS and prevent the onset and 
progression of degenerative diseases (Knekt et al., 1996). Medicinal plants were found 
to possess antioxidant activity due to the content of phenolic components such as 
flavonoids (Pietta, Simonetti, Gardana, et al., 1998), phenolic acids, and phenolic 
diterpenes (Shahidi et al., 1992) in the plants.  
 The antioxidant activity of phenolic compounds is attributed to (i) scavenging 
free radicals via donating a hydrogen atom to reduce ROS; (ii) their high tendency to 
chelate metal ions due to the presence of hydroxyl and carboxyl groups; and (iii) ability 
to inhibit enzyme involved in free-radical production (Hensley et al., 2004; Aruoma, 
2003; Yang et al., 2001). Antioxidant activity of medicinal plants against hydroxyl 
radicals, superoxide anions, singlet oxygen and lipid peroxides have been investigated 
(Yen & Chen, 1995; Masaki et al., 1995) and are associated to preventing occurrence of 
the above mentioned diseases. 
 Synthetic antioxidants such as butylated hydroxyanisole (BHA) and butylated 
hydroxytoluene (BHT) used in the food industry to prolong shelf life of food may cause 
liver damage and carcinogenesis (Wichi, 1988; Witschi, 1986). Therefore antioxidants 
from natural sources are preferred to synthetic ones.  
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2.6 Selection of Plant Species for Investigation 
 
Plants were selected based on several factors: (i) ethnobotanical approach which 
is local traditional folklore medical knowledge information (Anbarashan et al., 2011); 
(ii) chemotaxonomic approach where the relatives of plants known to produce useful 
compounds were selected; and (iii) by random selection (Jantan, 2004). In the  
chemotaxonomic approach, plants are selected based on the correlation between 
taxonomy and occurrence of plant secondary metabolites. The same active biological 
compounds may be present in related species, genera or families (Eloff & McGaw, 
2006). Based on the above criteria‘s Aloe vera, Azadirachta indica, Carica papaya, 
Centella asiatica, Hymenocallis speciosa and Vernonia amygdalina were chosen for 
investigation. 
Traditional medicine practitioners have little knowledge on the scientific 
rationale of their medicines and their knowledge is purely based on experience (Gurib-
Fakim, 2006). However, better knowledge on the therapeutic function of medicinal 
plants on treatment and prevention of diseases is required for more rational prescription. 
 
2.6.1 Aloe vera (L.) Burm. f. (A. vera) 
 
A. vera is a short-stemmed succulent perennial herb growing at 80 to 100 cm 
tall, spreading by offsets and root sprouts. The plant consists of elongated, pointed, 
thick and fleshy, green leaves with a serrated margin. The spike which is about 90 cm 
tall produces flowers. Each flower pendula has a yellow tubular corolla that is 2 to 3 cm 
long. The tissue in the centre of the aloe leaf contains a bitter, yellow latex and a 
transparent mucilaginous gel which is responsible for most of the bioactive compounds 
in the plant (Kumar et al., 2010; Chow et al., 2005).   
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A. vera comprises of over 400 different species and belongs to the Liliaceae 
family (Grover et al., 2011) formerly known as the Asphodelaceae family. Another 
well-known member of this family is A. ferox. The characteristic medicinal feature of 
the genus aloe are polysaccharides, antharanoids and anthraglycosides (aloe-emodin) 
that accumulates in the leaves (Gurib-Fakim, 2006).  
 
 
Figure 1- 11: Aloe vera (L.) Burm. f.                                
Figure displays the morphology of A. vera where 1- plant habitat; 2- part of 
inflorescence; 3- flower in longitudinal section. 
 
Image adapted from de Padua et al. (1999) 
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A. vera is native to North Africa, the Mediterranean region of South Europe and 
the Canary Islands. Now, it is widely cultivated in West Indies, tropical America and in 
tropical regions (Ross, 1999a). A. vera pulp is made up of 98.5% water, whereas the gel 
is made up of 99.5% water (Eshun & He, 2004). The remaining percentages of materials 
are fat soluble vitamins, minerals, enzymes, polysaccharides, phenolic compounds and 
organic acids (Boudreau & Beland, 2006).  
This plant has many healing properties such that it relieves burning sensations, 
and blisters, heals ulcers, wounds on the skin and gastrointestinal lining through the 
release of interleukin-1, interleukin-6, tumour necrosis factor and interferon (Kumar et 
al., 2010; Yates et al., 1992; Peng et al., 1991). The fresh leaf juice is used to treat  
rashes, vaginal infection, eczema, foot sores, fungus attacks, eye infections and fever 
(Anbarashan et al., 2011; Kumar et al., 2010). The leaf sap or juice is applied externally 
to treat pimples, blackheads and cuts.  
In Indonesia, the locals mix the sap with other ingredients to mask the bitter 
taste to cure asthma and cough. In Malaysia, aloe drug ‗jadam‘ is used as an aperient, to 
heal wounds and swelling and daubed in the abdomen when fever and after confinement 
(de Padua et al., 1999). It also aids digestion, blood circulation and the lymph system 
and  improves the function of the liver and gall bladder (Kumar et al., 2010). A. vera is 
a good absorbent and penetrates into tissues of the skin four times faster than water 
making it a good moisturizer, cleanser, exfoliator and it relieves joint and muscle pains 
(Lawrence et al., 2009). 
The bioactive compound, anthraquinone isolated from A. vera displays 
antimicrobial activity against gram-negative and positive bacteria (Habeeb et al., 2007). 
It inhibits Shigella flexneri, Streptococcus progenies, Staphylococcus aureus, Klebsiella 
pneumoniae, Streptococcus pyogenes, Pseudomonas aeruginosa, Escherichia coli, 
Propionibacterium acne, Helicobacter pylori and Salmonella typhi (Ferro et al., 2003; 
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Pugh et al., 2001; Lawless & Allan, 2000; Reynolds & Dweck, 1999; Urch, 1999). A. 
vera also inhibits oral bacteria which cause gum diseases and therefore it was 
incorporated into toothpaste and rubbed on the gums (Kumar et al., 2010).  
 
2.6.2 Azadirachta indica A. Juss (A. indica) 
 
A. indica or better known as ―neem‖ was discovered more than 2000 years as the 
most versatile medicinal plant with an array of biological activities. Every part of the 
plant is useful in treating various diseases. Hence it was given the Sanskrit name 
‗arisjtha‘ which means ‗reliever of sicknesses‘(Biswas et al., 2002). In 1992 this plant 
was recognized by the US National Academy of Sciences which published a report 
―Neem – A tree for solving Global Problems‖ (Schmutterer, 1995). 
A. indica is a tropical evergreen plant growing up to 25 m high. The bark is 
rough, dark brown with flat ridges separating the wide longitudinal fissures. Leaves are 
compound and imparipinnate, comprising of 5 to 15 leaflets arranged with the terminal 
leaflet in alternate pairs. Each leaf is about 6 cm long and 2 cm wide. Flowers have 
oblanceolate petals and are sweet scented with yellow, ellipsoid and gabrus drupes 
measuring about 12 to 20 cm long. The sepals are ovate, about 1 cm long. Most flower 
panicles are arranged in the leaf axils (Ross, 1999a). 
A. indica belongs to the Meliaceae family and is native to East India and Burma. 
It is widely distributed in Southeast Asia and West Africa. Recently it was found in the 
Caribbean and in South and Central America (Ross, 1999a).  
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Figure 1- 12: Azadirachta indica A. Juss                                
Figure displays the morphology of A. indica where 1- plant bark with leaves and fruits clustered 
towards ends of branches; 2- flower; 3- twig with flowers; 4- fruit cross section; 5- seed; 6- flower 
cross section. 
Image source from Kapoor (1990) 
 
 
Both the crude extracts and fractions of the leaf, root, seed, oil, fruit and bark of 
the neem tree display biological activities. In folk medicine, the natives use neem oil, 
bark and leaf extracts to treat leprosy, intestinal helminthiasis, respiratory disorders, 
constipation and to improve health (Kirtikar & Basu, 1935). The oil is used in skin 
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infections and to kill head lice. Mixtures containing bark, leaf, root, flower and fruit 
extracts are used to treat blood morbidity, biliary afflictions, itching, skin ulcers, 
burning sensations and pthysis (Biswas et al., 2002). Dried flowers are consumed orally 
for diabetes and hot water extracts of the dried fruit is used to treat piles, skin diseases 
and ulcers (Ross, 1999a). Leaf extracts cure ringworms, eczema and scabies. The bark 
is used to cure malarial fever and leaf paste was to sooth mumps (Anbarashan et al., 
2011).  
A. indica showed various pharmacological activities such as reported by Murty 
et al. (1978 ) where the blood glucose level significantly decreased and adrenaline and 
glucose-induced hyperglycaemia was prevented by aqueous extracts of neem leaves. 
Another study by El-Hawary and Kholief (1990) revealed that normal rats fed orally 
with aqueous leaf extracts developed hypoglycaemia whereas blood glucose level 
dropped in diabetes induced rats. Anti-acid secretory and antiulcer activity was 
observed in glycosides isolated from aqueous extracts of neem (Biswas et al., 2002). 
Bandyopadhyay et al. (2004) revealed that aqueous bark extracts inhibited gastric acid 
and pepsin secretion and was effective in healing duodenal ulcer  that was both H. 
pylori mediated and non- H. pylori mediated with no significant side effects even at 
high dosages.  
Seed extracts and purified fractions inhibited the growth and development of 
malarial parasite P. falciparum (Dhar et al., 1998). Fungi such as Trichophyton, 
Epidermophyton, Microsporum, Trichosporon, Geotricum and Candida were inhibited 
by leaf, oil and seed extracts (Schmutterer & Ascher, 1983). In vitro application of the 
oil extracted from neem leaf, seed and bark inhibited Gram-negative and Gram-positive 
bacteria such as Mycobacterium tuberculosis, Mycobacterium pyogenes, Streptococcus 
mutans, Streptococcus faecalis, Vibrio cholerae, Klebsiella pneumoniae and 
streptomycin resistant strains (Almas, 1999; Satyavati et al., 1976; Chopra et al., 1952).  
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2.6.3 Carica papaya Linn. (C. papaya) 
 
C. papaya belongs to the Caricaceae family. It is a perennial herbaceous plant of 
10 metres tall. The stem is about 25 cm thick and may be simple or branched above the 
middle. Leaves have a cylindrical stalk, clustered around the apex of the stem with 
branches that are 25 to 100 cm long. Each leaf blade has lobes and prominent veins. 
Flowers are hermaphrodite and the male plant may convert to female once beheaded. 
Otherwise male (with drooping peduncles) and female (short stalked) flowers are borne 
on separate plants. Flower consist of 5 white petals, are oblong, recurved and emerge 
singly or clustered from the main stem among the lower leaf.  The fruit comes in 
various forms and sizes with a smooth and thin skin, deep yellow to orange colour when 
ripe. The flesh is red, juicy and sweet, with a central cavity containing a mucous pulp 
which holds numerous black seeds.  
C. papaya originated from Southern Mexico and Central America. Currently this 
plant is widely cultivated in all tropical and subtropical countries, utilized as a 
commercial crop. Parts of the plant that are beneficial to humans are the leaves, fruit, 
seed, latex and root (Ross, 1999b). In Burma, the latex is used externally to cure 
diphtheria and tapeworms. In China, the pulp is utilized to reduce swelling and 
inflammation of the feet (Wiart, 2002). In Malaysia the fresh unripe fruit juice and hot 
water extract of flowers are consumed as an emmenagogue (Ross, 1999b). In the 
Peninsular the root paste is rubbed on the body during confinement; seeds are consumed 
to induce abortion; latex is used to remove patches on skin. The latex of unripe fruit was 
used to poison criminals in Kelantan (Wiart, 2002).  
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Figure 1- 13: Carica papaya Linn.                               
Figure displays the morphology of C. papaya where 1- whole plant; 2- flower bud; 3- fruit cross  
section; 4- female flower; 5- male reproductive part; 6- male flower; 7- flower; 8- female reproductive 
part; 9- seed; 10- fruit; 11- plant stem with leaves clustered around apex of stem. 
 
Image adapted from Wiart (2002) and Duke (1985)  
 
 
Natural compounds possessing high antitumor and pesticide properties are 
produced in the leaf, bark and twig. The tree has an array of natural self-defence 
compounds making it highly resistant towards pathogens (Baskaran et al., 2012). 
Ahmad et al. (2011) proved that C. papaya leaf extract could cure dengue fever when a 
45 year old patient who was bitten by a carrier mosquito was administered with aqueous 
leaf extract twice daily for five consecutive days. Based on the patient‘s condition and 
blood reports aqueous extracts of C. papaya leaves exhibited activity against dengue 
fever.   
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Plant latex was applied to the teeth to relieve inflammatory pain (Anbarashan et 
al., 2011). Leaf extracts possesses antitumor agents and the juice is consumed to treat 
warts, cancer, tumour, and induration of the skin (Hartwell, 1969). Aqueous leaf 
extracts inhibited Bacillus subtilis, Escherichia coli, Klebsiella pneumonia, 
Pseudomonas aeruginosa and Staphylococcus aureus (Suresh et al., 2008). Ethanolic 
extract of the leaf and stem inhibited E. coli, S. flexnert, S. paratyphi A, S. typhi, P. 
aeruginosa, M. luteus, P. mirabilis, B. subtilis and S. aureus (Rahman et al., 2011).  
This plant is anthelminthic as aqueous extract inhibited Heligmosomoides polygyrus 
parasite infection in mice (Satrija et al., 1995).    
 
2.6.4 Centella asiatica Linn. (C. asiatica) 
 
C. asiatica (syn Hydrocotyle asiatica), locally known as ‗pegaga‘ is one of the 
miracle ‗elixirs of life‘, and is an important herb. It is used as a cover crop in tea and 
rubber plantations, incorporated into food where locals eat it raw or cooked, in salads or 
curries, and leaves are used as a fish poison (Duke, 1985).  
C. asiatica belongs to the Apiaceae family, previously known as the 
Umbelliferae family, comprising of over 3000 herbaceous species. This family consists 
of many of the common spices and herbs used today. Some of the common herbs with 
medicinal properties belonging to this family are caraway (Carum carvi) used against 
bloats, coriander (Coriander sativum) and fennel (Foeniculum vulgare) used as a 
carminative and anis (Pimpinella anisum) (Gurib-Fakim, 2006). 
Centella is made up of about 40 species that are found widely growing only in 
South Africa. Exception is made for the species C. asiatica which is distributed 
throughout South-East Asia and some subtropical regions (Hargono et al., 1999). Parts 
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of the plant that are useful to humans are the whole plant, leaves, fruits, root and seed 
(Kapoor, 1990).  
 
Figure 1- 14: Centella asiatica Linn. 
Figure displays the morphology of C. asiatica where 1- whole plant; 2- leaf; 3- 
stem base with young leaf, flowers and fruits; 4- inflorescence; 5- flowers; 6- fruit. 
 
Image taken from de Padua et al. (1999) 
 
This plant has been around since prehistory to treat a wide range of health 
problems in southern-Asia, China and India. In China, this plant is known for its cooling 
properties and is used as a tonic. In India it is used as a tonic, to treat dysentery and as a 
non-alcoholic anti-epileptic medicine. In Sri Lanka, extracts are taken as galactagogue. 
In Vietnam,  it is used for the treatment against senility (Hargono et al., 1999). In 
Malaysia, according to Azmah (1989), C. asiatica was used to cure dizziness, 
hypertension, to improve memory, and relieve indigestion. It is also used to cure malaria 
and sore eyes in Kelantan (Sabariah, 1987). And in Sabah it is used to reduce fever, cool 
the body and to soothe toothaches (Ajik, 1990; Amandus, 1989). 
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This plant is popular amongst traditional medicine practitioners. The whole plant 
is used to cure skin related diseases. Plant extracts are used to heal surgical wounds 
minor burns, keloids, leg ulcers, slow healing wounds, lupus, scleroderma, leprosy and 
cellulitis. Pure extracts accelerate skin grafting and cicatrizing (Hargono et al., 1999).  
Seeds were used to cure dysentery, headache and fever. A small quantity of the plant 
stimulates appetite, aids indigestion and alleviates bowel trouble in children. Decoctions 
of young roots are administered for haemorrhoid (Duke, 2010). 
Triteropenoid isolated from C. asiatica such as asiaticosida, madecassoside, 
asiatic acid and madecassic acid were identified as biologically active compounds 
responsible for the medicinal properties of the plant. Aqueous extracts was discovered 
to inhibit Herpes simplex II virus and asiaticosida isolated from the plant accelerated the 
recovery of guinea-pigs induced with tuberculosis (Hargono et al., 1999).  
 
2.6.5 Hymenocallis speciosa (Salisb.) (H. speciosa) 
 
 H. speciosa is from the Amaryllidaceae family, genus Amaryllis and 
monocotyledon order Asparagales.  It is a herbaceous, perennial, bulbous flowering 
plant (Stevens, 2001; Meerow & Snijman, 1998). The plant has 7 to 9 evergreen, 
rosulate leaves that lasts more than a year and are long, broad, elliptic blades with a 
distinct petiole. Each plant produces about 7 to 12 white flowers that are wide-spreading 
with pedicels of 1 cm long. The stamina cup is funnel shaped, placed between the erect 
filaments (Sealy, 1954).     
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Figure 1- 15: Hymenocallis speciosa (Salisb.) 
Figure displays the morphology of H. speciosa where 1- roots; 2- tuber; 3- leaf 
blade; 4- flower buds; 5- flowers; 1,2- parts underground; 3,4,5- parts above the 
ground. 
 
Image adapted from Wiart (2002)  
 
Plants belonging to the Amaryllidaceae family were used as folk medicine to 
cure various diseases since thousands of years. Many bioactive compounds such as 
alkaloids, phenolics, flavonoids and glycosides were isolated from this family. Amongst 
these compounds, alkaloids isolated and identified as amaryllidaceae were associated 
with the pharmacological effects of the plant (Jin & Xu, 2013). A study by Şener et al. 
(2003) proved that four groups of amaryllidaceae alkaloids isolated from plant extracts 
of Amaryllidaceae plants had antimalarial activity by inhibiting the growth of 
Plasmodium falciparum in vitro. In Malaysia the leaves of H. speciosa which were 
locally known as ‗pokok demam panas‘ were used to cure jaundice. The leaf extract was 
prepared as a decoction and was administered to the patient by bath (Azliza et al., 
2012). 
1 
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2.6.6 Vernonia amygdalina Del. (V. amygdalina) 
 
V. amygdalina, also known as ―bitterleaf‖ belongs to the Asteraceae family, 
previously known as the Compositae family. It is a tropical plant growing in warmer 
regions, dominating South Africa and is popular as a leafy vegetable amongst the Ibos 
clan in Nigeria (Sule & Agbabiaka, 2008). About 35 species are distributed in Malaysia 
(Chuakul et al., 1999). 
 
 
 
Figure 1- 16: Vernonia amygdalina Del. 
Figure displays the morphology of V. amygdalina where 1- branch with leaves and 
flowers; 2- leaf; 3- flower; 4- flower head. 
 
Image adapted and redrawn by Iskak Syamsudin 
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V. amygdalina is a perennial, evergreen shrub, climbers and small sized trees 
growing at 2 to 5 m in height. The petiolate leaves are about 6 mm in diameter, elliptic 
with a characteristic odour and bitter taste. Bark is rough with dense black straits (Sule 
& Agbabiaka, 2008; Owolabi et al., 2008). Flowers are white or purple coloured, 
bisexual with a funnel shaped limb and fused anthers (Chuakul et al., 1999). 
The Asteraceae family comprises of 25000 species and 1400 genera, well distributed 
in most ecosystems. Some members of this family produce sesquiterpene lactones that 
are important bioactive compounds for example Chrysanthemum parthenium and 
Arnica montana. Some produce pyrrolizidine alkaloids responsible for hepatotoxic 
activity in Senecio species. Others produce diterpene glycoside stevioside which has 
intense sweetness (Gurib-Fakim, 2006). 
The leaves of V. amygdalina are extremely bitter due to the presence of bioactive 
compounds such as alkaloids, saponins, tannins and glycosides. Leaves are added into 
the famous ‗bitterleaf soup‘ and the water extract are consumed as a tonic to promote 
health (Farombi & Owoeye, 2011). It was also consumed by wild chimpanzees to cure 
parasitic infection (Huffman & Seifu, 1989). In Nigeria and other African countries, the 
leaf is used to treat fever, emesis, nausea, dysentery, gastrointestinal disorders, diabetes 
mellitus and sexually transmitted diseases (Aregheore et al., 1998).    
Bioactive compounds isolated from the plant were saponins, sesquiterpene 
lactones (vernodalin and vernoamygdalin), flavonoids, tannins and glycosides (Audu et 
al., 2012; Igile et al., 1994). Flavonoids were responsible for antioxidant properties in 
plant and saponins stimulate antitumor activity in leukaemia cells (Jisaka et al., 1993). 
V. amygdalina possess anticancer, antidiabetic, antioxidant, antimalarial and 
antimicrobial activities. 
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Anticancer activity was observed in the treatment of breast cancer where low 
doses of aqueous leaf extracts inactivated the human breast cancer cells (MCF-7) in 
vitro (Gresham et al., 2008). Antidiabetic activity was observed by Ekpenyong et al. 
(1999) when aqueous leaf extracts of V. amygdalina lowered blood glucose levels in 
diabetic induced rabbits. The reduction of blood glucose levels in normal and diabetic 
rats were significant when compared to the diabetic drug chlorpropamide (Osinubi, 
2008).  
Aqueous extracts of the plant exhibited antioxidant activity (Adesanoye & 
Farombi, 2010; Iwalokun et al., 2006) due to the presence of flavonoids in the plant 
(Igile et al., 1994). Leaf extracts inhibited Plasmodium berghei in mice, with 
antimalarial activity (Audu et al., 2012). The plant also possessed amoebicidal activity 
in treating amoebic dysentery (Huffman & Seifu, 1989). 
  Antimicrobial activity of V. amygdalina was detected in the leaf sap against 
Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and 
Pseudomonas aeruginosa (Ijeh et al., 1996). Methanolic extract of leaves inhibited 
Bacillus subtilis, Klebsiella pneumonia, P. aeruginosa, Proteus vulgaris, Shigella 
dysenteriae and S. aureus (Akinpelu, 1999). Erasto et al. (2006) isolated vernolide and 
vernodal from V. amygdalina which successfully inhibited Bacillus cereus, S. 
epidermidis, S. aureus, Micrococcus kristinae, Streptococcus pyrogens, and Salmonella 
pooni. The stems inhibit oral bacteria and are used as chew sticks to treat dental 
problems (Ijeh & Ejike, 2011). 
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2.7 General Extraction of Bioactive Compounds from Plants 
 
Extraction of plants involves the use of selective solvents and extraction 
techniques to isolate biologically active compounds of plant tissue. The solvents diffuse 
into the solid plant tissues and solubilize compounds of similar polarity (Green, 2004). 
Quality and efficiency of plant extracts depends on plant material (wet or dry), type of 
solvent used and extraction technique (Das et al., 2010). 
 
2.7.1 Collection and drying of plant materials 
  
Firstly, plant materials are carefully selected for collection. Leaves that were 
infested with insect or fungus are discarded because these contaminants could affect the 
chemical composition and biological activity. Underground parts of a plant such as the 
roots, tuber, rhizome, and bulb are preferred to isolate bioactive compounds possessing 
antimicrobial properties compared to aerial parts of plants. 
The source for extraction of secondary metabolites in plant tissues could be 
either fresh or dried materials. Dried plant materials were favoured based on several 
factors. Firstly, bioactive compounds are more prominent in extracts from dry material 
because drying lyses the membranes of plant organelle containing different secondary 
metabolites making the extraction more efficient. However, liable compounds may be 
destroyed during the drying process (Eloff & McGaw, 2006). 
 Secondly, traditional medicine practitioners commonly use dried material or 
aqueous extracts. Thirdly, fresh plant materials are difficult to work with as there is time 
delay between plant collection and processing (Angeh, 2006). Fourthly, during 
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separation by liquid-liquid extraction, the solubility will be affected by the differences 
in water content making the secondary metabolites unstable (Ncube et al., 2008).  
Before extraction, plants are air dried (Baris et al., 2006; Dilika et al., 1997) to a 
constant weight or dried in an oven at 40°C for 72 hours (Salie et al., 1996). Plant 
materials are dried at a low temperature to prevent the loss of volatile bioactive 
compounds (Wang et al., 2002). Different drying techniques may produce different 
results. An example is the efficiency of antimicrobial activity in Combretum 
erythrophyllum leaf extracts. The lowest antibacterial activity was observed in 
lyophilized materials because volatile antibacterial compounds were lost. The highest 
activity was observed when plant materials were dried slowly at a low temperature 
(Martini et al., 2004).  
 
2.7.2 Choice of Solvent 
 
 The type of solvent used in extraction of medicinal plants determines the 
different bioactive compounds isolated. Solvents are chosen based on the yield of 
extracts, rate of extraction, toxicity of the solvents in bioassay, ease of evaporation at 
low heat, physiological absorption of extracts, ability to preserve plant materials and 
inability to cause the extract to complex or dissociate (Hughes, 2002). Traces of residual 
solvent may be present in the final product of extract even after evaporation, thus the 
solvent chosen should be non-toxic, non-hazardous to health  and should not affect 
bioassays used to isolate bioactive compounds (Ncube et al., 2008).  
 Another important factor in the choice of solvent is the type of bioactive 
compound that needs to be isolated from the plant such as phenolic compounds or 
antimicrobial compounds. Crude or alcohol extracts are used for the initial screening of 
plants for antimicrobial activity which is then followed by organic solvent extraction. 
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Aqueous extracts are most commonly used because traditional medicine practitioners 
use water to make their concoctions and water is a universal solvent. However, it was 
discovered that plant extracts from organic solutions effectively isolated bioactive 
compounds and showed higher antimicrobial activity (Parekh et al., 2005). For example 
water soluble phenolic compounds such as flavonoids (mainly anthocyanins), failed to 
exhibit antimicrobial activity and only exhibited antioxidant activity (Nang et al., 2007; 
Yamaji et al., 2005).  
Most plant antimicrobial are aromatic/ saturated organic compounds, therefore 
the most effective solvents used for preliminary screening of plant antimicrobial activity 
are methanol,  ethanol and water (Parekh et al., 2006; Rojas et al., 2006; Lourens et al., 
2004; Bisignano et al., 1996; Salie et al., 1996).  
 
2.7.3 Extraction technique 
 
 Extraction technique differs by the extraction time, type of solvent, pH of 
solvent, temperature, size of the plant tissue particles and the solvent-to-sample ratio. 
The most important step in extraction is the wet or dry plant material must be 
homogenized to form finer tissue particles to increase the surface area for extraction 
thereby increasing the rate of extraction. This will also shorten the extraction time. Eloff 
(1998), proved that fine plant particles (10 µm diameter) produced higher extraction 
yield over a period of 5 minutes compared to coarsely ground materials that were placed 
in a shaker for 24 hours. Thus the rate of extraction is increased by grinding plant 
materials to finer particles, increasing the time of contact between material and solvent 
and shaking the plant material in the solvent (Ncube et al., 2008). 
 The most commonly used extraction technique is maceration (Basri & Fan, 
2005; Parekh et al., 2005; Meyer & Dilika, 1996) whereby wet or dry plant parts are 
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homogenized to fine particles, placed in contact with a certain quantity of solvent in a 
stoppered bottle for a defined period of time (usually 24 hours) with vigorous shaking 
(Handa, 2008). The ideal solvent to sample ratio is 10:1 (v/w) (Green, 2004). The 
extract is filtered and the filtrate is dried down under reduced pressure. Then it is re-
dissolved in solvent to a defined concentration. The extract is centrifuged for 30 minutes 
for clarification (Cichewicz & Thorpe, 1996; Taylor et al., 1996).  
 Apart from that, soxhlet extraction technique is used whereby dried plant tissues 
are extracted by continually exposing the materials with organic solvent (Kianbakht & 
Jahaniani, 2003). This method is suitable for compounds that can withstand high 
temperatures, and is not appropriate for thermolabile compounds as continues heating 
may lead to degradation of bioactive components (de Paiva et al., 2004).  
 Serial exhaustive extraction involves continual extraction with solvents of 
increasing polarity from non-polar (hexane) to polar solvents (methanol) to ensure that 
compounds of all polarity are extracted (Green, 2004). Other methods are used to isolate 
particular compounds such as sequential grinding to isolate alkaloids, steroids and 
triterpenoids; gradial centrifugation to isolate lectins and polypeptides; and acid 
hydrolysis to isolate phenols (Eloff, 1999).  
 Specific solvent is used for the screening of specific secondary metabolites such 
as methanol or ethanol are used to isolate alkaloid; acetone for flavonoids and steroids; 
hexane, diethyl ether and chloroform for fat soluble oils, wax, lipids and esters; 
dichloromethane for terpenoids; ethyl acetate for esters; ethanol for sterols, polyphenols, 
and tannins; and water for the water soluble components such as glycosides, 
polysaccharides, polypeptides and lectins (Harborne, 1998).  
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2.8 Test Microorganism Used in the Study 
 
 Over the years, bacteria have become increasingly resistant towards antibiotics. 
Genetically, bacteria are able to transmit and develop resistance towards antimicrobial 
drugs (Cohen, 1992). Resistance towards antimicrobial drugs are developed through (i) 
reduction in bacteria efficiency to bind with the drug by modification of targeted active 
site; (ii) bacteria destructs or modifies the drug by producing enzymes or; (iii) the drug 
is efflux from the cell (Sheldon, 2005).  
 Five test microorganisms were selected in this study: Gram-negative bacteria 
(Escherichia coli and Pseudomonas aeruginosa) and Gram-positive bacteria (Bacillus 
cereus, Staphylococcus aureus and Streptococcus mutans). Both Gram-positive and 
Gram-negative bacteria were chosen because the latter is more resistant to antimicrobial 
agents due to the presence of an outer membrane layer (Alberts et al., 2002). 
 Most plant pathogens belong to the Gram-negative strains which are mostly 
resistant to the bioactive compounds isolated from plants. Whereas Gram-positive 
bacteria are usually susceptible to plant bioactive compounds suggesting that the 
difference in cell wall and outer membrane layer morphology of the two bacteria strains 
determine the susceptibility towards plant secondary metabolites (González-Lamothe et 
al., 2009). 
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2.8.1 Bacillus cereus (B. cereus) 
 
 B. cereus belongs to the genus Bacillus, is a Gram-positive, motile, spore-
forming rod. It is about 1 - 1.2 µm by 3 – 5 µm with square ends. This bacterium has the 
ability to grow both aerobically at 37 °C and anaerobically at 45 °C and exists as spore 
and vegetative cells. Spores are the infective agent for the bacterium and are 1 - 1.5 µm, 
ellipsoidal shaped, formed in aerobic conditions and are able to withstand extreme 
environmental conditions, such as heat, freezing, drying and radiation (Jensen et al., 
2003; Davenport & Smith, 1952). Spores germinate when contacted with organic matter 
or within a host cell (Arnesen et al., 2008). The vegetative cells contain an outermost 
crystalline surface protein (S layer) which is formed during the cell colonization stage 
of the bacteria lifecycle (Kotiranta et al., 2000; Kotiranta et al., 1998). They can grow at 
optimal temperatures ranging from 25 °C – 37 °C (Drobniewski, 1993).  
 
  Figure 1- 17: Morphology of B. cereus 
Figure displays the Gram staining of blood culture showing Gram-positive bacilli with rounded ends, 
found singly, in pairs and short chains (A) and grey, opaque, granular spreading colonies with irregular 
perimeters growing on 5% sheep blood agar at 37°C under aerobic conditions. The smaller smooth 
colonies admixed among spreading growth (B).   
 
Image retrieved from Bottone (2010) 
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B. cereus is known as a soil bacterium and is found in decayed organic matter, 
fresh and marine waters, vegetable and the intestinal tracts of invertebrates. It can 
germinate, grow and sporulate in the soil contaminating soil and food products causing 
infection to the human intestine (Vilain et al., 2006; Jensen et al., 2003; Ghosh, 1978).     
B. cereus is commonly associated with two types of food poisoning diseases, the 
diarrhoeal and emetic type (Gaur et al., 2001). The diarrhoeal type is caused by 
enterotoxins produced by vegetative cells in the small intestine which are ingested. 
Protein rich food such as meat, vegetables and milk products are the source. After 
ingestion, the incubation time is between 8 to 16 hours or longer, while symptoms such 
as abdominal cramps, diarrhoea, nausea and vomiting usually last for 12 to 24 hours or 
several days (Kotiranta et al., 2000). 
The emetic type is caused by a plasmid encoded cyclic peptide (cerulide) 
produced by growing cells in the food before ingestion (Bottone, 2010). Food sources 
are starch rich foods such as fried and cooked rice, pasta and noodles. This type was 
first identified by (Mortimer & McCann) in 1974 following several outbreaks of the 
disease in the United Kingdom. Symptoms such as nausea and vomiting occur 30 
minutes to 6 hours after ingestion and may last up to 24 hours (Ehling‐Schulz et al., 
2004).  
B. cereus can be transmitted through food sources that are heat treated because 
the spores can withstand high temperatures. Temperature of about 48 °C, achieved after 
cooking and cooling of food facilitates the germination of spores and with the absence 
of other competing flora results in the healthy growth of B. cereus. It is also easily 
spread through food sources of plant origin because it is a soil saprophyte (Drobniewski, 
1993).   
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 Non-gastrointestinal diseases related to B. cereus are burns; traumatic or 
postsurgical wounds; ocular infections; bacteraemia and septicaemia; infections of the 
central nervous system such as meningitis and brain abscesses; and respiratory 
infections such as pneumonia, endocarditis and pericarditis (Bottone, 2010; 
Drobniewski, 1993). 
 In the antibiotic resistance test, it was discovered that most B. cereus strains 
were susceptible towards aminoglycosides, clindamycin, vancomycin, chloramphenicol, 
erythromycin and tetracycline (Drobniewski, 1993). Resistance was also discovered 
towards clindamycin, cefazolin, cefotaxime, cephalosporin and penicillin due to the 
production of β-lactamase (Bottone, 2010; Drobniewski, 1993). 
 
2.8.2 Escherichia coli (E. coli) 
 
E. coli is a Gram-negative bacilli that are approximately 1.0 – 3.0 μm long with 
a diameter of 0.5 μm. They are non-sporus and a single layer of peptidoglycan is found 
in the periplasm. They have peritrichous flagella, making them motile in liquid and the 
most abundant facultative anaerobes in nature (Harshey, 1994).  
The first E. coli was isolated by Escherich (1885) from the feces of a child in 
Austria and was named as the ―Bacterium coli commune‖. E. coli colonizes the 
gastrointestinal tract of infants within hours after birth and coexists in mutualism with 
humans for their entire life as a harmless commensal of the intestinal tract. However, 
some strains developed virulence forming pathotypes, adapting to new niches as fecal 
contaminant of soil and water causing intestinal and extra-intestinal diseases (Kaper et 
al., 2004). 
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Figure 1- 18: Morphology of E. coli 
Figure displays the Scanning electron microscopy of E. coli, grown in culture and adhered to a cover 
slip (A) and E. coli streaked onto Luria agar and incubated at 37°C for 24 hours (B). 
 
Image retrieved from: http://en.wikipedia.org/wiki/Image:EscherichiaColi_NIAID.jpg and 
http://www.microbelibrary.org/images/atlas_lb/escherichia%20coli%20topview.jpg 
 
Infection of these pathotypes caused three clinical diseases such as enteric or 
diarrhoeal disease, urinary tract infection (UTI) and sepsis or meningitis. There are six 
types of intestinal pathogens such as enterotoxigenic E. coli (ETEC); enteropathogenic 
E. coli (EPEC); enterohaemorrhagic E. coli (EHEC); enteroaggregative E. coli (EAEC); 
enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC). Extraintestinal 
types include uropathogenic E. coli (UPEC) and meningitis associated E. coli (MNEC) 
(Kaper et al., 2004).  
Enterotoxigenic E. coli (ETEC) causes diarrhoea, and usually infects children 
under the age of 5. Symptoms of the infection are mild watery diarrhoea or in some 
cases severe, cholera-like illness which can rapidly dehydrate the body and may lead to 
death (Welch, 2006). Enteropathogenic E. coli (EPEC) is a diarrhoeagenic E. coli strain 
that lack Shiga-toxins (verocytoxin). EPEC causes watery diarrhoea with mucus, 
vomiting, fever and dehydration which lasts for several days (Welch, 
2006).Enterohaemorrhagic E. coli (EHEC) are Shiga-toxic producing bacteria such as 
E. coli 0157. The disease is transmitted to humans who consume beef contaminated 
with cattle feces. However in cattle‘s this strain is a member for the intestinal microflora 
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thus are not harmful to the animals. Pathogenic strains that do not possess enterotoxins 
or Shiga-toxins and self-aggregate are known as Enteroaggregative E. coli (EAEC) 
(Nataro et al., 1987). Symptoms include chronic watery diarrhoea and abdominal 
cramps (Nataro et al., 1995).  
Diffusely adherent E. coli (DAEC) causes diarrhoea in infants and is different 
from the other pathogenic strains because it possesses a special adhesion phenotype. 
Enteroinvasive E. coli (EIEC) are phylogenetically related to Shigella species and infect 
the large intestine. Patients infected experience inflammatory colitis, dysentery, bloody 
diarrhoea, severe cramps and fever similar to infection caused by Shigella  (Goldberg & 
Theriot, 1995). 
An extraintestinal pathotype of E. coli is the uropathogenic E. coli (UPEC), also 
known as the urinary tract and bloodstream E. coli. About 60% of women acquire 
urinary tract infection (UTI) in their lifetime (Kunin, 1994), where a large percentage is 
associated with  infection by UPEC (Haley et al., 1985). Another is the meningitis 
associated E. coli (MNEC) which is the most common cause of neonatal meningitis. 
New-borns are infected with the strain during birth when passing through the birth canal 
which will cross the endothelial surface into the brain through the bloodstream. It is a 
severe disease where the infected patient faces death and survivors possibly face long 
term neurological problems (Stoll et al., 2002; Unhanand et al., 1993).  
E.coli is used as a test microorganism for determining antimicrobial resistance 
towards antimicrobial agents because it is easily cultured in clinical laboratories, 
biochemically, physiologically and genetically well characterized (Welch, 2006), found 
frequently in a wide range of hosts, and acquires resistance easily (Erb et al., 2007).  
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2.8.3 Pseudomonas aeruginosa (P. aeruginosa)  
 
P. aeruginosa is a motile, rod-shaped, Gram-negative bacterium from the 
Pseudomonadaceae family (Balasubramanian et al., 2013). It comprises of an outermost 
slime layer, an outer membrane, peptidoglycan layer and inner cytoplastic membrane. 
The bacteria contains pathogenic components such as (i) the cell envelope that controls 
adhesion, formation of microcolony, and the transport of antibacterial agents across the 
cell (Peterson, 1980), (ii) pili which enables the bacterium to adhere to surfaces and for 
conjugation (Weppelman & Brinton, 1971) and (iii) exotoxins (Liu, 1974). Gram-
staining of clinical specimen produces slender Gram-negative bacilli arranged singly, in 
pairs or in short chains. The bacterial colony is identified by the presence of a blue-
green pigment with a grape-like odour (Stratton, 1990).     
 
 
Figure 1- 19: Morphology of P. aeruginosa 
Figure displays the Scanning electron microscopy of P. aeruginosa (A) and P. aeruginosa streaked 
onto Luria agar and incubated at 37°C for 48 hours (B). 
 
Image retrieve from: CDC/ Janice Haney Carr and 
http://www.microbelibrary.org/images/atlas_lb/pseudomonas%20aeruginosa%20topview(48).jpg 
 
P. aeruginosa exists widely in nature, thriving in aqueous environments and 
moist soil (Stanley, 1947). It is a nosocomial pathogen infecting immune compromised 
patients (Balasubramanian et al., 2013). The microorganism infects patients with burn 
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wounds, cystic fibrosis (CF), acute immunodeficiency syndrome (AIDS), organ 
transplant, acute leukaemia and cancer (Morita et al., 2014; Bodey et al., 1983). It 
causes catheter-related bloodstream infection in patients with a device inserted in the 
body (Maki et al., 1973) and ‗ventilator-associated pneumonia‘ in patients receiving 
mechanical ventilation via an endotracheal tube (Kollef, 2000).  
P. aeruginosa also causes urinary tract infection in structurally abnormal urinary 
tracts and corneal ulcer through the use of contaminated contact lenses (Wilson et al., 
1981). Intravenous drug abusers are at risk of P. aeruginosa endocarditis infection 
(Jackson, 1994). It infects areas in the skin that are constantly exposed to moisture such 
as the nails leading to the ―green nail syndrome‖ where the nails develops greenish 
discolouration (Goldman & Fox, 1944). 
A common factor amongst patients infected by P. aeruginosa is their host 
defence mechanism is disrupted which in some cases may lead to death. However, 
recovery from infection depends to the severity of the patients underlying disease 
(Bodey et al., 1983). P. aeruginosa is a prominent pathogen because it possesses innate 
and acquired resistance towards antimicrobials and disinfectants such as 0.25% acetic 
acid, phenolic disinfectant, chlorhexidine, isopropyl alcohol, tetracycline and 
chloramphenicol (Morita et al., 2014; Stratton, 1990). The resistant characteristic is due 
to the outer membrane barrier, multi drug efflux transporters, endogenous antimicrobial 
inactivation and their ability to form biofilm (Poole, 2011; Lewis, 2007; Mah et al., 
2003).  
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2.8.4 Staphylococcus aureus (S. aureus) 
 
 S. aureus belongs to the Staphylococcaceae family. It‘s a Gram-positive strain, 
with spherical shape of 0.5 – 1.0 µm in diameter, immobile and growing in grape-like 
clusters. Colonies formed are yellow, growing on rich nutrient medium (Foster, 1996). 
S. aureus are facultative anaerobes and common human commensal, however some 
strains are pathogenic. They exist asymptomatically in the nasal cavity of about 30% of 
the human population (Kluytmans et al., 1997) and are transmitted through skin-to-skin 
contact and contaminated objects (Lowy, 1998). 
 S. aureus develops the ability to infect humans when the skin barrier is 
disrupted, presence of immunodeficiency syndrome and presence of underlying diseases 
such as diabetes (Grundmann et al., 2006). The medical problems caused by S. aureus 
includes (i) superficial lesion such as boils, abscesses and wound infections; (ii) deep-
seated, nosocomial infections such as osteomyletis, endocarditis, pneumonia, surgical 
wound infection and bacteremia; (iii) toxemic syndromes such as toxic shock, scarlet 
fever and food poisoning; and (iv) infections associated with indwelling medical 
devices such as joint prostheses, cardiovascular devices and artificial heart valves 
(Jarraud et al., 2002; Foster, 1996).  
 An infection by S. aureus starts by the colonization of the bacteria in the anterior 
nares which is carried by the host for weeks or months which is then followed by 
infection which spreads locally or to the blood. Once in the blood, it moves to distant 
organs causing sepsis which could lead to death if left untreated (Archer, 1998). 
Virulence factors include surface proteins that colonize tissues; capsule and 
immunoglobulin binding protein A that inhibits phagocytosis; and toxins that damages 
host tissues and promotes disease symptoms (Foster, 1996).  
Literature review 
54 
 
 S. aureus is an alarming pathogen in the community because it acquires 
resistance towards most antibiotics (Chambers & DeLeo, 2009). In 1940s penicillin was 
able to treat S. aureus infections. However, the bacteria developed resistance towards 
penicillin in 1942 (Rammelkamp & Maxon, 1942). In 1961, methicillin was discovered 
to inhibit  S. aureus, which later developed resistance forming methicillin resistant S. 
aureus (MRSA). MRSA acquired resistance to all β-lactam antibiotics (Knight et al., 
2012). S. aureus developed resistance to almost all antimicrobial agent due to its 
commensal nature. Hence antibody based vaccines fail to immunize patients (Verkaik et 
al., 2010) and this bacterium evolved to escape the host immune system (Daum & 
Spellberg, 2012). 
 
 
  Figure 1- 20: Morphology of S. aureus 
Figure displays the Scanning electron microscopy of S. aureus (A) and Gram staining of S. aureus (B). 
 
Image retrieved from http://microbewiki.kenyon.edu 
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2.8.5 Streptococcus mutans (S.mutans) 
 
The oral S. mutans is a non-motile, negative-catalase, Gram-positive 
streptococci that infects the oral cavity (Hamada & Slade, 1980). The first bacterial 
species was isolated from carious lesions in 1924 by Clarke. The name Streptococcus 
mutans was designated when Gram staining of the bacterium showed oval structures 
which appeared to resemble a mutant form of a coccus (Clarke, 1924). Clarke 
associated this organism with dental decay. However researchers later failed to isolate 
this bacterium. It was rediscovered later in the 1960s in rodents (Carlsson, 1968; 
Guggenheim, 1968; Larson & Fitzgerald, 1968). 
 
 
Figure 1- 21: Morphology of S. mutans 
Figure displays the Scanning electron microscopy of S. mutans biofilm present on toothbrush bristles (A) 
and Gram staining of S. mutans (B). 
 
Image retrieved from http://www.msi-lab.com/tl_files/msi/images/bacteries.jpg and 
http://www.publicdomainfiles.com/show_file.php?id=13528513816662 
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Bacterial isolates that exhibited similar characteristic to S. mutans species were 
collectively known as mutans streptococci (MS) (Coykendall, 1989). MS that ferment 
mannitol, sorbitol and various other sugars and synthesize extracellular water soluble 
glucans from sucrose were identified as S. mutans (Hamada & Slade, 1980; Stiles et al., 
1976; Ferretti & Ward, 1976). S. mutans was found to be widely distributed in animals 
as it was isolated from Patas monkeys, rhesus monkeys, wild rats, and indian fruit bats 
(Dent et al., 1978; Coykendall et al., 1976; Lehner et al., 1975). This microorganism 
was known to be the most cariogenic oral Streptococci (Ophori et al., 2013). 
The cell wall of S. mutans is made up of four antigenic polymers such as 
peptidoglycan; group and type-specific polysaccharides; protein; and teichoic and 
lipoteichoic acids in the glycerol form. The virulence factors include the ability of S. 
mutans to adhere to smooth surfaces and the acidogenic properties exhibited by the 
bacteria. These factors are responsible for the bacterium‘s cariogenicity in both humans 
and animals. Plaque formation by S. mutans is caused by the adherence of the bacterium 
to smooth tooth surfaces along with the formation of glucose from the intake of sucrose 
in the diet (Hamada & Slade, 1980; Ikeda et al., 1980). Plaque formation due to dietary 
intake was supported by scientific findings whereby high dental decay was observed 
shortly after sucrose was introduced into the diet (Loesche, 1986).  
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3.0.  MATERIALS AND METHODS 
 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3- 1: Flow chart of the research 
Figure displays the flow chart describing the research outline and steps taken 
* the choice of plant parts used in the study are discussed in pg 138 and 139 
 
 
* 
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3.1. Selection of Plant Samples 
 
Six medicinal plants commonly found in Malaysia were selected for this study 
(Appendix A). The plant samples were collected from the housing area of Seksyen 4 
Petaling Jaya, Selangor, Malaysia in May 2012. Plants were chosen based on folklore 
medicinal values and were identified by Dr. Sugumaran Manickam of Institute of 
Biological Sciences, Faculty of Science, University of Malaya, Malaysia. The voucher 
specimens were prepared and deposited at the herbarium of the Institute of Biological 
Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia (Table 3-
1, Appendix B). 
 
Table 3- 1: Plant species screened for antimicrobial activity 
Scientific name Common name Family Voucher number 
Part of plant 
used 
Aloe vera Aloe Asphodeloideae 47777 
leaf 
pulp 
Azadirachta indica Neem Meliaceae 47778 leaf 
Carica papaya Papaya Caricaceae 47779 leaf 
Centella asiatica Pegaga Umbeliferae 47781 whole plant 
Hymenocallis spesiosa Lily Amaryllidaceae 47783 
leaf 
root 
tuber 
Vernonia amygdalina/ 
Gymnanthemum 
amygdalinum 
Bitterleaf Asteraceae 47784 
leaf 
stem 
Table displays the details of the selected medicinal plants and parts of plant used with voucher deposited 
at the Herbarium of University of Malaya. 
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3.2. Preparation of Plant Materials 
3.2.1. Preparing plant leaf, root and tuber 
 
The plant parts were cleaned under tap water and air-dried to a constant weight 
(Das et al., 2010) at room temperature away from the exposure to sunlight to prevent 
the loss of active components in the plant (Thakare, 2004). Dried plant parts were 
pulverized to produce fine homogenous powder using an electrical blender (National, 
Panasonic) and sifted to obtain fine powder and then stored in sterile 50 ml centrifuge 
tubes at 4 °C until required (Rafat et al., 2010). 
 
3.2.2. Preparation of Aloe vera (A. vera) pulp 
 
The outermost whorls of leaves of mature A.vera were selected from the plants, 
and washed with distilled water. The yellow liquid was drained off before removing the 
rind from the leaves. The leaves were sliced across the width with a sharp knife. The 
inner exposed surfaces revealed a transparent gooey pulp without the addition of sap. 
The pulp was scooped with a spatula and homogenized using a blender (National 
Panasonic). At this stage, the homogenized pulp was lyophilized (Labconco
®
, 
UltraScientific Sdn. Bhd.) before being processed and stored at 4 °C until required (Ni 
& Tizard, 2004).  
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3.3 Extraction Procedure of Plant Samples 
3.3.1 Aqueous extraction 
 
Plant sample powder was weighed and placed in a 100 ml Schott bottle. Double 
distilled water was measured and poured into the Schott bottle following a solvent to 
dry weight ratio of 10:1 (v/w) (Das et al., 2010). The plant samples were placed on an 
orbital shaker (Edmund Bühler, Germany) for 24 hours at room temperature. The 
extract was filtered through Whatman no.1 filter paper. The filtrate was lyophilized and 
then re-dissolved in distilled water to make up a stock solution of 100 mg/ml 
concentration and stored at 4˚C. Working solution was prepared at a desired 
concentration by diluting the stock solution with double distilled water (Busani et al., 
2012).   
 
3.3.2 Ethanolic and methanolic extraction. 
 
Fine plant powder was weighed and placed in a 100 ml Schott bottle. 95% 
analytical grade ethanol (Friendemann Schmidt Chemicals, USA) or HPLC grade 
methanol (Tedia Company Inc, USA) was measured and poured into the Schott bottles 
following a solvent to dry weight ratio of 10:1 (v/w) (Das et al., 2010). The plant 
sample was placed on a shaker for 72 hours at room temperature in the dark. The 
solution was then filtered through Whatman no. 1 filter paper and evaporated to dryness 
using a rotary evaporator (Buchi Rotarvapor, Switzerland) at a temperature between  
36 ˚C to 40 ºC.  
A stock solution of 100 mg/ml of the plant extracts was prepared in 5% 
Polyoxyethylene sorbitan mono-oleate (Tween 80, Hopkins & Williams, London) 
dissolved in isotonic phosphate buffer (IPB) pH 7.4 (bioWorld, USA) and stored at 4 ºC 
Materials and methods 
61 
 
until required for experiments. The working solution was made by diluting the stock 
solution with IPB (Rafat et al., 2010). 
 
3.3.3 Determination of percentage of yield for plant extracts 
 
The percentages of yield of the extracts were based on dry weight (d.w.) sample 
and were calculated as follows: 
Yield of extracts (%) =               Weight of extracts (g)                    x    100%        
                                               Weight of dry plant powder/  
                                       Weight of freeze dried A. vera gel (g) 
  
The percentage of yield for A. vera gel was calculated based on the weight of the 
freeze dried gel before extraction. The yield of extract for A. indica (leaf); A. vera (leaf 
and gel); C. papaya (leaf); H. spesiosa (leaf, root, and tuber) and V. amygdalina (stem) 
was determined with no replicates. The yield of extracts for the selected plants C. 
asiatica (whole plant) and V. amygdalina (leaf) was determined in trplicate. 
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3.4. Authentication of Selected Medicinal Plant with DNA Barcoding Method 
 
 Medical plants used in the study, C. asiatica and V. amygdalina were identified 
using ITS2 region as a DNA barcode based on the findings of Chen and colleagues 
(2010). 
 
3.4.1 DNA extraction  
 
Genomic DNA of plant samples C. asiatica and V. amygdalina was extracted using 
a commercially available DNeasy
®
 Plant Mini Kit (Qiagen
®
, USA, Appendix L1) as 
follows: 
The first step was tissue dissociation, where 100 mg of fresh plant leaves were cut 
and weighed. Next, the plant sample was ground with pestle and mortar under liquid 
nitrogen to obtain a fine powder and then transferred into a 1.5 ml microcentrifuge tube 
(Eppendorf
® 
GmbH, Germany).  
The second step was DNA lysis. AP1 buffer, 400 µl and RNase A, 4 µl were added 
into the sample tube and mixed by vortexing with a vortex machine (Grant-bio, 
England). The sample was incubated in a dry bath (Thermoline, Australia) at 65 ºC for 
10 minutes and during incubation, the tubes were inverted 2-3 times. Next, Buffer P3, 
130 µl was added into the sample and mixed. The tubes were incubated on ice for 5 
minutes. The lysate was centrifuged for 5 minutes at 20,000 x g. Then, the lysate was 
pipetted into a QIAshredder spin column placed in a 2 ml collection tube and 
centrifuged with a refrigerated centrifuge (ThermoScientific Inc, USA) at 20,000 x g for 
2 minutes. The flow-through was transferred into a new tube without disturbing the 
pellet (if present).  
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The third step was DNA binding where 1.5 volumes of Buffer AW1 was added to 
the tubes and mixed by pipetting. The mixture, 650 µl was transferred into a DNeasy 
Mini spin column placed in a 2 ml collection tube. The tube was centrifuged at ≥6000 x 
g for 1 min. The flow-through was discarded and this step was repeated for the 
remaining samples.  
The fourth step was washing. The spin column was placed back into a new 2 ml 
collection tube. Buffer AW2, 500 µl was added and centrifuged at ≥ 6000 x g for 1 min. 
The flow-through was discarded and another 500 µl Buffer AW2 was added. The tube 
was centrifuged at 20,000 x g for 2 minutes.  
The fifth and final step was DNA elution. The spin column was transferred into a 
new 1.5 ml microcentrifuge tube. The spin column was carefully removed from the 
collection tube so that the column did not come into contact with the flow-through. 
Finally 100 µl of Buffer AE was added for elution. The tube was incubated at room 
temperature for 5 minutes and then centrifuged at at ≥ 6000 x g for 1 min. The genomic 
DNA extracted was kept at -20 °C until further analysis. 
 
3.4.2 Polymerase Chain Reaction (PCR) amplification 
 
The concentration of the genomic DNA obtained was checked with nanodrop 
(Thermo Scientific™, USA). The primers used in the research for ITS2 region were 
forward primer (5‘–ATG CGA TAC TTG GTG TGA AT–3‘) and reverse primer (5‘-
GAC GCT TCT CCA GAC TAC AAT-3‘) (Chen et al., 2010) supplied by (First BASE 
Laboratories, Malaysia). Both the forward and reverse primers, 100 µM were diluted to 
1.0 µM with nuclease-free water (Promega, USA). PCR amplification was conducted in 
a 25 µl reaction mixtures containing the following: 
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Table 3- 2: PCR Master Mix  
Component Volume (µl) Final concentration 
PCR Master Mix (Promega
©
, USA), 2X 12.5 1X 
Forward primer, 100 µM 2.5 1.0 µM 
Reverse primer, 100 µM 2.5 1.0 µM 
DNA template, 30 ng/ml 5.0 16.39 ng/ml 
Nuclease-free water 2.5 - 
TOTAL 25.0 - 
Table displays the components added into the 0.5 ml microcentrifuge tube for PCR. 
                                              
                                           Modified from  Chen et al. (2010) 
 
Next, the PCR Mastercycler Personal (Eppendorf
® 
GmbH, Germany) was set 
with the program for 40 cycles as follows: 
 
Table 3- 3: PCR Thermocycler program 
Temperature (ºC) Time 
94 5 min 
94 30 sec 
56 30 min 
72 45 min 
72 10 min 
4 hold 
Table displays the thermocycler program followed for 40 cycles for 
ITS2 region of plant genomic DNA 
       
             
Adapted from  Chen et al. (2010) 
 
3.4.3 Agarose gel electrophoresis  
 
Firstly, the electrophoresis buffer, 5 X Tris-Borate-EDTA (TBE) buffer was 
prepared where 13.5 g of tris (First BASE Laboratories, Malaysia), 6.875 g of boric acid 
(Promega, USA) and 5 ml of EDTA were measured and added into a beaker and 
distilled water was added up to 250 ml. The mixture was stirred with a stirrer. Then the 
5 X TBE buffer was diluted to 0.5 X where 100 ml of 5 X TBE buffer was diluted with 
900 ml of distilled water.  
 
Materials and methods 
65 
 
Secondly 1% (w/v) agarose gel was prepared for separating the particular size 
fragments expected in the DNA sample by dissolving 0.2 g of agarose (First BASE 
Laboratories, Malaysia) in 20 ml of 0.5 X TBE buffer. The slurry was heated in a 
microwave oven until the agarose dissolved. The molten gel was left to cool on the 
bench for about 5 minutes to 60 ºC. Next, 1 µl of 10 mg/ml ethidium bromide (GibcoBrl 
Life Technologies, Japan) was added to a final concentration of 0.5 µg/ml. The gel 
solution was mixed thoroughly by gentle swirling.  
Thirdly, the gel was slowly poured into the casting tray preventing the formation 
of bubbles. A comb was positioned about 0.5 - 1.0 mm above the casting tray so that a 
complete well was formed when the molten agarose was added to the mold. A small 
toothed comb allowed 15 µl of sample per well. The gel was allowed to set completely 
for 30 minutes at room temperature. Once set, the comb was carefully removed and the 
gel was mounted into the electrophoresis tank (Bio-Rad, USA). 0.5 X TBE running 
buffer was poured into the tank to submerge the gel so that it is completely covered in 
buffer.  
Next, 1 µl of 6 X DNA loading dye (Promega, USA) was pipetted onto the 
parafilm. Pipetting one sample at a time, firstly 2 µl of DNA sample from the PCR 
reaction was mixed with DNA loading dye by resuspending three times with a 
micropipette on the parafilm. Next the sample was loaded into the appropriate well 
carefully. This step was repeated with 1 µl of 100 bp DNA ladder (Promega, USA). 
The lid of the gel tank was closed, and the electrical leads were attached so that 
the DNA migrated towards the positive anode (red lead). A voltage of 1 – 5 V/cm 
(measured as the distance between the positive and negative electrodes) was applied. 
The gel was run at 90 V for 35 minutes until the blue dye migrated to an appropriate 
distance (75%) through the gel. When the DNA samples / dyes have migrated to a 
sufficient distance through the gel, the power was turned off and the leads and lid were 
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removed from the gel tank. The gel was examined under ultraviolet (UV) light and 
photographed using a Gel Documentation System Biospectrum 410, UVP (Fischer 
Scientific, USA). The gels were analysed for presence of a band at 500 bp which was 
the ITS2 region. 
 
3.4.4 PCR product purification 
 
The PCR product was purified with MEGAquick-spin™ Total Fragment DNA 
Purification Kit (Intron Biotechnology Inc, Korea, Appendix L2). Firstly, 5 volumes of 
BNL Buffer was added to the PCR reaction product and mixed well by vortexing. For 
20 µl of PCR product, 100 µl of BNL Buffer was added to the tube directly. Secondly, 
one MEGAquick-spin
™
 column was placed in a Collection Tube for each DNA sample. 
Thirdly the DNA sample was transferred to the MEGAquick-spin
™
 column 
assembly and centrifuged at 13,000 rpm for 1 minute to bind the DNA. The flow-
through was discarded and the MEGAquick-spin
™
 column was placed back into the 
same 2 ml collection tube. Fourthly, 700 µl of Washing Buffer was added to the column 
and centrifuged at 13,000 rpm for 1 minute. The flow-through was discarded and the 
MEGAquick-spin
™
 column was placed back into the same 2 ml collection tube and 
centrifuged at 13,000 rpm for 1 minute to dry the spin membrane. 
Fifthly, the MEGAquick-spin
™
 column was placed in a clean 1.5 ml 
microcentrifuge tube. Elution Buffer, 30 µl was applied directly to the centre of the 
column without touching the membrane with the pipette tip and the tube was incubated 
at room temperature for 1 minute before it was centrifuged at 13,000 rpm for 1 minute. 
Finally the MEGAquick-spin
™
 column was discarded and the microcentrifuge tube 
containing the eluted purified PCR product was stored at -20 °C.   
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3.4.5 DNA sequencing 
  
The purified PCR product was sent for sequencing to FirstBase Sdn. Bhd. 
(Malaysia), and was sequenced in both directions with the same primers used for PCR 
amplification. The sequence alignment was conducted with Mega 5.2 software. Firstly 
the forward and reverse sequence files were opened with Mega 5.2 software. Next one 
of the sequences was converted to reverse complement sequence. Then, the sequences 
were aligned by ClustalW. Both ends of the sequences were trimmed to remove the 
gaps.  
The sequence was then compared with a known sequence in GenBank 
(www.ncbi.nlm.nih.gov/BLAST). An unknown sample was identified if the ITS2 region 
matched that of a reference species with ≥ 99% identity.      
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3.5 Antimicrobial Susceptibility Test 
3.5.1 Test microorganisms used in the study 
 
Antibacterial activity of plant extracts was investigated against five test 
microorganisms. Three Gram-positive test bacteria Staphylococcus aureus, Bacillus 
cereus and Streptococcus mutans and two Gram-negative bacteria Escherichia coli and 
Pseudomonas aeruginosa (Table 3-4) were used. The registered bacterial isolates were 
obtained from the American Type Culture Collection (ATCC) maintained in the  
Fermentation Laboratory, Microbiology Division, Institute of Biological Sciences, 
Faculty of Science, University of Malaya, Malaysia. The test bacteria were cultured on 
Nutrient Agar (Difco™, USA) at 37 °C for 24 hours. The cultures were sub cultured 
regularly (every 30 days) and stored at 4 °C. 
 
Table 3- 4: Test microorganism in study  
Bacteria Name Type Strain 
Bacillus cereus Gram positive ATCC 14579 
Escherichia coli Gram negative UT189 
Pseudomonas aeruginosa Gram negative PA7 
Staphylococcus aureus Gram positive RF 122 
Streptococcus mutans Gram positive GEJ 11 
Table displays the strain for the five test microorganism obtained from the Fermentation Laboratory in the 
University of Malaya.  
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3.5.2 Preparation of Muller Hinton agar medium 
 
 Difco™ Muller Hinton Agar, 38.0 g (Becton, Dickson, USA) medium was 
weighed and mixed thoroughly in one litre of distilled water. The dissolved medium 
was then autoclaved at 121°C for 15 minutes. After autoclaving, the medium was 
cooled to about 50 °C. Next, the melted, sterile agar was poured into a series of sterile 
petri dishes 90 × 15 mm (Axygen Biotechnology, China) following strict aseptic 
conditions. The plates were filled to about one-third capacity of the molten agar that is 
about 10 ml per plate. Next, the plates were allowed to cool in the laminar flow (Holten 
LaminAir, USA) for about fifteen minutes. The cooled, set agar medium was checked 
for contamination and the plates were sealed with parafilm and stored at 4 °C until 
required.  
 
3.5.3 Preparation of inoculums 
 
Two or three colonies of the test microorganism were picked with a sterilized 
wire loop from the original culture plate and introduced into a test tube containing 5 ml 
of sterile nutrient broth. Next, the tubes were incubated for 24 hours to produce a 
bacterial suspension of moderate cloudiness. After 24 hours, the turbidity of the 
suspension was compared to a 0.5 McFarland standard (10
8
 CFU /ml) (bioMérieux Inc, 
USA) and the turbidity of this suspension was adjusted by adding more organism if the 
suspension was too light or diluting with sterile saline solution 0.85% sodium chloride 
(Merck, Germany) if the suspension was too heavy. This suspension was used to 
inoculate the Muller Hinton agar within 15 minutes of preparation. 
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3.5.4  Antimicrobial assay 
 
Antimicrobial assay was carried out using the modified well diffusion assay 
method by Perez and team (1990) following an accepted standard (Clinical and 
Laboratory Standards Institute, 2007). Firstly, a sterile cotton swab was dipped into the 
tube containing the nutrient broth with inoculums. The dried surface of a Muller Hinton 
agar plate was inoculated with the test microorganism by streaking evenly on the plate 
in three even planes with the swab over the entire agar surface. The plate was rotated 
approximately 60° each time the streaking was done to produce an even distribution of 
the inoculum.  Excess liquid was removed by running the swab along the rim of the agar 
plate and the swab was discarded.  
Following this, wells with a diameter of 6 mm were bored with a sterile cork 
borer (Appendix C, Figure 3a) and filled with 50 µl of aqueous, ethanolic and 
methanolic plant extracts using four different concentrations (10, 25, 50 and 100 
mg/ml), antibiotic tetracycline at a concentration of 2.5 mg/ml (positive control) and 
distilled water / IPB (pH 7.4, negative control). Finally the plates were sealed with 
parafilm and incubated in an incubator (WTC Binder, Germany) at 37 ºC. Results were 
read after 18 hours of incubation. 
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3.5.5 Measuring the zone of inhibition 
 
The zone of inhibition was measured using a vernier caliper after 18 hours of 
incubation. Measurements were made with the unaided eye while viewing the back of 
the petri dish. The petri dish was held a few inches above a black, non-reflecting surface 
illuminated with reflected light. The diameter of the zone of inhibition was determined 
by measuring the radius of the zone. This was done by measuring the centre of the 
antibiotic well to a point on the circumference of the zone where a distinct edge is 
present which was multiplied by two (Appendix C, Figure 3b). If individual colonies 
were apparent across the plate the test was repeated. 
 
3.5.6 Statistical analysis 
 
 Antimicrobial activity of different medicinal plant extracts using well diffusion 
assay was measured by mean ± SD (standard deviation), n = 3. The results were 
expressed in mm excluding the 6 mm well diameter. Mean changes between the 
samples/positive control were compared to the negative control (IPB/ distilled water) by 
one-way ANOVA followed by Dunnett‘s Multiple Comparison Test. The p value < 
0.001 was considered highly significant***. All statistical analysis was performed using 
GraphPad Prism 5 software. 
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3.6 Saturated Ammonium Sulphate Precipitation of Plant Peptides 
 
 Firstly, saturated ammonium sulphate solution was prepared by dissolving 
anhydrous ammonium sulphate (BDH Limited, England) in distilled water. Secondly, 
10 ml of ethanolic extract with a concentration of 100 mg/ml was centrifuged at 30,000 
rpm for 20 minutes. The pellet was discarded and the supernatant was added into a 50 
ml beaker. Thirdly, 6.97 g of ammonium sulphate to be added was weighed depending 
on the volume of the solution which was 10 ml and the percent saturation of the salt 
needed which was 100 % according to a nomogram (Table 3-5). The extract was stirred 
with a magnetic stirrer (Thermoline Scientific, Australia) and the entire procedure was 
performed on ice to maintain 0 °C temperature. 
Ammonium  sulphate was added bit by bit slowly with a spatula into the extract 
with constant slow stirring. A small amount of ammonium sulphate was added at a time 
and then allowed to dissolve before further addition. When the solution turned cloudy, 
the addition of saturated ammonium sulphate solution was paused to allow mixing of 
the solution. Rapid addition of saturated ammonium sulphate solution leads to the 
formation of precipitate trapped with unwanted soluble peptides. When all the weighed 
ammonium sulphate was dissolved, it was maintained on the stirrer for 1 hour to allow 
precipitation to occur on ice. Finally the solution was centrifuged at 10,000 g for 15 
minutes at 4 ºC (Thermo Scientific, USA). The supernatant was carefully removed into 
a 15 ml centrifuge tube. The pellet containing the precipitated protein was dissolved in 
IPB pH 7.4 (Wenk & Fernandis, 2007). Both the pellet and supernatant were stored at -  
20 ºC for further analysis. Antimicrobial susceptibility tests by well diffusion assay 
were performed on both the pellet and supernatant.      
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Results were expressed in mm excluding the 7 mm well diameter and the mean 
changes between the samples / positive control were compared to the negative control 
(saturated ammonium sulphate solution). 
 
                                                                     
Table 3- 5: Nomogram for ammonium sulphate precipitation at 0 °C 
 
Table shows the nomogram for determining the amount of solid ammonium sulphate in grams to be added in 1 
litre of solution which will yield the desired percentage saturation at 0 ºC. 
 
Modified from Kornberg et al. (1955) 
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3.7 Determination of Total Phenolic Content (TPC).  
 
Total phenolic content of the plant was determined based on the Folin-Ciocalteu 
colorimetry assay method as deduced by Waterhouse (2001) using gallic acid as a 
standard. 
 
3.7.1 Gallic acid calibration standard preparation 
 
 Gallic acid (Sigma Aldrich®, Germany), 0.5 g was dissolved in 10 ml of 
absolute ethanol and then diluted to 100 ml with distilled water to obtain a concentration 
of 5 g/l of gallic acid solution which can be stored at 4 ºC, up to 2 weeks. Standards (50, 
100, 200, 300, 400, and 500 mg/l) concentrations were prepared by diluting the stock 
with distilled water (Table 3-6).  
 
Table 3- 6: Concentration of gallic acid standard in Folin-Ciocalteu assay 
Concentration 
(mg/l) 
Volume of gallic acid stock  
(µl) 
Volume of distilled water 
(µl) 
50 10 990 
100 20 980 
200 40 960 
300 60 940 
400 80 920 
500 100 900 
Table shows the different concentration of gallic acid standard (50 – 500 mg/l) prepared from 
the stock solution of gallic acid which has a concentration of 5 g/l.  
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3.7.2 Sodium carbonate preparation 
 
 Anhydrous sodium carbonate (Merck, Germany), 20 g was dissolved in 80 ml of 
distilled water and was brought to a boil on a hotplate (Thermoline Scientific, 
Australia). The solution was left to cool to room temperature and a few crystals of 
sodium carbonate were added into the solution and the solution was left at room 
temperature for 24 hours. Finally, the sodium carbonate solution was filtered through 
Whatman no. 1 filter paper and water was added to make up to 100 ml. The solution 
was stored indefinitely at room temperature. 
 
3.7.3 Folin-Ciocalteu assay 
 
Firstly, 20 µl of plant sample (2.5 mg/ml), gallic acid standard or blank (distilled 
water) were added into a 2 ml plastic cuvette. Secondly, 1.58 ml of distilled water, 
followed by 100 µl of Folin-Ciocalteu‘s phenol reagent, 2N (Sigma Aldrich®, Germany) 
was added. The mixture was mixed thoroughly by re-suspending with a micropipette 
and was incubated for 1 - 8 minutes. Incubation time should never exceed 8 minutes. 
Thirdly, 300 µl of sodium carbonate solution was added and the mixture was mixed 
thoroughly. Finally, the mixture was left to incubate for 2 hours, at room temperature. 
All samples and standards were prepared in trplicate. Next, the absorbance of the 
sample, standards and blank were measured at 765 nm with a spectrophotometer 
(Varians Carry 50, Agilent Technologies, USA).  
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3.7.4 Calculation of total phenolic content of plant samples 
 
The absorbance of the blank was subtracted from all the readings and a calibration 
curve was plotted with the standard values. The curve was used to determine the 
corresponding gallic acid concentration of all the samples. In order to obtain results 
based on the correct concentration of the sample, the dilution factor was multiplied. All 
determinations were carried out in triplicate, and the results were expressed as 
milligrams of gallic acid equivalent per gram of dry weight (mg GAE/g d.w.).  
The total phenolic content of the plant was calculated as follows: 
C = c x V/ m 
Where C = total phenolic content in gallic acid equivalent (mg GAE/g), c = 
concentration of gallic acid established from the calibration curve (mg/l), V = volume of 
extract (ml) and m = weight of pure plant extract (g).  
 
3.7.5 Statistical analysis 
 
The mean changes between the samples were analysed by one-way ANOVA 
followed by Tukey‘s Multiple Comparison Test. The p value p < 0.05 was considered 
statistically significant. The software GraphPad Prism 5 was used to analyse the data. 
Results were presented as mean ± standard deviation, where n = 3. 
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3.8 Antioxidant Assay 
3.8.1 DPPH (2, 2-diphenyl-1-picrylhydrazyl) radical scavenging activity assay 
 
 The DPPH radical scavenging activity assay to determine amount of antioxidant 
present in the plant was performed based on a method by Razali and colleagues (2008). 
Initially, DPPH solution is dark violet in colour, but the colour fades when an 
antioxidant added donates hydrogen (Szabo et al., 2007). The change in colour is 
measured through absorbance with a spectrophotometer.  
 
3.8.1.1  Preparing standard, positive control and sample 
 
 Firstly 100 µM 2, 2-diphenyl-1-picrylhydrazyl (DPPH) (Sigma Aldrich
®
, 
Germany) was prepared by mixing 0.004 g of DPPH in 100 ml methanol, HPLC grade 
(Tedia Company Inc, USA) and was stored in the dark. DPPH was prepared freshly for 
the assay and was stored at 4 ºC. Secondly, the standard, Trolox (Sigma Aldrich
®
, 
Germany) was prepared. Thirdly, the positive control ascorbic acid, butylated 
hydroxytoluene (BHT) and quercetin (Sigma Aldrich
®
, Germany) were prepared.  
The standard, positive controls and the sample were prepared by dissolving in 
HPLC grade methanol to obtain a stock solution with a concentration of 1 mg/ml. The 
stock solution of the sample and positive control were further dissolved in serial two-
fold dilution in methanol to obtain the desired concentration 15.625 – 1 000 µg/ml 
(Table 3-7). The stock solution of the standard was diluted in methanol to obtain a 
concentration of 25 – 500 µg/ml (Table 3-8).  
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Table 3- 7: Concentration of sample and positive control in DPPH assay 
Concentration 
(µg/ml) 
Volume of stock solution 
(µl) 
Volume of methanol 
(µl) 
1000 200 0 
500 100 100 
250 100 100 
125 100 100 
62.5 100 100 
31.25 100 100 
15.625 100 100 
Table shows the serial two-fold dilution of the sample and positive control in 
methanol to obtain concentration of (15.625 – 1 000 µg/ml) for DPPH assay. 
 
Table 3- 8: Concentration of standard, Trolox in DPPH assay 
Concentration 
(µg/ml) 
Volume of stock solution 
(µl) 
Volume of methanol 
(µl) 
25 25 975 
50 50 950 
75 75 925 
100 100 900 
200 200 800 
300 300 700 
400 400 600 
500 500 500 
Table shows the different concentration (25 – 500 µg/ml) of the standard Trolox 
prepared from a stock solution with the concentration of 1 mg/ml for DPPH 
assay. 
 
 
3.8.1.2  DPPH assay 
 
 Firstly, 20 µl of standard, positive control and sample was added to a 96 well 
plate. Secondly, the prepared DPPH reagent was added into the well and was re-
suspended with micro-pipette. The mixture was left in the dark at room temperature for 
10 to 20 minutes. The reactions were performed in triplicate and the entire assay was 
performed in the dark. The changes in absorbance were measured at 515 nm with a 
microplate reader (Bio-Rad, USA). 
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3.8.1.3  Calculation of antioxidant capacity in plant of study  
 
Percentage of inhibition was calculated as follows:- 
% Inhibition = A0 – As  × 100% 
                       A0 
Where A0 = absorbance of the blank, As = absorbance of the tested sample, standard or 
positive control. 
The antioxidant activity of plant extracts, standards and positive controls were 
expressed as IC50, which is defined as the concentration in µg/ml of plant extracts, 
standards, or positive controls required to inhibit the formation of DPPH radicals by 
50%. IC50 was determined using a non-linear regression analysis computed using 
GraphPad Prism 5. 
The antioxidant activity was based on the Trolox standard curve at concentration 25 
– 500 µg/ml (Table 3-8) expressed as milimole Trolox equivalent antioxidant capacity 
per gram dried weight of plant sample (mmol TE/g d.w.). The assay was conducted in 
triplicate and results were presented as mean ± SD. The mean changes between the 
samples for each test were analysed by one-way ANOVA followed by Tukey‘s Multiple 
Comparison Test.  
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3.8.2 Ferric Reducing Antioxidant Power (FRAP) Assay 
 
Total antioxidant activity was measured by ferric reducing antioxidant power 
(FRAP) assay of Benzie and Strain (1996). In the FRAP assay, the 
Fe
3+
/tripyridyltriazine complex is reduced to a ferrous form by plant extracts with an 
intense blue colour and absorbance maximum at 593 nm (Benzie & Szeto, 1999). 
 
3.8.2.1  Preparing reagent, standard, positive control and sample 
 
 The FRAP reagent consists of 300 mM acetate buffer (pH 3.6), 10 mM 2,4,6-tri 
(2-pyridyl)-S-triazine (TPTZ) (Sigma-Aldrich
®
, Germany) and 20 mM ferric (III) 
chloride (FeCl3.6H2O) in the ratio of 10:1:1.  
Firstly, 300 mM acetate buffer, (pH 3.6) was prepared whereby 0.155 g of 
sodium acetate trihydrate (Fischer Scientific, UK) was dissolved in 0.8 ml of 100% 
acetic acid (Merck, Germany) and 49.2 ml of double distilled water. Secondly, 10 mM 
2,4,6-tri(2-pyridyl)-S-triazine (TPTZ) was prepared by dissolving 0.0156 g of TPTZ in 
0.2 ml of 1N hydrochloric acid, HCl (Fischer Scientific, UK) and 4.8 ml of double 
distilled water. Thirdly, 20 mM ferric (III) chloride (FeCl3.6H2O) was prepared by 
dissolving 0.027 g of iron (III) chloride hexahydrate (FeCl3) (Merck, Germany) in 5 ml 
of double distilled water.  
The standard used was 10 mM ferrous sulphate (FeSO4.7H2O), and a stock 
solution 100 mmole/L consisting of 0.0139 g of ferrous sulphate (Fischer Scientific, 
UK) in 5 ml of distilled water was prepared. Six concentrations of standards were 
prepared (Table 3-9) for the standard curve. Ascorbic acid and butylated 
hydroxytoluene (BHT) (Sigma Aldrich
®
, Germany) were used as positive controls and 
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were prepared in two concentrations (1 mg/ml and 0.5 mg/ml) by dissolving each 
compound in distilled water. Sample was prepared in two concentrations (1mg/ml and 
0.5 mg/ml) in distilled water.  
Table 3- 9: Concentration of standard, ferrous sulphate FeSO4.7H2O in FRAP assay 
Concentration  
(µmol/L) 
FeSO4.7H2O  
(µl) 
Double distilled water 
 (µl) 
100 100 900 
200 200 800 
400 400 600 
600 600 400 
800 800 200 
1000 1000 0 
Table shows the different concentration (100 – 1000 µmol/L) of the standard ferrous sulphate 
FeSO4.7H2O prepared from a stock solution with the concentration of 100 mmol/L for FRAP 
assay. 
 
3.8.2.2  FRAP assay 
 
The working solution of the FRAP reagent was freshly prepared by mixing 300 
mM acetate buffer (pH 3.6), 10 mM 2,4,6-tri(2-pyridyl)-S-triazine (TPTZ) and 20 mM 
ferric (III) chloride (FeCl3.6H2O) in the ratio of 10:1:1 at the time of use. The FRAP 
reagent was incubated at 37 ºC for 5 minutes before the experiment. For the assay, 300 
µl of FRAP reagent was mixed with 10 µl of sample, standard or positive control and 
the mixture was vortexed well. A mixture of FRAP reagent with distilled water was 
used to zero the machine. The absorbance of the mixture was read at 595 nm at 0 
minutes and every 15 seconds for 4 minutes. The assay was carried out in triplicate and 
the results were presented as mean ± SD.  
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3.8.2.3  Calculation of antioxidant capacity  
 
The antioxidant activity of plant extracts, and positive controls (1 mg/ml) in the 
reaction time 0 - 4 minutes were expressed as milimole ferrous sulphate per gram dried 
weight (mmol Fe
2+
/g d.w.) and was determined based on the ferrous sulphate 
(FeSO4.7H2O) standard curve. One unit of FRAP is defined as the reduction of 1 mole 
of Fe (III) to Fe (II).  
Results were presented as mean ± SD where n = 3. The mean changes between 
the samples for each test were analysed by one-way ANOVA followed by Tukey‘s 
Multiple Comparison Test.  
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3.8.3 Investigation of the Protective Effect of the Test Plant Against Hydrogen 
Peroxide (H2O2) Induced Red Blood Cell Lysis. 
3.8.3.1  Preparation of rabbit erythrocyte suspension 
 
Blood was withdrawn from the marginal vein of healthy normal white rabbits 
using a 27G × 1/2‖ sterile needle (TERUMO®, Belgium) and aspirated into silicone 
coated blood collection tubes (Vacutainer
®
, Becton Dickson, USA). Next, 5 ml of 
defibrinated blood was centrifuged in a 15 ml centrifuge tube at 1000 × g in a bench top 
clinical centrifuge at 4 ºC for 20 minutes. The buffy coat and plasma layer were 
removed with a pipette and discarded. Cold IPB, 5 ml (pH 7.4, bioWorld, USA) was 
added to the packed erythrocytes, mixed gently, and then centrifuged at 2400 rpm for 5 
minutes at 4 ºC. The supernatant was discarded. This step of washing was repeated two 
more times as described. After the final wash, the volume of the packed erythrocytes in 
the centrifuge tube was noted. A 10% erythrocyte suspension in IPB was prepared 
where 1 ml of the pellet of packed erythrocytes was added to 9 ml of IPB. The 
suspension was stored at 4 ºC until required (Rose & Okrend, 1998). 
 
3.8.3.2  In vitro anti-haemolysis assay 
 
The protective effect of the plant leaf extracts on rabbit erythrocyte was 
performed according to the procedure described by Ajila and Rao (2008) with slight 
modifications. The free radical initiator used in the study was hydrogen peroxide (H2O2) 
(Merck, Germany). To evaluate haemolysis induced by plant extracts, the rabbit 
erythrocytes were pre-incubated with 50 µl of extracts at 1.0 mg/ml concentration for 1 
hour to determine effect of extract on haemolysis. Next, 50 µl of plant leaf extracts with 
different concentrations (0.1-1 mg/ml) were added to 100 µl of 10% (v/v) erythrocyte 
suspension in IPB. Then, 100 µl of 10 mM H2O2 in IPB was added into the samples.  
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A standard was prepared by replacing the plant extract with ascorbic acid 
(Sigma Aldrich®, Germany). Complete haemolysis was achieved by treating the 
erythrocytes with distilled water (without H2O2 and plant extract). The reaction mixture 
was then incubated in a water bath at 37 ºC for 18 hours. Next, 1 ml of IPB was added 
to dilute the reaction mixture and then the mixture was centrifuged at 2000 × g for 10 
minutes. The absorbance of the supernatant was measured at 540 nm with a 
spectrophotometer (Varians Carry 50, Agilent Technologies, USA) to determine 
haemolysis. The entire assay was performed in triplicate.  
 
3.8.3.3  Calculation of anti-haemolytic activity  
 
Percentage of haemolysis was based on the 100% haemolysis of distilled water 
and was calculated as follows: 
% Haemolysis =     As     –  A0     × 100% 
                       Adw  –  A0 
 
Where As = plant sample or standard, Adw = distilled water and A0 = absorbance of 
blank. Results were presented as mean ± SD. 
 The concentration (mg/ml) of plant extracts and positive control required to 
inhibit haemolysis of red blood cells by 50% (IC50), whereby 10 mM and 50 mM H2O2 
was used to induce haemolysis was determined by non-linear regression analysis 
computed using GraphPad Prism 5. Results were presented as mean ± SD for three 
replicate. The mean changes between the samples against 10 mM and 50 mM were 
analysed by one-way ANOVA followed by Tukey‘s Multiple Comparison Test 
separately.  
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 Antioxidant capacity of extracts and positive control were determined by 
comparing with ascorbic acid standard curve and expressed as milimole ascorbic acid 
equivalent (AAE) per gram dried weight plant sample (mmol AAE/g d.w.). Results 
were expressed as mean ± SD where n = 3. The mean changes between the samples for 
each test were analysed by one-way ANOVA followed by Tukey‘s Multiple 
Comparison Test.  
 
3.9 Correlation between the Phenolic Compounds with the Antimicrobial and 
Antioxidant Activity of C. asiatica and V. amygdalina Extracts 
3.9.1 Correlation between the Total Phenolic Content (TPC) and Antimicrobial 
Activity of C. asiatica and V. amygdalina Extracts. 
 
 Regression analysis was performed to correlate TPC with antimicrobial activity 
in comparison between (i) aqueous, ethanolic and methanolic extracts of each plant and 
(ii) ethanolic extracts of both C. asiatica and V. amygdalina. Correlation was performed 
separately for each test microorganism in the study which were  B. cereus, E. coli, S. 
aureus, S. mutans and P. aeruginosa. TPC was determined by Folin‘s Ciocalteu assay, 
presented as milligram gallic acid equivalent per gram dry weight (mg GAE/g d.w.). 
The antimicrobial activity was presented as diameter of the zone of inhibition (mm).  
Statistical significance between correlation coefficient (p value) was determined 
by Pearson correlation analysis whereby p < 0.05 was statistically significant. Results 
were presented as mean ± SD where n = 3. 
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3.9.2 Correlation between the Total Phenolic Content (TPC) and Antioxidant 
Activity and between Antioxidant Assays of Extracts of C.asiatica and 
V.amygdalina 
 
Regression analysis was performed to correlate TPC with antioxidant capacity 
and various antioxidant assays for (i) aqueous, ethanolic and methanolic extracts of each 
plant and (ii) both the plants (ethanolic extract). Correlation coefficient (r) between TPC 
and DPPH, TPC and FRAP, TPC and anti-haemolysis assay, DPPH and FRAP, DPPH 
and anti-haemolysis assay, and FRAP and anti-haemolysis assay was determined.  
TPC was determined by Folin‘s Ciocalteu assay, presented as milligram gallic 
acid equivalent per gram dry weight (mg GAE/g d.w.). The antioxidant capacity was 
determined by (i) DPPH assay presented as milimole Trolox equivalent per gram dried 
weight (mmol TE/g d.w.); (ii) FRAP assay presented as milimole ferrous sulphate per 
gram dried weight (mmol Fe
2+
 /g d.w.);  and (iii) anti-haemolysis assay presented as 
milimole ascorbic acid equivalent per gram dried weight (mmol AAE/g d.w.).  
Statistical significant between correlation coefficient (p value) was determined 
by Pearson correlation analysis where p < 0.05 was statistically significant. Results were 
presented as mean ± SD where n = 3. 
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3.10 Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) 
3.10.1  Preparing the mobile phase  
 
The mobile phase was a binary solvent system consisting of solvent A and 
solvent B. Solvent A was 0.1% of trifluoroacetic acid (TFA) (Sigma Aldrich
®
, 
Germany) in Milli-Q grade water (v/v) with pH 2.6 (Sartorius, Germany). Solvent B 
was HPLC grade methanol (Tedia Company Inc, USA). Both the solvents were passed 
through a vacuum degasser with a 0.45 µm pore size membrane filter (Fisher Scientific 
(M) Sdn Bhd). 
 
3.10.2 Pre-treatment of plant crude extracts  
 
 Stock solution of plant extracts for HPLC analysis was prepared by re-dissolving 
the aqueous, ethanolic and methanolic extracts in HPLC grade methanol to obtain a 
final extract concentration of 100 mg/ml. Next, the respective extracts were pre-treated 
with ISOLUTE
®
 C18 SPE Columns (Biotage, Sweden) before injection of samples into 
a HPLC system. 
 
3.10.3 Preparing standards for comparison 
 
Gallic acid, caffeic acid, p-coumaric acid, benzoic acid, chlorogenic acid, (+)-
catechin, chloramphenicol, and quercetin were purchased from (Sigma Aldrich
®
, 
Germany). Stock solutions of the individual standards were prepared at a concentration 
of 1.0 mg/ml in methanol. Prior to injection, all the standard solution were filtered 
through a PTFE filter with 0.20 µm pore size (Waters, USA).  
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3.10.4 Instrumentation and analytical conditions 
 
Phenolic compounds were evaluated with a reverse phase-high performance 
liquid chromatography (RP-HPLC; Shimadzu LC, Japan) from the Department of 
Molecular Medicine, Faculty of Medicine, University of Malaya. Detection and 
quantification was carried out with a CBM-20A system controller, a LC-20AD binary 
pump, a CTO-10ASvp oven and a SPD-20A ultraviolet detector with 280 nm detection 
wavelength. The column fitted was a Jones Chromatography Genesis C18 (150 × 4.6 
mm, 4 µm) column (Jones Genesis
®
, UK).  
Chromatography for C. asiatica was achieved at 30 ºC with a flow rate of 1 
ml/min following the gradient profile displayed in Table 3-10. Chromatography for V. 
amygdalina was achieved at 30 ºC with a flow rate of 0.5 ml/min, following the  
gradient profile displayed in Table 3-11. Injection volume of the samples were 20 µl via 
a thin layer chromatography syringe (Hamilton
®
, USA). The data was integrated and 
analysed with the Shimadzu LCSolution Analysis Report Software system. The well 
separated, major peaks were collected manually several times and stored in -20 ºC for 
further analysis.   
 
Table 3- 10: Solvent gradient profile in RP-HPLC for C.asiatica 
Time  
(min) 
Solvent A concentration 
(%) 
Solvent B concentration 
(%) 
0.01 90 10 
10.00 75 25 
20.00 40 60 
30.00 30 70 
45.00 0 100 
55.00 90 10 
Table shows the solvent gradient that was performed by varying the 
proportion of Solvent A (0.1% of trifluoroacetic acid in Milli-Q water v/v) to 
Solvent B (methanol) at respective time in minutes. 
 
Method adapted from Mišan et al. (2010) 
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Table 3- 11: Solvent gradient profile in RP-HPLC for V. amygdalina 
Time 
(min) 
Solvent A 
concentration (%) 
Solvent B concentration 
(%) 
0.01 90 10 
10.00 40 60 
30.00 35 65 
50.00 30 70 
55.00 0 100 
60.00 100 0 
Table shows the solvent gradient that was performed by varying the proportion 
of Solvent A (0.1% of trifluoroacetic acid in Milli-Q water v/v) to Solvent B 
(methanol) at respective time in minutes.  
 
3.10.5 Identification and Quantitation 
 
Phenolic compounds were identified by comparing the retention times obtained 
for the plant extract with pure standards. To further confirm the phenolic compounds 
present in the samples, samples were spiked with pure standards. Data was analysed 
with Shimadzu LCsolution Software. 
Concentration of unknown samples were determined by two methods. Firstly 
using response factor (RF) as shown by Ghafoor et al. (2012) as follows: 
RF = Area of standard / Concentration of standard 
Concentration of sample = sample area / RF.   
Results were presented as mg per g dry weight (mg/g d.w.) of sample extract. 
Secondly Folin Coicalteu‘s assay was performed on the major peaks collected 
and the total phenolic content of the peaks were expressed as mg gallic acid equivalent 
per 100g dry weight (mg GAE/100g d.w.).   
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3.11 Fourier Transform Infrared Spectroscopy (FT-IR) 
 
Major peaks obtained from RP-HPLC of C. asiatica methanol extract were 
collected in 1.5 ml microcentrifuge tubes (Eppendorf
® 
GmbH, Germany). The peaks 
were dried down with a centrifuge concentrator (Labconco
®
, USA) to a powder and 
weighed. Next, FT-IR spectra of the peaks were recorded on a Perkin Elmer Spectrum R 
x I at the Department of Chemistry, Faculty of Science, University of Malaya. The 
spectra of the peaks were scanned at room temperature in the 4000-400 cm
-1
 spectral 
range. 
 
3.12 Liquid Chromatography – Mass Spectroscopy (LC-MS) Analysis 
3.12.1 Preparing the mobile phase  
 
 For LC-MS, the mobile phase was a binary solvent system consisting of solvent 
A and solvent B. Solvent A was 0.1% of formic acid (Sigma Aldrich®, Germany) in 
Milli-Q grade water (v/v). Solvent B was 0.1% of formic acid in acetonitrile (Tedia 
Company Inc, USA). Both the solvents were passed through a vacuum degasser with 
0.45 µm pore size membrane filter (Fisher Scientific (M) Sdn Bhd). 
 
3.12.2 Pre-treatment of plant crude extracts  
  
The stock solution of plant extracts for LC-MS analysis were prepared by re-
dissolving the methanol extract in HPLC grade methanol to obtain a final extract 
concentration of 100 mg/ml concentration. Next, the extracts were pre-treated with 
ISOLUTE
®
 C18 SPE Columns (Biotage, Sweden) and the concentration was adjusted to 
about 20 ppm before injection of the samples into the LC-MS system. 
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3.12.3 Instrumentation and analytical conditions 
 
The separation of phenolic compounds was performed on an Agilent 6530 
Accurate-Mass Q-TOF LC-MS system (Agilent Technologies, USA) at the Department 
of Chemistry, Faculty of Science, University of Malaya. Mass spectra were acquired 
with a TOF/Q-TOF mass spectrometer with gas temperature 250°C; gas flow 8 l/min; 
and nebulizer 35 psig. The mass spectrometer was operated in both negative and 
positive ion modes with a scanning range of 100 to 1000 m/z. Liquid chromatography 
separation was performed with a Hardware Kit ZORBAX Eclipse XDB-C18 column 
(150 × 4.6 mm; particle size, 5 μm; Agilent Technologies). The gradient profile for LC-
MS was the same as HPLC. Data analysis performed with the Mass Hunter software.  
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4.0 RESULTS 
 
4.1 Extraction Yield of the Selected Medicinal Plants  
 
 Extraction yields for the selected medicinal plants A.vera – leaf and gel, A.indica 
– leaf, C. asiatica whole plant, C. papaya leaf, H. speciosa leaf, tuber and root, and V. 
amygdalina leaf and stem were determined based on dry weight as described in Section 
3.3.3 and presented in Figure 4-1. The ethanolic extract of H. speciosa root had the 
highest yield (66.67%) followed by the ethanolic extract of A. vera gel (35.14%). The 
lowest yield was observed for ethanolic extract of H. spesiosa tuber (2 %).  
 
 
 
Figure 4-1: Extraction yield in percentage for medicinal plants screened in the study  
Yield of in aqueous (       ) and ethanol (       ) extracts were determined based on the dry weight of the 
plant parts.   
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4.2 Preliminary Screening of Medicinal Plants for Antimicrobial Activity by 
Well Diffusion Assay 
 
In this study, parts of medicinal plants (A. vera - leaf and gel, A. indica - leaf, C. 
papaya - leaf, C. asiatica - whole plant, H. spesiosa - leaf, tuber and root, and V. 
amygdalina - leaf and stem) were used. For antimicrobial activity, aqueous extracts 
(Table 4-1) and ethanolic extracts (Table 4-2) of the selected medicinal plants were 
tested against the five test microorganisms namely Bacillus cereus, Escherichia coli, 
Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus mutans. Assays 
were performed in triplicate and each well was filled with 50 µl of various 
concentrations of plant extracts (10, 25, 50 and 100 milligram extract per millilitre 
isotonic phosphate buffer, mg/ml). The positive control was 50 µl of antibiotic 
tetracycline at 2.5 mg/ml.  
Plant extracts showed varying antimicrobial activity towards the test 
microorganisms compared to the control tetracycline which showed antimicrobial 
activity against test microorganisms except P. aeruginosa at 2.5 mg/ml concentration. 
For antimicrobial screening of the aqueous extract (Table 4-1) from the 6 plants studied, 
only C. asiatica showed significant antimicrobial activity (p <.05) against all the five 
test strains. The antimicrobial activity was in a dose dependent manner whereby the 
minimum inhibitory concentration (MIC) of the aqueous extract was 25 mg/ml for B. 
cereus, E. coli and S. mutans (3.00±0.00 mm, 6.00±0.00 mm, and 3.00±0.00 mm 
respectively). P. aeruginosa and S. aureus were inhibited at MIC 50 mg/ml of aqueous 
plant extract (6.33±0.58 mm and 10.0±0.00 mm respectively).   
Antimicrobial screening of ethanolic extracts (Table 4-2) revealed that all five 
test microorganisms exhibited remarkable susceptibility towards C. asiatica. It was 
observed that the ethanolic extract of C. asiatica exhibited the highest antimicrobial 
activity towards S. aureus at 100 mg/ml concentration (13.00 ± 0.00 mm). The ethanolic 
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extract of V. amygdalina leaf exhibited significant antimicrobial activity (p <.05) 
towards B. cereus (4.00±0.00 mm and 6.67±0.58 mm at 50 mg/ml and 100 mg/ml 
respectively). 
Slight antimicrobial activity was observed in ethanolic extract of A. vera leaf 
against B. cereus (MIC 25 mg/ml; 2.00±0.00 mm) and E. coli (MIC 100 mg/ml; 
2.00±0.00 mm). A. vera gel showed insignificant activity (p >.05) towards B. cereus 
(3.33±0.58 mm) and S. aureus (2.00±0.00 mm). Apart from that, H. spesiosa leaf 
showed slight inhibition against B. cereus (2.33±0.58 mm) and P. aeruginosa (2.00 ± 
0.00 mm respectively) which were insignificant (p >.05).  
Overall comparison between the antimicrobial activity of aqueous and ethanolic 
extracts of the six medicinal plants revealed that ethanolic extracts possessed stronger 
antimicrobial activity compared to aqueous extracts. But the aqueous extracts of C. 
asiatica exhibited better antimicrobial activity compared to ethanol extract (Appendix 
D). Thus C. asiatica and V. amygdalina were selected for further tests based on the 
screening for antimicrobial properties.      
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Table 4-1: Antimicrobial Activity of Aqueous Plant Extracts 
 
 
Plant 
Sample 
(aqueous) 
 
Concentrati
on 
(mg/ml) 
Diameter of the zone of inhibition (mm)a 
 B. cereus E. coli 
P. 
aeruginosa 
S. aureus S. mutans 
A. vera 
(leaf) 
 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
A. vera 
(gel) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
A. indica 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
C. papaya 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
C. asiatica 
(whole 
plant) 
10 NI NI NI NI NI 
25 3.00±0.00** 6.00±0.00*** NI NI 3.00±0.00ns 
50 5.67±0.58*** 7.33±0.58*** 6.33±0.58*** 10.0±0.00*** 15.33±1.15*** 
100 10.0±0.00*** 10.0±0.00*** 8.33±1.15*** 14.0±0.00*** 18.00±1.73*** 
H. spesiosa 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
H. spesiosa 
(tuber) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
Speciosa 
(root) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
V. 
amygdalina 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
V. 
amygdalina 
(stem) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
Positive 
controlb 
2.5 
16.67±0.58 
*** 
22.33±0.58 
*** 
NI 
27.33±1.15 
*** 
24.67±0.58 
*** 
Negative 
controlc 
- <0.5±0.00 <0.5±0.00 <0.5±0.00 <0.5±0.00 <0.5±0.00 
 
 
Table displays 
a
diameter of the zone of inhibition (excluding 7 mm well diameter in mm) after 18 hours 
of incubation against 5 test microorganism in well diffusion assay. Each well was filled with 50 µl of 
extract. 
b
Positive control was tetracycline (2.5mg/ml). cNegative control was double distilled water. ‗NI‘ 
presents no inhibition zone observed. Assay was performed in trplicate and results were presented as 
mean ± SD. The mean changes between the extracts and positive control compared to the negative 
control were analysed by one-way ANOVA followed by Dunnett‘s Multiple Comparison Test. p < .001 
- highly significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant. 
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Table 4- 2: Antimicrobial Activity of Ethanolic Plant Extracts 
 
 
Plant 
Sample 
(ethanolic) 
 
Concentration 
(mg/ml) 
Diameter of the zone of inhibition (mm)a 
 B. cereus E. coli 
P. 
aeruginosa 
S. aureus S. mutans 
A. vera 
(leaf) 
 
10 NI NI NI NI NI 
25 2.00±0.00ns NI NI NI NI 
50 3.00±0.58** NI NI NI NI 
100 5.33±0.58*** 2.00±0.00ns NI NI NI 
A. vera 
(gel) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 3.33±0.58ns NI NI 2.0±0.00ns NI 
A. indica 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
C. papaya 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
C. asiatica 
(whole 
plant) 
10 NI NI NI NI NI 
25 3.00±0.00** 4.67±0.58** 3.00±0.00* NI 4.00±0.00** 
50 5.33±0.58*** 6.33±1.15*** 6.00±1.00*** 9.00±0.00*** 7.00±0.00*** 
100 8.33±0.58*** 9.33±0.58*** 8.67±0.58*** 13.00±0.00*** 9.67±1.15*** 
H. spesiosa 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 2.33±0.58ns NI 2.00±0.00ns NI NI 
H. spesiosa 
(tuber) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
H. spesiosa 
(root) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
V. 
amygdalina 
(leaf) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 4.00±0.00*** NI NI NI NI 
100 6.67±0.58*** NI NI NI NI 
V. 
amygdalina 
(stem) 
10 NI NI NI NI NI 
25 NI NI NI NI NI 
50 NI NI NI NI NI 
100 NI NI NI NI NI 
Positive 
controlb 
2.5 
16.67±0.58 
*** 
22.33±0.58 
*** 
NI 
27.33±1.15 
*** 
24.67±0.58 
*** 
Negative 
controlc 
- <0.5±0.00 <0.5±0.00 <0.5±0.00 <0.5±0.00 <0.5±0.00 
 
 
Table displays 
a
diameter of the zone of inhibition (excluding 7 mm well diameter in mm) after 18 hours 
of incubation against 5 test microorganisms in well diffusion assay. Each well was filled with 50 µl of 
extract. 
b
Positive control was 2.5mg/ml of tetracycline. 
c
Negative control was isotonic phosphate buffer,  
pH 7.4. ‗NI‘ presents no inhibition zone observed. Assay was performed in trplicate and results were 
presented as mean ± SD. The mean changes between the extracts and positive control compared to the 
negative control were analysed by one-way ANOVA followed by Dunnett‘s Multiple Comparison Test. p 
< .001 - highly significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant. 
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4.3 Authentication of Selected Medicinal Plants by DNA Barcoding  
 
Authentication of the selected medicinal plants C. asiatica and V. amygdalina 
was performed by DNA barcoding method using the well characterized internal 
transcribed spacer 2 (ITS2) region. The primers used in the study for ITS2 region were 
forward primer (5‘–ATG CGA TAC TTG GTG TGA AT–3‘) and reverse primer (5‘-
GAC GCT TCT CCA GAC TAC AAT-3‘) (Chen et al., 2010).  
 Agarose gel electrophoresis of the polymerase chain reaction (PCR) amplified 
DNA fragment extracted from dried leaf material for both the medicinal plants produced 
bands that were about 500 bp long when compared with a standard 100 bp DNA ladder 
(Figure 4-2). The numbers of nucleotide after multiple sequence alignment by ClustalW 
of the query sequence for CA and VA were 414 bp and 390 bp respectively.  
The unknown sequences were BLAST searched with sequences in GenBank and 
CA was identified as Centella asiatica accession number AF 272352 (Figure 4-3) with 
99% identity and E-value 1e-152 (Appendix E Figure 5a).VA was identified as 
Gynthemum amygdalina/Vernonia amygdalina accession number AY 504695 (Figure 4-
4) with 99% identity and E-value 5e-141(Appendix E Figure 5c).  
 
 
 
Figure 4- 2: Agarose gel electrophoresis of PCR products subjected to DNA 
barcoding with ITS2 primers 
Figure illustrates PCR amplified DNA for each of the sample electrophoresed on 2.0% 
agarose gels, where 1 - 100 bp DNA ladder marker; 2 – ITS2 region of CA; 3 – ITS2 
region of VA and 4 – negative control. 
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CA    1    TCGAGTCTTTGAACGCAAGTTGCGCCCGAAGCCACTCGGCCGAGGGCACGTCTGCCTGGG 60    
C.asi 322  TCGAGTCTTTGAACGCAAGTTGCGCCCGAAGCCACTCGGCCGAGGGCACGTCTGCCTGGG 381 
CA    61   CGTCACGCATCGCGTCGcccccccccACCCGTCGACCTCGAAAGGGGTCGGGGCGGAGGG 120 
C.asi 382  CGTCACGCATCGCGTCGCCCCCCCC-ACCCGTCGGCCTCGAAAGGGGTCGGGGCGGAGGG 440 
 
CA    121  GCGGAGAATGGCCTCCCGTGCCTCGGGGCGCGGTTGGCCCAAACGTCAGCCCGCGGCGAC 180 
C.asi 441  GCGGAGAATGGCCTCCCGTGCCTCGGGGCGCGGTTGGCCCAAACGTCAGCCCGCGGCGAC 500 
 
CA    181  GGACGTCACGACAAGTGGTGGTTTGACAAAGGCCCTCGCATGTTGTCGTGCGGTGATCCG 240 
C.asi 501  GGACGTCACGACAAGTGGTGG-TTGTCAAAGGCCCTCGCATGTTGTCGTGCGGTGATCCG 559 
 
CA    241  TCGTCGGCGTGAGCTCGTGCGACCCTGTTGCCACGCCGTGCTCGGCGCGCGCTCCGACCG 300 
C.asi 560  TCGTCGGCGTGAGCTCGTGCGACCCTGTTGCCACGCCGTGCTCGGCGCGCGCTCCGACCG 619 
 
CA    301  CGACCCC  307 
C.asi 620  CGACCCC  626 
 
Figure 4- 3: Sequence alignment of the ITS2 region for C. asiatica 
ClustalW alignment of the ITS2 region for unknown (CA) sequence and sequence from GenBank C. 
asiatica (C. asi - AF 272352, BLAST).The ITS2 was PCR amplified with forward primer (5‘–ATG 
CGA TAC TTG GTG TGA AT–3‘) and reverse primer (5‘-GAC GCT TCT CCA GAC TAC AAT-3‘). 
Red alphabets indicate differences in nucleotide. 
 
 
 
VA    117  TCGAAGCGTCATCATAAGACGACTCATTAAGGGATTTTTACAAACCTTTCCTTACGGTTA 176 
V.amy 645  TCGAAGCGTCATCATAAGACGACTCATTAAGGGATTTTTACAACCTTTCCCTTACGGTTA 586 
 
VA    177  ACGACACACAACTCCAAACGAAGGTCTTGTCAACCACCACTAGTCATGTATCCACCGAAA 236 
V.amy 585  ACGACACACAACTCCAAACGAAGGTCTTGTCAACCACCACTAGTCATGTATCCACCGAAA 526 
 
VA    237  GGGAGTTACGTTTAGGCCAACCACACCATCAGCATGGGAGACCAATCTCCGCCCCGAACA 296 
V.amy 525  GGGAGTTACGTTTAGGCCAACCACACCATCAGCATGGGAGACCAATCTCCGCCCCGAACA 466 
 
VA    297  ACAAGCCTACTAAGGAAGGAGGCATTGAAGGAGGCGATGCAATGCGTGACGCCCAGGCAG 356 
V.amy 465  ACAAGCCTACTAAGGAAGGAGGCATTGAAGGAGGCGATGCAATGCGTGACGCCCAGGCAG 406 
 
VA    357  ACGTGCCCTCGACCAAATGGCTTCGGGCGCAACT  390 
V.amy 405  ACGTGCCCTCGACCAAATGGCTTCGGGCGCAACT  372 
 
Figure 4- 4: Sequence alignment of the ITS2 region for V. amygdalina. 
ClustalW alignment of the ITS2 region for unknown (VA) sequence and sequence from GenBank V. 
amygdalina (V.amy - AY 504695, BLAST).The ITS2 was PCR amplified with forward primer (5‘–ATG 
CGA TAC TTG GTG TGA AT–3‘) and reverse primer (5‘-GAC GCT TCT CCA GAC TAC AAT-3‘). 
Red alphabets indicate differences in nucleotide.  
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4.4 Extraction Yield and Antimicrobial Activity in Aqueous, Ethanolic and 
Methanolic Extracts of C. asiatica and V. amygdalina 
 
The extraction yields of aqueous, ethanolic and methanolic extracts of the 
selected medicinal plants were compared based on dry weight (Figure 4-5). For the 
medicinal plant C. asiatica, the highest yield was observed in aqueous extract (18.31%). 
Ethanolic extract and methanolic extracts had similar yields (16.83% and 16.80% 
respectively). The yield for V. amygdalina was highest in methanolic extract followed 
by ethanolic and aqueous extracts (16.71%, 16.26% and 14.61%) respectively, 
nevertheless not significantly different. 
 Antimicrobial activity in aqueous, ethanolic and methanolic extracts of the 
selected medicinal plants C. asiatica (whole plant) and V. amygdalina (leaf) was 
compared at various concentrations (10, 25, 50 and 100 mg/ml) against the five test 
microorganisms. Each well contained 50 µl of each extract.  
For C. asiatica, the highest antimicrobial activity was observed in aqueous 
extract against S. mutans (18.00±1.73 mm at 100 mg/ml) while the lowest activity was 
observed in the methanolic extract against S. mutans (2.00±0.00 mm at 25 mg/ml).  
Generally aqueous extract showed greater antimicrobial activity against the tested 
strains compared ethanolic and methanolic extracts at corresponding concentrations. 
Antimicrobial activities for both ethanolic and methanolic extracts were similar for 
corresponding concentrations (Table 4-3).  
The MIC value of aqueous extract was 25 mg/ml against B. cereus, E. coli, and 
S. mutans and 50 mg/ml against P. aeruginosa and S. aureus. For ethanolic extract, the 
MIC was 25 mg/ml against B. cereus, E.coli, P. aeruginosa and S. mutans and 50 
mg/ml against S. aureus. Methanolic extracts exhibited MIC values of 25 mg/ml 
towards B. cereus, E.coli, and S. mutans and 50 mg/ml for P. aeruginosa and S. aureus. 
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Overall, the three extracts of C. asiatica inhibited all the test microorganisms at varying 
levels.  
Ethanolic and methanolic extracts of V. amygdalina showed significant 
antimicrobial activity towards B. cereus. Slight antimicrobial activity was observed 
towards S.mutans in methanolic extract (Table 4-4). The highest antimicrobial activity 
was recorded in methanolic extract against B. cereus (10.00±0.00 mm at 100 mg/ml) 
whereas the lowest antimicrobial activity was recorded in methanolic extract against S. 
mutans (3.00 ± 0.00 mm at 50 mg/ml). 
The MIC value for ethanolic extract was 50 mg/ml against B. cereus. For 
methanolic extract, the MIC values were 25 mg/ml against B. cereus and 50 mg/ml 
against S. mutans. Overall it was observed that antimicrobial activity was present in 
ethanolic and methanolic extracts but absent in aqueous extract of V. amygdalina 
(Appendix D). 
 
 
Figure 4- 5: The yield of extract in percentage for C. asiatica and V. amygdalina. 
Yield of in aqueous (      ), ethanol (        ), and methanol (        ) extracts were determined based on the 
dry weight of the plant parts. Data was presented as mean ± SD, n = 3. The mean changes between the 
extracts for each plant were analysed by one-way ANOVA followed by Tukey‘s Multiple Comparison 
Test. Samples represented by same alphabet indicated statistical insignificant difference between 
samples (p > .05). 
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Table 4- 3: Antimicrobial Activity of C. asiatica using well diffusion assay 
 
Test 
microorganism 
Diameter of the zone of inhibition (mm)a 
Positive 
controlb 
Negative 
controlc 
Ethanol (mg/ml) Methanol (mg/ml) Aqueous (mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
B. cereus 
16.67±0.58 
*** 
<0.5±0.00 NI 
3.00±0.00 
** 
5.33±0.58 
*** 
8.33±0.58 
*** 
25 NI 
3.67±0.58 
** 
7.33±0.58 
*** 
9.00±0.00 
*** 
25 NI 
3.00±0.00 
** 
5.67±0.58 
*** 
10.0±0.00 
*** 
25 
E. coli 
22.33±0.58 
*** 
<0.5±0.00 NI 
4.67±0.58 
** 
6.33±1.15 
*** 
9.33±0.58 
*** 
25 NI 
4.00±0.00 
*** 
6.00±0.00 
*** 
8.00±0.00 
*** 
25 NI 
5.67±0.58 
*** 
7.33±0.58 
*** 
10.0±0.00 
*** 
25 
P. aeruginosa NI <0.5±0.00 NI 
3.00±0.00 
* 
6.00±1.00 
*** 
8.67±0.58 
*** 
25 NI NI 
5.00±0.00 
*** 
6.33±0.58 
*** 
50 NI NI 
6.33±0.58 
*** 
8.33±1.15 
*** 
50 
S. aureus 
27.33±1.15 
*** 
<0.5±0.00 NI NI 
9.00±0.00 
*** 
13.00±0.00 
*** 
50 NI NI 
5.00±0.00 
*** 
8.67±0.58 
*** 
50 NI NI 
10.0±0.00 
*** 
14.0±0.00 
*** 
50 
S. mutans 
24.67±0.58 
*** 
<0.5±0.00 NI 
4.00±0.00 
** 
7.00±0.00 
*** 
9.67±1.15 
*** 
25 NI 
2.00±0.00 
ns 
4.00±0.00 
*** 
7.33±0.58 
*** 
25 NI 
3.00±0.00 
ns 
15.33±1.15 
*** 
18.00±1.73 
*** 
25 
 
Table displays the antimicrobial activity of ethanolic, methanolic and aqueous extracts of C. asiatica whole plant  against five test microorganism B. cereus, E. coli, P. aeruginosa, 
S. aureus, and S. mutans in trplicate at different concentration of sample (10, 25, 50 100 mg/ml) as determined by well diffusion assay. Each well was filled with 50 µl of extract.
 
a
Diameter of the zone of inhibition in exclusion of 6 mm well diameter in mm; 
b
Positive control - 2.5mg/ml tetracycline; 
c
Negative control - isotonic phosphate buffer, pH 7.4 for 
ethanol and methanol extract and distilled water for aqueous extract; 
d
MIC – Minimum Inhibitory Concentration (mg/ml); NI - no inhibition. Results were presented as mean ± SD. 
n = 3. The mean changes between the extracts and negative control were analysed by one-way ANOVA followed by Dunnett‘s Multiple Comparison Test.  
p < .001 – highly significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant.
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Table 4- 4: Antimicrobial Activity of V. amygdalina using well diffusion assay 
 
 
Test 
microorganism 
Diameter of the zone of inhibition (mm)a 
Positive 
controlb 
Negative 
controlc 
Ethanol (mg/ml) Methanol (mg/ml) Aqueous (mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
10 25 50 100 
MICd 
(mg/ml) 
B. cereus 
16.67±0.58 
*** 
<0.5±0.00 NI NI 
4.00±0.00 
*** 
6.67±0.58 
*** 
50 NI 
5.00±0.00 
*** 
8.33±0.58 
*** 
10.00±0.00 
*** 
25 NI NI NI NI - 
E. coli 
22.33±0.58 
*** 
<0.5±0.00 NI NI NI NI - NI NI NI NI - NI NI NI NI - 
P. aeruginosa NI <0.5±0.00 NI NI NI NI - NI NI NI NI - NI NI NI NI - 
S. aureus 
27.33±1.15 
*** 
<0.5±0.00 NI NI NI NI - NI NI NI NI - NI NI NI NI - 
S. mutans 
24.67±0.58 
*** 
<0.5±0.00 NI NI NI NI - NI NI 
3.00±0.00 
** 
4.00±0.00 
*** 
50 NI NI NI NI - 
 
Table displays the antimicrobial activity of ethanolic, methanolic and aqueous extracts of V. amygdalina leaf against five test microorganism B. cereus, E. coli, P. aeruginosa,  S. 
aureus, and S. mutans in trplicate at different concentration of sample (10, 25, 50 100 mg/ml) as determined by well diffusion assay. Each well was filled with 50 µl of extract. 
a
Diameter of the zone of inhibition is presented in exclusion of 6 mm well diameter in mm; 
b
Positive control - 2.5mg/ml tetracycline; 
c
 Negative control - isotonic phosphate buffer, 
pH 7.4 for ethanol and methanol extract and distilled water for aqueous extract; 
d
MIC – Minimum Inhibitory Concentration (mg/ml); NI is no inhibition. Results were presented as 
mean ± SD, n = 3. The mean changes between the extracts and negative control were analysed by one-way ANOVA followed by Dunnett‘s Multiple Comparison Test.  
p < .001 - highly significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant. 
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4.5 Antimicrobial Activity after Ammonium Sulphate Precipitation of 
Ethanolic Extracts. 
 
After 100% ammonium sulphate precipitation of ethanolic extracts, the pellet 
and supernatant were tested for their antimicrobial activity against the five test 
microorganisms (B. cereus, E. coli, S. aureus, P. aeruginosa and S. mutans, Figure 4-6). 
Results of the assay indicated that the supernatant for both the tested plant extract 
showed various level of antimicrobial activity while ammonium sulphate precipitates 
had relatively low or no antimicrobial activity.  
For C. asiatica, it was observed that the supernatant showed the highest 
antimicrobial activity towards B. cereus (14.00±1.73 mm) and S. aureus (14.00±0.00 
mm) followed by E.coli (13.33±1.53 mm), and P. aeruginosa (12.67±0.58 mm) and no 
activity towards S. mutans. It was interesting to note that there was significant 
antimicrobial activity (p <.05) of C. asiatica towards P. aeruginosa compared to the 
standard antibiotic, tetracycline that had no antimicrobial activity towards P. aeruginosa 
at 2.5mg/ml concentration (Figure 4-6A). The pellet showed low activity against E. coli 
(4.33±0.58 mm) followed by P. aeruginosa (3.67±0.58 mm) and no activity against B. 
cereus, S. aureus and S. mutans.  
Supernatant of V. amygdalina showed antimicrobial activity towards B. cereus 
(5.00 ±0.00 mm) and pellet showed lower activity against the same test microorganism 
(4.67±0.58 mm). No antimicrobial activity was observed against the other 4 test 
microorganisms (Figure 4-6B). Figure 4-3C shows the zone of inhibition for the well 
diffusion assay.  
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Figure 4- 6: Antimicrobial activity of pellet and supernatant obtained from ammonium sulphate 
precipitation by well diffusion assay of C. asiatica (A) and V. amygdalina (B) ethanolic extracts and 
their images (C). 
Figures A and B displays the antimicrobial activity of pellet and supernatant for the ethanolic extract of 
C. asiatica and V. amygdalina against test microorganisms where diameter of the zone of inhibition for 
the pellet           , supernatant             , positive control            and negative control           excluded 7 mm 
well diameter. Each well was filled with 50 µl of extract. Positive control - 2.5 mg/ml tetracycline. 
Negative control – saturated ammonium sulphate solution. Results were presented as mean ± SD, n = 3. 
The mean changes between the samples and negative control were analysed by one-way ANOVA 
followed by Dunnett‘s Multiple Comparison Test (p < .001 - highly significant***; p < .01 -very 
significant**; p < .05 – significant*; ns - not significant). 
Figure C displays the zone of inhibition for the antimicrobial activity of pellet and supernatant of the 
selected medicinal plants. +ve – Positive control (tetracycline 2.5mg/ml); -ve- Negative control (saturated 
ammonium sulphate solution); CP- C. asiatica pellet; CS – C. asiatica supernatant; VP – V. amygdalina 
pellet and VS – V. amaygdalina supernatant.  
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4.6 Total Phenolic Content (TPC) in C. asiatica and V. amygdalina 
 
 TPC was determined by Folin-Ciocalteu‘s method (Section 3.7) for aqueous, 
ethanolic and methanolic extracts of the plant of study by reference to a gallic acid 
standard curve (y = 0.0006x + 0.0017, R
2
 = 0.9961 Appendix F Figure 6). TPC was 
expressed as milligrams of gallic acid equivalent per gram of dry weight of extract (mg 
GAE/g d.w.).  
Significant difference (p < .05) was observed in the TPC of C. asiatica extracted 
using different solvents. The ethanolic extract contained the highest amount of 
phenolics (4.006±0.032 mg GAE/g d.w.) followed by methanolic extract (3.346±0.029 
mg GAE/g d.w.). The lowest amount of phenol was in aqueous extract (1.120±0.063 mg 
GAE/g d.w).  
The TPC in V. amygdalina was lower than C. asiatica for all the extracts tested. 
The highest TPC was in the methanolic extract (1.168±0.101 mg GAE/g d.w) while the 
lowest TPC was observed in ethanolic and aqueous extract which showed no 
significance (p > .05) from each other (Figure 4-7 and Appendix F Table 1). 
  
       
 
Figure 4- 7 : Total phenolic content of extracts determined by Folin-Coicalteu’s method 
TPC from aqueous (     ), ethanolic (     ) and methanolic (     ) extracts of C. asiatica and V. 
amygdalina based on the gallic acid standard curve. TPC was expressed as mg of gallic acid 
equivalence per gram dry weight of extract (mg GAE/g d.w). The tested concentration of each plant 
extract was 2.5 mg/ml. Data was presented as mean ± SD, n = 3. The mean changes between the 
extracts for each plant were analysed separately by one-way ANOVA followed by Tukey‘s Multiple 
Comparison Test. Samples represented by different alphabets indicated significant different (p < .05).       
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4.7 Antioxidant Activity in C. asiatica and V. amygdalina 
4.7.1 DPPH (2, 2-diphenyl-1-picrylhydrazyl) radical scavenging activity 
 
Figure 4-8 (Appendix G Table 2) shows the DPPH radical scavenging activity 
in C. asiatica and V. amygdalina extracts compared with standards BHT and ascorbic 
acid. Table 4-5 shows the antioxidant activity of the extracts expressed as the 
concentration required to inhibit the formation of DPPH radicals by 50% (IC50). Non-
linear regression curve (Appendix G Figure 7b) was plot to determine IC50. 
 
Table 4- 5: IC50 (µg/ml) of DPPH radical scavenging assay 
Sample
 
Aqueous 
extract 
Ethanol 
extract 
Methanol 
extract Ascorbic acid BHT 
C. asiatica 4039.00±0.03
a 
122.40±0.04
b 
210.70±0.03
c 
67.38±0.10
g 
1290.00±0.05
h 
V. amygdalina 2706.00±0.15
d 
1063.00±0.04
e 
1049.00±0.06
f 
IC50 (µg/ml) of C. asiatica and V. amygdalina towards DPPH radicals were determined. Ascorbic acid and 
BHT were the standards used for comparison. Results were expressed as mean ± SD, where n = 3. The 
mean changes between the extracts and standards were analysed by one-way ANOVA followed by 
Tukey‘s Multiple Comparison Test. Samples presented by different alphabets were significantly different 
(p < .05) from each other. 
 
Figure 4-8A depicts a steady increase in the inhibition of the formation of DPPH 
radicals by all the extracts of C. asiatica revealing a dose dependant increase in the 
radical scavenging activity. At the dosage of 400 µg/ml, the radical scavenging activity 
of C. asiatica extracts and standards towards DPPH radical was in the following order: 
ascorbic acid (90.49±0.60%) > ethanolic extract (88.83±0.23%) > methanolic extract 
(73.17±0.17%) > BHT (26.34±1.47%) > aqueous extract (8.28±0.74%) at 400 µg/ml 
dosage. The IC50 of ethanolic extract was the lowest (122.40±0.04 µg/ml), lower than 
standard BHT (1290.00±0.05 µg/ml). The IC50 of the aqueous extract was the highest 
(4039.00±0.03 µg/ml Table 4-5).  
At the dosage of 400 µg/ml, the radical scavenging activity of V. amygdalina 
and the standards towards DPPH radical was as follows: ascorbic acid (90.49±0.60%) > 
BHT (26.34±1.47%) > ethanolic extract (26.07±5.32%) > methanolic extract 
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(25.97±4.39%) > aqueous extract (5.95±1.37%). The aqueous extract showed unstable 
scavenging activity towards DPPH radical. Ethanolic and methanolic extracts of V. 
amygdalina showed low DPPH radical scavenging activity compared to ethanolic and 
methanolic extracts of C. asiatica. The IC50 for all the tested extracts were relatively 
high (Table 4-5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 8: Percentage inhibition of DPPH radical in C. asiatica (A), V. amygdalina (B) extracts 
and positive controls (C).    
The percentage inhibition of DPPH radical with varying concentration (0-400µg/ml) of aqueous ( ), 
ethanolic ( ) and methanolic ( ) extracts of C. asiatica, V. amygdalina and the positive controls 
ascorbic acid ( ) and BHT (  ) were analysed by measuring the inhibitory effects on DPPH radical 
at 517 nm. Results are presented as mean ± SD, n = 3.   
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4.7.2 Ferric reducing antioxidant power (FRAP) assay 
 
 FRAP assays were conducted on aqueous, ethanolic and methanolic extracts of 
C. asiatica and V. amygdalina. All assays were performed simultaneously and ascorbic 
acid and BHT were used as the positive controls. Each sample was tested at 0.5 mg/ml 
and 1.0 mg/ml (Figure 4-9 and 4-10). In the FRAP assay, reductants antioxidants in the 
sample reduces Fe
3+
/tripyridyltriazine complex to the blue coloured ferrous form, with 
an increase in absorbance at 595 nm. The absorbance of the samples and positive 
control showed gradual increase and reached a plateau by the fourth
 
minute of 
incubation. For all samples and positive control the absorbance doubled at 1 mg/ml 
compared to the rate at 0.5 mg/ml (Figure 4-9 and 4-10).  
At 1.0 mg/ml concentration, C. asiatica methanol extracts and standards were 
able to reduce ferric ions efficiently with absorbance unit (AU) as follows: ascorbic acid 
(3.224±0.103 AU at 0 seconds to 3.318±0.021 AU at 4 minutes) > methanolic extract 
(0.466±0.012 AU at 0 seconds to 0.555±0.012 AU at 4 minutes) > ethanolic extract 
(0.421±0.011 AU at 0 seconds to 0.502±0.014 AU at 4 minutes) > BHT (0.048±0.017 
AU at 0 seconds to 0.179±0.017 AU at 4 minutes) > aqueous extract (0.041±0.003 AU 
at 0 seconds to 0.096±0.006 AU at 4 minutes Figure 4-9).  
 Figure 4-10 generally depicts that V. amygdalina extracts had lower absorbance 
compared to C. asiatica extracts at the same concentration where only methanolic 
extracts showed reducing capabilities (0.142±0.020 AU at 0 seconds to 0.222±0.012 
AU at 4 minutes) for the same concentration (1.0 mg/ml). Both ethanolic and aqueous 
extract showed low absorbance 0.093±0.006 AU at 0 seconds to 0.137±0.011 AU at 4 
minutes) and (0.041±0.003 AU at 0 seconds to 0.096±0.006 AU at 4 minutes) 
respectively (Appendix H Table 3a and 3b). 
 
Results 
109 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 9: Ferric Reducing Antioxidant Power (FRAP) activity in 0.5 mg/ml (A) and 1 mg/ml (B) 
C. asiatica extracts 
Aqueous ( ), ethanol ( ) and methanol ( ) extracts of C. asiatica were tested. The reaction 
time was followed every 15 seconds for 4 minutes and the absorbance was recorded at 595 nm. Ascorbic 
acid ( ) and BHT (  ) were the standard antioxidant used. Results are an average of 3 readings ± 
standard deviation. 
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Figure 4- 10: Ferric Reducing Antioxidant Power (FRAP) activity in 0.5 mg/ml (A) and 1 mg/ml 
(B) V. amygdalina extracts. 
Aqueous ( ), ethanol ( ) and methanol ( ) extracts of V. amygdalina were tested. The 
reaction time was followed every 15 seconds for 4 minutes and the absorbance was  recorded at 595 
nm. Ascorbic acid ( ) and BHT ( ) were the standard antioxidant used. Results are an average of 
3 readings ± standard deviation.  
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4.7.3 Protective Effect of Extracts of C. asiatica and V. amygdalina Against 
Hydrogen Peroxide (H2O2) Induced Haemolysis. 
 
It was observed that the aqueous, ethanolic and methanolic extracts of C. asiatica 
and V. amygdalina thereafter did not exhibit any harmful effect towards the rabbit 
erythrocytes after pre-incubation of the extracts with erythrocytes for 1 hour. 
Interestingly, it was found that the extracts inhibited haemolysis at various 
concentrations (0.1 – 1.0 mg/ml) through in vitro haemolysis assays. The assays were 
conducted for 18 hours to evaluate the protective effects of extracts against H2O2 (10 
mM and 50 mM) induced haemolysis.  
Table 4-6 shows the concentration (mg/ml) required to inhibit haemolysis of red 
blood cells by 50% (IC50), whereby 10 mM and 50 mM H2O2 was used to induce 
haemolysis. Non-linear regression curves (Appendix I Figures 9a and 9b) were used to 
determine IC50. The percentage of haemolysis was based on 100% haemolysis of 
distilled water. The negative control used was isotonic phosphate buffer which 
displayed 72.44±1.04% and 57.13±0.80% protective effect against 10 mM and 50 mM 
H2O2 induced haemolysis respectively.    
Inhibition of haemolysis by the extracts of C. asiatica and standards at 1 mg/ml 
dosage against 10 mM H2O2 were as follows: methanolic extract (88.14±0.83%) > 
ascorbic acid (86.05±0.66%) > ethanolic extract (85.12±1.69%) > aqueous extract 
(76.47±0.79%). Inhibition of the extracts at the same dosage against 50 mM H2O2 was 
as follows: methanolic extract (91.81±0.55%) > ethanolic extract (84.73±0.65%) > 
ascorbic acid (71.97±0.76%) ≈ aqueous extract (71.61±0.53%; Figure 4-11 and 
Appendix J Tables 4a and 4b).  
All extracts showed low IC50 values against 10 mM H2O2 and were compatible with 
ascorbic acid. IC50 value against 50 mM H202 was lowest for both ethanolic and 
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methanolic extract (0.1 mg/ml) which was comparable with that of ascorbic acid. 
However, aqueous extract showed a higher value (0.29 mg/ml Table 4-6). 
 
Table 4- 6: IC50 (mg/ml) values of the protective effect of extracts of C. asiatica and V. 
amygdalina against H2O2 induced red blood cell lysis. 
Sample 
IC50 against 10 mM H2O2 
(mg/ml) 
IC50 against 50 mM 
H2O2 (mg/ml) 
C. asiatica aqueous extract 0.13±0.08
a 
0.29±0.04
cf 
C. asiatica ethanolic extract 0.11±0.04
a 
0.10±0.04
d 
C. asiatica methanolic extract 0.11±0.03
a 
0.10±0.04
d 
V. amygdalina aqueous extract 0.28±0.04
b 
0.31±0.04
ef 
V. amygdalina ethanolic extract 0.14±0.06
a 
0.11±0.07
d 
V. amygdalina methanolic extract 0.22±0.03
ab 
0.13±0.08
d 
Ascorbic acid 0.11±0.04
a 
0.12±0.08
d 
IC50 of C. asiatica and V. amygdalina towards 10 mM and 50 mM H2O2 were determined by non-
linear regression curve. Ascorbic acid was the standard used for comparison. Results were presented 
as mean ± SD of three replicates. The mean changes between the extracts and standard were analysed 
separately against 10 mM and 50 mM H2O2 by one-way ANOVA followed by Tukey‘s Multiple 
Comparison Test. Values represented by different alphabets within columns indicated significant 
differences (p < .05). 
 
Inhibition of haemolysis by the extracts of V. amygdalina and standards at 1 mg/ml 
dosage against 10 mM H2O2 were as follows: ascorbic acid (86.05±0.66%) > 
methanolic extract  (79.25±0.64%) > ethanolic extract (78.46±0.35%) > aqueous extract 
(72.92±0.77%). At the same dosage, inhibition against 50 mM H2O2 were as follows: 
methanolic extract (81.77±0.23%) > ethanolic extract (78.10±0.26%) > ascorbic acid 
(71.97±0.76%) > aqueous extract (57.55±1.46% Figure 4-12 and Appendix I Tables 4a 
and 4b).  
The IC50 against 50 mM H2O2 was lowest for the ethanolic extract (0.11±0.07 
mg/ml) and was comparable with ascorbic acid (0.12±0.08 mg/ml) whereas the highest 
IC50 was recorded in the aqueous extract (0.31±0.04 mg/ml Table 4-6). Overall, for 
increasing concentration of extracts, an increasing pattern was observed in the 
protective effect of methanolic and ethanolic extracts whereas aqueous extract showed 
varying protective effect (Figure 4-12).  
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Figure 4- 11: In vitro protective effect of C. asiatica against 10 mM (A) and 50 mM (B) 
H2O2 induced haemolysis of rabbit erythrocytes.  
Aqueous ( ), ethanol ( ) and methanol ( ) extract of C. asiatica and positive control - 
ascorbic acid ( ) were tested at (0.1, 0.25, 0.5, 0.75 and 1.0 mg/ml) concentration. Protective 
effect of distilled water ( ) and negative control – IPB (  ) were displayed. Absorbance was 
measured at 540 nm. Percentages of haemolysis were based on 100% haemolysis of water. 
Results were presented as mean ± SD whereby n = 3.  
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Figure 4- 12: In vitro protective effects of V. amygdalina against 10 mM (A) and 50 Mm (B) 
H2O2 induced haemolysis of rabbit erythrocytes.  
Aqueous (  ), ethanol ( ) and methanol (  ) extract of V. amygdalina and positive control - 
ascorbic acid ( ) were tested at (0.1, 0.25, 0.5, 0.75 and 1.0 mg/ml) concentration. Protective 
effect of distilled water (  ) and negative control – IPB (  ) were displayed. Absorbance was 
measured at 540 nm. Percentages of haemolysis were based on 100% haemolysis of water. 
Results were presented as mean ± SD whereby n = 3.  
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4.7.4 Antioxidant capacity of C. asiatica and V. amygdalina extracts 
 
Antioxidant capacity of extracts and positive control were determined by three 
methods. Firstly, using the DPPH assay by comparing with Trolox standard curve 
(Appendix G Figure 7a) and expressed as milimole Trolox equivalent (TE) antioxidant 
capacity per gram dry weight sample (mmol TE/g d.w.) as described in Section 3.8.1.3. 
Secondly, using the FRAP assay by comparing with ferrous sulphate (FeSO4.7H2O) 
standard curve in a 0 - 4 minute reaction time (Appendix H Figure 8) and expressed as 
milimole ferrous sulphate (Fe
2+
) per gram of dry weight (mmole Fe
2+
/g dry weight) as 
described in Section 3.8.2.3. Thirdly using anti-haemolysis assay by comparing with 
ascorbic acid standard curve (Appendix I Figure 9c) and expressed as milimole 
ascorbic acid equivalent (AAE) per gram dry weight plant sample (mmol AAE/g d.w.) 
described in Section 3.8.3.3. 
The DPPH antioxidant capacity of C. asiatica displayed that ethanolic extract 
had the highest antioxidant activity (1.8824±0.0062 mmol AAE/g d.w.) being more 
potent than aqueous extract but had similar potency to methanolic extract. Ethanolic 
extract had a higher potency compared to BHT (Table 4-7). 
In the FRAP assay, 1 mg/ml of samples and controls were chosen to determine 
the antioxidant capacity. The ferric reducing activity in methanolic extract of C. asiatica 
was the highest followed by ethanolic extract. The activity was higher compared to 
ascorbic acid and lower than BHT (positive controls). Aqueous extract had the lowest 
reducing activity (Table 4-7). 
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Results of anti-haemolysis antioxidant capacity in C. asiatica, proved that 
methanolic extract possess the strongest activity (13.7316±0.2052 mmol AAE/g d.w.) 
being stronger than the control ascorbic acid (6.3724±0.2806 mmol AAE/g d.w.). The 
weakest activity was observed in aqueous extracts (6.1151±0.4082 mmol AAE/g d.w. 
(Table 4-7). 
 
Table 4- 7: Antioxidant Capacity of C. asiatica extracts and controls. 
Samples 
ADPPH 
 (mmol TE/g d.w.) 
BFRAP 
 (mmol Fe2+/g d.w.) 
Canti-haemolysis 
 (mmol AAE/g d.w.) 
C. asiatica aqueous extract 0.0000±0.0000a 0.1567±0.0285ab 6.1151±0.4082a 
C. asiatica ethanol extract 1.8824±0.0062b 0.2711±0.0482ad 11.1076±0.2394b 
C. asiatica methanol extract 1.4582±0.0192c 0.2967±0.0731d 13.7316±0.2052c 
Ascorbic acid 7.7364±0.0329d 0.0922±0.0367b 6.3724±0.2806a 
BHT 0.1895±0.0398e 0.4356±0.0051c - 
Table displays the antioxidant activity of aqueous, ethanolic and methanolic extracts. Ascorbic acid and 
BHT were standards used for comparison. Results were expressed as mean ± SD where n = 3. The mean 
changes between the samples for each test were analysed separately by one-way ANOVA followed by 
Tukey‘s Multiple Comparison Test. Values represented by different alphabets within columns indicated 
significant different (p < .05). 
A
DPPH presented as milimole Trolox equivalent per gram dry weight 
(mmol TE/g d.w.). 
B
FRAP presented as milimole ferrous sulphate per gram dry weight (mmol Fe
2+
/g 
d.w.). 
C
Anti-haemolysis presented as milimole ascorbic acid equivalent per gram dry weight (mmol 
AAE/g d.w.). 
 
 
Studies on the extracts of V. amygdalina through DPPH antioxidant capacity, 
revealed that ethanolic and methanolic extracts possess similar antioxidant potency. It 
was interesting to note that the antioxidant potency was also similar to that of the BHT. 
However, there was no antioxidant activity in aqueous extract (Table 4-8). Overall it 
was discovered that the antioxidant activity was lower in V. amygdalina extracts 
compared to C. asiatica extracts.  
Through the FRAP assay, methanolic extract of V. amygdalina was able to 
reduce ferric ions effectively and was higher than ascorbic acid. Aqueous extract had 
low reducing capability whereas ethanolic extract had the lowest reducing capacity 
(Table 4-8). Overall the methanolic and ethanolic extracts of V. amygdalina had lower 
reducing capacity but aqueous extract had higher reducing capacity when compared to 
C. asiatica. 
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Antioxidant capacity in anti-haemolysis assay showed that methanolic extract of 
V. amygdalina was the most potent extract (10.0081±0.0845 mmol AAE/g d.w.) in 
inhibiting haemolysis. This was followed by the ethanolic extract (8.6454±0.0980 mmol 
AAE/g d.w.), while the lowest potency was observed in aqueous extract (1.0241±0.5429 
mmol AAE/g d.w.), being lower than ascorbic acid (Table 4-8).  
 
Table 4- 8: Antioxidant Capacity of V. amygdalina extracts and controls. 
Samples ADPPH 
(mmol TE/g d.w.) 
BFRAP 
(mmol Fe2+/g d.w.) 
Canti-hemolysis 
 (mmol AAE/g d.w.) 
V. amygdalina aqueous extract 0.0000±0.0000abd 0.1822±0.0255abc 1.0241±0.5429a 
V. amygdalina ethanol extract 0.1823±0.1441aef 0.1467±0.0176ae 8.6454±0.0980b 
V. amygdalina methanol extract 0.1797±0.1189beg 0.2656±0.0769b 10.0081±0.0845c 
Ascorbic acid 7.7364±0.0329c 0.0922±0.0367ce 6.3724±0.2806d 
BHT 0.1895±0.0398dfg 0.4356±0.0051d - 
Table displays the antioxidant activity of aqueous, ethanolic and methanolic extracts. Ascorbic acid and 
BHT were standards used for comparison. Results were expressed as mean ± SD where n = 3. The mean 
changes between the samples for each test were analysed by one-way ANOVA followed by Tukey‘s 
Multiple Comparison Test. Values represented by different alphabets within columns indicated 
significantly different (p < .05). 
A
DPPH presented as milimole Trolox equivalent per gram dry weight 
(mmol TE/g d.w.). 
B
FRAP presented as milimole ferrous sulphate per gram dy weight (mmol Fe
2+
/g 
d.w.). 
C
Anti-haemolysis presented as milimole ascorbic acid equivalent per gram dry weight (mmol 
AAE/g d.w.). 
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4.8 Relationship between the Phenolic Compounds with the Antimicrobial and 
Antioxidant Activity of C. asiatica and V. amygdalina Extracts. 
 
4.8.1 Relationship between the Phenolic Compounds and Antimicrobial Activity 
of Plant Extracts 
 
 Correlation analysis was performed to compare the relationship between total 
phenolic content (TPC) and antimicrobial activities between (i) aqueous, ethanolic and 
methanolic extracts of each plant and (ii) ethanolic extract of both the plants in this 
study using regression analysis.  
 
Table 4- 9: Correlation coefficient (r) between 
a
total phenolic content (TPC) and 
b
antimicrobial 
activity of C. asiatica and V. amygdalina. 
Plant of study 
TPC vs Antimicrobial activity 
B. cereus E. coli P. aeruginosa S. aureus S. mutans 
c
C. asiatica -0.9151*** 0.4978
ns
 -0.0955
ns 
 0.2659
ns
 -0.8876** 
c
V. amygdalina 0.4412
ns
 - - - 0.7723* 
d
C. asiatica and 
 V. amygdalina 
0.8720* 0.9967*** 0.9974*** 0.9997*** 0.7994
ns 
Table displays the correlation coefficient, r between TPC and antimicrobial activity of C. asiatica and 
V. amygdalina between (i) extracts of each plant and (ii) both plants. Statistical significant between 
correlation coefficient was determined by Pearson correlation analysis for two-tailed p value. p < .001 - 
highly significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant. ― – ― 
indicated no antimicrobial activity. 
a
Total phenolic content (TPC) - milligram gallic acid equivalent per 
gram dry weight (mg GAE/g d.w.). 
b
Antimicrobial activity – Diameter of zone of inhibition (mm). 
c
Correlation between aqueous, ethanolic and methanolic extracts of each plant. 
d
Correlation between C. 
asiatica and V. amygdalina ethanolic extract. 
 
 C. asiatica displayed weak correlation between the antimicrobial activity and 
TPC of the three aqueous, ethanolic and methanolic extracts against each bacteria. The r 
values were between 0.4978 and -0.0955 and decreased in the following order: E. coli (r 
= 0.4978) > S. aureus (r = 0.2659) > B. cereus (r = -0.9151) > S. mutans (r = -0.8876) > 
P. aeruginosa (r = -0.0955). The negative correlation coefficient indicated inverse 
relationship between phenolic content and antimicrobial activity whereby extracts with 
the highest phenolic content displayed lowest antimicrobial activity (Table 4-9 and 
Figure 4-13).   
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Figure 4- 13: Relationship between total phenolic content and antimicrobial activity of C. asiatica 
extracts 
Graph displays the linear correlation between diameter of the zone of inhibition (mm) of the five test 
microorganisms (B. cereus, E. coli, P. aeruginosa, S. aureus and S. mutans) and total phenolic content 
(milligram gallic acid equivalent per gram dry weight mg GAE/g d.w) of aqueous, ethanolic and 
methanolic extracts of C. asiatica. Results were displayed as mean ± SD, n = 3. Coefficient of 
determinant (R
2
) - measures how well the regression line represents the data. 
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 Higher correlation between the antimicrobial activity and TPC was detected in 
extracts of V. amygdalina. However, antimicrobial activity was displayed only towards 
B. cereus and S. mutans and not towards E. coli, P. aureus and S. aureus.  The 
correlation coefficients obtained were (r = 0.7723; R
2
 = 0.5964) and (r = 0.4412; R
2
 = 
0.1946) for S. mutans and B. cereus respectively (Table 4-9 and Figure 4-14).  
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Figure 4- 14: Relationship between total phenolic content and antimicrobial activity of V. 
amygdalina extracts 
Graph displays the linear correlation between diameter of the zone of inhibition (mm) of the two test 
microorganisms (B. cereus and S. mutans) and total phenolic content (milligram gallic acid equivalent 
per gram dry weight mg GAE/g d.w) of aqueous, ethanolic and methanolic extracts of V. amygdalina. 
Results were displayed as mean ± SD, n = 3. Coefficient of determinant (R
2
) - measures how well the 
regression line represents the data. 
 
 
 Strong correlations were observed between the antimicrobial activity TPC when 
compared between ethanolic extract of C. asiatica and V. amygdalina. The r values 
obtained were between 0.9997 and 0.7994 and decreased in the following order: S. 
aureus (r = 0.9997) > P. aeruginosa (r = 0.9974) > E. coli (r = 0.9967) > B. cereus (r = 
0.8720) > S. mutans (r = 0.7794; Table 4-9, Figure 4-15). 
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Figure 4- 15: Relationship between total phenolic content and antimicrobial activity of C. asiatica 
and V. amygdalina ethanolic extract 
Graph displays the linear correlation between diameter of the zone of inhibition (mm) of the five test 
microorganisms (B. cereus, E. coli, P. aeruginosa, S. aureus and S. mutans) and total phenolic content 
(milligram gallic acid equivalent per gram dry weight mg GAE/g d.w) of ethanolic extract of C. 
asiatica and V. amygdalina. Results were displayed as mean ± SD, n = 3. Coefficient of determinant 
(R
2
) - measures how well the regression line represents the data. 
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4.8.2 Relationship between the Phenolic Compounds and Antioxidant Activity 
and Relationship between the Antioxidant Assays of the Plant of Study.  
 
Regression analysis was performed to correlate total phenolic content (TPC) 
determined by the Folin-Ciocalteu method with antioxidant capacity determined by 
DPPH, FRAP and anti-haemolysis assay in order to correlate antioxidant assays. The 
correlation analysis was performed to determine the relationship of the various assays 
between aqueous, ethanolic and methanolic extracts of each plant and between ethanolic 
extract of both plants. 
Significantly high correlations were found between the TPC and antioxidant 
capacity of C. asiatica extracts. The strongest positive correlation was observed 
between TPC and DPPH radical scavenging activity (r = 0.9996; R
2
 = 0.9991; p < 
0.001) and the lowest correlation was between TPC and FRAP (r = 0.7624; R
2
 = 
0.5813; p < 0.05). Likewise, significant correlation was observed between various 
assays used to determine antioxidant capacity especially between DPPH and anti-
haemolysis assay (r = 0.8435; R
2
 = 0.7115; p < .01; Table 4-10, Figure 4-16). 
 
Table 4- 10: Correlation coefficient (r) between total phenolic content and antioxidant capacities 
and between antioxidant assays of C. asiatica and V. amygdalina extracts.  
Plant of study  
A
TPC vs 
B
DPPH
 
TPC vs 
C
FRAP
 
TPC vs 
D
Anti-
haemolysis
 
DPPH vs 
FRAP 
DPPH vs 
Anti-
haemolysis 
FRAP vs 
Anti-
haemolysis 
E
C. asiatica 0.9996*** 0.7624* 0.8403**  0.7556* 0.8435** 0.8040** 
E
V. amygdalina 0.0665
ns
 0.4336
ns
 0.2926
ns
 0.4311
ns
 0.6885* 0.2810
ns
 
F
C. asiatica and 
V. amygdalina 
0.9968*** 0.9099* 0.9933*** 0.9109* 0.9878*** 0.9211** 
Table displays the correlation coefficient, r between assays. Statistical significant between correlation 
coefficient was determined by Pearson correlation analysis for two-tailed p value. p < .001 - highly 
significant***; p < .01 -very significant**; p < .05 – significant*; ns - not significant. ATotal phenolic 
content (TPC) - milligram gallic acid equivalent per gram dry weight (mg GAE/g d.w.). 
B
Antioxidant 
capacity (DPPH) - milimole Trolox  equivalent per gram dry weight (mmol TE/g d.w.). 
C
Antioxidant 
capacity (FRAP) - milimole ferrous sulphate per gram dry weight (mmol Fe
2+
 /g d.w.). 
D
Antioxidant 
capacity (anti-haemolysis assay) - milimole ascorbic acid equivalent per gram dry weight (mmol 
AAE/g d.w.). 
E
Correlation between aqueous, ethanolic and methanolic extracts of each plant. 
F
Correlation between C. asiatica and V. amygdalina ethanolic extract. 
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V. amygdalina extracts displayed weak correlation between TPC and antioxidant 
capacity and between the antioxidant assays. The highest correlation was between 
DPPH and anti-haemolysis assay (r = 0.6885, R
2
 = 0.4740, p < 0.05). The lowest 
correlation was observed between TPC and DPPH (r = 0.0665, R
2
 = 0.0044, p > 0.05; 
Table 4-10, Figure 4-17). 
Comparison of the correlation of TPC with antioxidant capacity and between 
antioxidant assays were was made between ethanolic extract of C. asiatica and V. 
amygdalina. The results generally showed strong significant correlation (p < 0.05) with 
r values between 0.9968 and 0.9099. The strongest correlation was observed between 
TPC and DPPH (r = 0.9968; R
2
 = 0.9935; p < 0.001) followed by TPC and anti-
haemolysis assay (r = 0.9933; R
2
 = 0.9867; p < 0.001). The lowest correlation was 
displayed between TPC and FRAP (r = 0.9099; R
2
 = 0.8280; p < 0.05; Table 4-10, 
Figure 4-18). 
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Figure 4- 16: Correlation between total phenolic content and antioxidant capacity and 
between antioxidant capacities of C. asiatica extracts. 
Correlation between TPC of C. asiatica extracts and their antioxidant capacity determined by 
DPPH assay (A), FRAP assay (B) and anti-haemolysis assay (C) and between antioxidant 
capacities DPPH and FRAP (D), DPPH and anti-haemolysis assay (E), and FRAP and anti-
haemolysis assay (F). The total phenolic content (TPC) was determined by Folin‘s Ciocalteu assay, 
presented as milligram gallic acid equivalent per gram dry weight (mg GAE/g d.w.). The 
antioxidant activity were DPPH presented as milimole Trolox equivalent per gram dry weight 
(mmol TE/g d.w.), FRAP assay presented as milimole ferrous sulphate per gram dry weight (mmol 
Fe
2+
 /g d.w.) and anti-haemolysis assay presented as milimole ascorbic acid equivalent per gram 
dry weight (mmol AAE/g d.w.). Aqueous, ethanolic and methanolic extracts were used. Results 
were presented as mean ± SD where n = 3. Coefficient of determinant (R
2
) - measures how well the 
regression line represents the data. 
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Figure 4- 17: Correlation between total phenolic content and antioxidant capacity and between 
antioxidant assays of V. amygdalina extracts. 
Correlation between TPC of V. amygdalina extracts and their antioxidant capacity determined by 
DPPH assay (A), FRAP assay (B) and anti-haemolysis assay (C) and between antioxidant capacities 
DPPH and FRAP (D), DPPH and anti-haemolysis assay (E), and FRAP and anti-haemolysis assay (F). 
The total phenolic content (TPC) was determined by Folin‘s Ciocalteu assay, presented as milligram 
gallic acid equivalent per gram dry weight (mg GAE/g d.w.). The antioxidant activity were DPPH 
presented as milimole Trolox equivalent per gram dry weight (mmol TE/g d.w.), FRAP assay 
presented as milimole ferrous sulphate per gram dry weight (mmol Fe
2+
 /g d.w.) and anti-haemolysis 
assay presented as milimole ascorbic acid equivalent per gram dry weight (mmol AAE/g d.w.). 
Aqueous, ethanolic and methanolic extracts were used. Results were presented as mean ± SD where n 
= 3. Coefficient of determinant (R
2
) - measures how well the regression line represents the data. 
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Figure 4- 18: Correlation between total phenolic content and antioxidant capacity and between 
antioxidant assays of C. asiatica and V. amygdalina ethanolic extract. 
Correlation between TPC of C. asiatica and V. amygdalina extracts and their antioxidant capacity 
determined by DPPH assay (A), FRAP assay (B) and anti-haemolysis assay (C) and between 
antioxidant capacities DPPH and FRAP (D), DPPH and anti-haemolysis assay (E), and FRAP and anti-
haemolysis assay (F). The total phenolic content (TPC) was determined by Folin‘s Ciocalteu assay, 
presented as milligram gallic acid equivalent per gram dry weight (mg GAE/g d.w.). The antioxidant 
activity were DPPH presented as milimole Trolox equivalent per gram dry weight (mmol TE/g d.w.), 
FRAP assay presented as milimole ferrous sulphate per gram dry weight (mmol Fe
2+
 /g d.w.) and anti-
haemolysis assay presented as milimole ascorbic acid equivalent per gram dry weight (mmol AAE/g 
d.w.). Results were presented as mean ± SD where n = 3. Coefficient of determinant (R
2
) - measures 
how well the regression line represents the data. 
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4.9 Comparison of the Bioactivity in the Aqueous Ethanolic and Methanolic 
extracts of C. asiatica and V. amygdalina 
  
 The extracts with the highest bioactivity to the lowest bioactivity for 
antimicrobial activity, total phenolic content and antioxidant capacity by DPPH, FRAP, 
and anti-haemolysis assays are shown (Table 4-11). It was observed for C. asiatica, the 
aqueous extract displayed strong antimicrobial activity whereas the alcoholic extracts 
displayed strong phenolic and antioxidant activity. For V. amygdalina, the methanolic 
extract showed highest activity for most of the assays tested and the aqueous extract 
showed the lowest activity. 
 
  
Table 4- 11: Bioactivity of C. asiatica and V. amygdalina aqueous, ethanolic and methanolic 
extracts.  
Bioactivity 
C. asiatica V. amygdalina 
Extract with 
highest activity 
Extract with 
lowest activity 
Extract with 
highest activity 
Extract with 
lowest activity 
Antimicrobial 
activity 
aqueous ethanol and 
methanol 
methanol aqueous 
Total phenolic 
content 
ethanol aqueous methanol ethanol 
DPPH antioxidant 
capacity 
ethanol aqueous ethanol aqueous 
FRAP antioxidant 
capacity 
methanol aqueous methanol ethanol 
Anti-haemolysis 
assay antioxidant 
capacity 
methanol aqueous methanol aqueous 
Table displays the summary of the bioactivity of C. asiatica and V. amygdalina aqueous, ethanolic and 
methanolic extracts evaluated by extracts showing the highest and lowest antimicrobial, antioxidant 
activity and total phenolic content. 
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4.10 Reverse Phase High Performance Liquid Chromatography (RP-HPLC) 
Analysis of Phenolic Compounds in Extracts of C. asiatica and V. 
amygdalina 
 
Phenolic compounds present in the medicinal plants studied were separated and 
identified by RP-HPLC using a C18 column (280 nm detection wavelength). Methanolic 
and ethanolic extracts displayed good separation.  
For C. asiatica good separation of peaks were observed and compared with 
retention time of eight standards (Table 4-12). The peaks of phenolic compounds were 
identified as chloramphenicol (peak 6) and benzoic acid (peak 7; Figure 4-19). The 
presence of the detected phenolic compounds was confirmed by spiking the samples 
with the appropriate standard (Appendix J).    
 
Table 4- 12: Retention time of standards for phenolic compounds of C. asiatica 
Peak Compound RT
a 
Area Height Area (%) Height (%) 
1 Gallic acid 4.481 2139145 80255 17.089 10.081 
2 Catechin 12.555 540913 29833 4.321 3.748 
3 Chlorogenic acid 14.539 1639647 97907 13.098 12.299 
4 Caffeic acid 15.990 3013046 206966 24.070 25.999 
5 p-coumaric acid nd nd nd nd nd 
6 Chloramphenicol 19.965 4232124 294366 33.808 36.978 
7 Benzoic acid 21.067 745940 63391 5.959 7.963 
8 Quercetin 24.071 19033 2858 0.152 0.359 
Table displays the retention time of eight commercially available standards by reverse phase high 
performance liquid chromatography (RP-HPLC). 
a
RT - Retention time of standards. nd – not detected. 
  
Table 4- 13: Retention time and concentration of phenolic compounds of major peaks of C. asiatica 
methanolic extract 
Peak 
Compound 
identified 
RTa Area Height 
Area 
(%) 
Height 
(%) 
Concentration 
(mg/100g 
d.w.)b 
Total 
phenolic 
content 
(mg 
GAE/100g 
d.w.)c 
6 Chloramphenicol 20.561 7903550 835184 73.871 79.114 46.69 738±1.76 
7 Benzoic acid 21.751 1288734 104011 12.045 9.853 43.19 94±0.42 
Table displays the peak profile of C. asiatica methanolic extract by reverse phase high performance liquid 
chromatography (RP-HPLC). Absorbance was measured at 280 nm. Results were presented as mean ± 
SD. 
a
Retention time of compounds. 
b
Concentration determined by RP-HPLC expressed as mg per g dry 
weight of extracts (mg/g d.w.). 
c
Total phenolic content determined by Folin-Ciocalteu‘s assay expressed 
as mg gallic acid equivalent per g dry weight (mg GAE/g d.w.).  
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Quantitation of the major detected peaks of C. asiatica was performed as 
described in Section 3.10.5 based on the peak profiles of standards chloramphenicol and 
benzoic acid (Table 4-12) and sample (Table 4-13). The concentration of 
chloramphenicol and benzoic acid obtained were 46.69 and 43.19 mg/ 100g dry weight 
respectively.  
The fractions corresponding to the two major peaks obtained were collected and 
the total phenolic content was determined with the Folin Coicalteu assay. The 
chloramphenicol obtained had total phenolic content of 7.38±1.76 mg GAE/g d.w. The 
benzoic acid obtained had total phenolic content of 0.94±0.42 mg GAE/g d.w. 
Retention time of peaks obtained in chromatography of V. amygdalina 
methanolic and ethanolic extract (U1, U2, U3, U4, U5, U6; Figure 4-20B, C) were 
compared with eight standards (Figure 4-20A). None of the retention time of the 
standards matched that of the sample. The phenolic compounds present in V. 
amygdalina could not be identified by RP-HPLC (Figure 4-20). 
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Figure 4- 19: Chromatogram of C. asiatica 
Chromatogram of external standards (A), C. asiatica  ethanol extract (B) and  C. asiatica methanol 
extract (C) at 280 nm absorbance.1-gallic acid, 2-catechin, 3-chlorogenic acid, 4-caffeic acid, 5-
coumaric acid, 6- chloramphenicol, 7-benzoic acid and 8-quercetin.               
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Figure 4- 20: Chromatogram of V. amygdalina 
Chromatogram of external standards (A), V. amygdalina ethanol extract (B) and V. amygdalina methanol 
extract (C) at 280 nm absorbance.1-gallic acid, 2-catechin, 3- chlorogenic acid, 4-caffeic acid, 5-coumaric 
acid, 6-chloramphenicol, 7-benzoic acid and 8-quercetin. (U1, U2, U3, U4, U5, U6) - unknown 
compounds. 
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4.11 Fourier Transform Infrared Spectroscopy (FT-IR) analysis of major peaks 
from C. asiatica.  
 
 Fourier Transform Infrared Spectroscopy (FT-IR) was performed to characterize 
the bonds and functional groups present in peak 6 (retention time – 20.56 mins) and 
peak 7 (retention time 21.75) collected from RP-HPLC analysis of C. asiatica methanol 
extract. Table 4-14 and 4-15 shows the wave number and assignment of the main bands 
observed in Figure 4-21. 
 
Table 4- 14: IR spectrum data of peak 6 from C. asiatica  
Wave number (cm-1) Bond(s) Functional group(s) 
3304.45 O–H stretch, H–bonded alcohols, phenols 
1672.93 C=C aromatic 
1065.44 C–O phenols 
980.70 =C–H bend alkenes 
858.26 C–H ―oop‖ aromatics, para-disub benzene 
Table depicts the main bands obtained by IR spectrum for peak 6 – chloramphenicol from RP-HPLC 
 
Table 4- 15: IR spectrum data of peak 7 from C. asiatica  
Wave number (cm-1) Bond(s) Functional group(s) 
3321.07 O–H stretch, H–bonded alcohols, phenols 
1671.18 C=O aromatic carboxylic acid 
1070.98 C–O phenols 
980.96 =C–H bend alkenes 
859.72 C–H ―oop‖ aromatics, para-disub benzene 
Table depicts the main bands obtained by IR spectrum for peak 7 – benzoic acid from RP-HPLC 
  
The FT-IR of peak 6 consisted of 6 peaks (Figure 4-21A). Of that 5 peaks were 
characteristics of chloramphenicol (Table 4-14). The peaks were 3304.45, 1672.93, 
1065.44, 980.70 and 858.26cm
-1
. The FT-IR of peak 7 consisted of 7 peaks (Figure 4-
21B). Of that 5 peaks were characteristics of benzoic acid (Table 4-15). The peaks were 
3321.07, 1671.18, 1070.98, 980.96 and 859.72 cm
-1
.   
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Figure 4- 21: FT-IR Spectrum of C. asiatica major peaks 
Fourier Transform Infrared Spectroscopy (FT-IR) of C. asiatica peak 6 – chloramphenicol (A) and peak 
7- benzoic acid (B) and their respective molecular structures. 
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4.12 Identification of Phenolic Compounds in Methanolic Extract of C. asiatica and 
V. amygdalina by Liquid Chromatography-Mass Spectroscopy (LC-MS) 
  
Liquid chromatography (LC) coupled to negative and positive electrospray 
ionization (±ESI) mass spectrometry (MS) was used for the identification of phenolic 
compounds in the methanolic extract of C. asiatica and V. amygdalina. Table 4-16 and 4-
17 summarizes the acquired time, molecular weight, molecular formula and the mass 
spectra with their respective ionization mode of the compounds identified. The total ion 
chromatogram (TIC) and the electrospray ionisation-mass spectra in the positive mode 
(+ESI-MS) for the major peak are displayed in Figure 4-22. The +ESI-MS and –ESI-MS 
spectra of all the phenolic compounds identified with their respective molecular structure 
are shown in Appendix K. 
LC-MS analysis revealed the presence of thirty eight phenolic compounds in the 
methanolic extract of C. asiatica. Among them were theobromine, isorhamnetin-3-O-
rutinoside, rhamnetin-O-rutinoside, syringic acid and naringin were. Chloramphenicol and 
benzoic acid which had been previously identified by RP-HPLC were also detected by LC-
MS (Table 4-16). 
In the methanolic extract of V. amygdalina, forty phenolic compounds were 
detected when analysed using LC-MS. Among them were syringic acid, phloridzin, 
dicaffeoylquinic acid, rhamnetin-O-rutinoside, feruloylquinic acid and rutin (Table 4-17). 
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Table 4- 16: Phenolic compounds identified in methanolic extract of C. asiatica by LC-MS 
Compound Identified RT
a
 
(min)
 
MW
b 
ESI-MS m/z 
(+/−) 
Abundance
c
 
(%) 
MF
d 
Gallic acid derivatives 
5-galloylquinic acid 0.623 344.3 343.9901 (−) 14.17 C14H16O10 
Hydroxybenzoic acid 
Syringic acid 0.315 198.17 197.8091 (−) 25.16 C9H10O5  
Ellagic acid pentoside 1.162 434.0 435.2061 (+) 6.63 C19H14O12 
Hydroxybenzoic acid-O-hexoside 30.229 300 301.1415 (+) 20.65 C13H16O8 
Protocatechuic acid/ 
3,4-Dihydroxybenzoic acid 
37.822 154.12 153.8673 (−) 12.73 C7H6O4 
Methyl gallate 38.579 184.15 183.9348 (−) 9.8 C8H8O5 
Hydroxycinnamic acid 
Caftaric acid 1.126 312.23 313.1412 (+) 5.56 C13H12O9 
Sinapic acid 1.262 224.21 223.8468 (−) 5.63 C11H12O5 
Ferulic acid 38.262 194.18 195.1279 (+) 5.04 C10H10O4 
Hydroxycinammate quinic esters 
Dicaffeoylquinic acid 1.055 516.45 517.9470 (+) 8.55 C25H24O12 
Caffeoylquinic acid 1.191 354.31 353.0879 (−) 5.82 C16H18O9 
Coumaroylquinic acid 38.155 338.31 339.3445 (+) 18.91 C16H18O8 
Feruloylquinic acid 38.191 368.34 369.2952 (+) 9.89 C17H20O9 
Flavan-3-ols 
(-)-Gallocatechin 1.333 306.27 305.0695 (−) 8.82 C15H14O7 
(-)-Gallocatechin gallate 38.191 458.37 459.2932 (+) 5.73 C22H18O11 
Flavonol and flavonol glycosides 
Rutin 0.949 610.52 611.3295 (+) 9.27 C27H30O16 
Isorhamnetin-3-O-glucoside 1.126 478.4 479.2369 (+) 8.61 C22H22O12 
Isorhamnetin-3-O-rutinoside 1.162 624.54 625.2829 (+) 38.23 C28H32O16 
Quercetin-3-O-glucuronide 1.162 478.36 479.2386 (+) 8.28 C21H18O13 
Rhamnetin-O-rutinoside 1.162 624.54 625.2829 (+) 38.23 C28H32O16 
Cirsimaritin 1.162 314.29 315.1560 (+) 6.52 C17H14O6 
(±)-Taxifolin 1.162 304.25 305.1554 (+) 7.09 C15H12O7 
Phloridzin 1.197 436.41 437.2345 (+) 12.99 C21H24O10 
Myricetin 1.262 318.24 317.0846 (−) 13.01 C15H10O8 
Acacetin / Methyl apigenin 1.446 284.26 285.2887 (+) 7.11 C16H12O5 
Chrysin 1.569 254.24 253.8795 (−) 6.28 C15H10O4 
Kaempferol 15.034 286.24 285.0749 (−) 5.8 C15H10O6 
Apigenin-7-O-glucoside 20.181 432.38 431.1807 (−) 12.94 C21H20O10 
Quercetin 3-O-rhamnoside 28.265 448.38 449.2850 (+) 7.26 C21H20O11 
Quercetin-3-O-glucoside 28.159 464.38 465.2626 (+) 9.58 C21H20O12 
Isorhamnetin 30.300 316.26 317.1147 (+) 10.5 C16H12O7 
Flavanone and flavanone glycosides 
Naringin 1.162 580.54 581.2579 (+) 24.9 C27H32O14 
Luteolin-7-O-glucoside 28.123 448.38 449.2856 (+) 6.31 C21H20O11 
Purine alkaloids 
Theobromine 1.131 180.16 181.0716 (+) 53.99 C7H8N4O2 
Phenolic terpenes and lignin 
Rosmadial 0.481 344.40 343.9946 (−) 14.69 C20H24O5 
Medioresinol 1.162 388.41 389.0855 (+) 13.59 C21H24O7 
Others 
Chloramphenicol 23.387 323.13 322.2112 (−) 9.94 C11H12Cl2N2O5 
Benzoic acid 35.387 122.12 123.0697 (+) 13.53 C7H6O2 
Table displays the phenolic compounds identified in the methanolic extract of C. asiatica analysed by Liquid 
Chromatography-Mass Spectroscopy (LC-MS Q-TOF). The analysis was performed with an Electrospray 
Ionisation (ESI-MS) source in negative and positive mode. 
a
RT - Retention time; 
b
MW - Molecular weight; 
Abundance
c 
 - Relative abundance of the major ion and 
d
MF - Molecular formula of the compounds identified. 
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Table 4- 17: Phenolic compounds identified in methanolic extract of V. amygdalina by LC-MS 
Compound Identified RT
a
 
(min)
 
MW
b 
ESI-MS m/z 
(+/−) 
Abundance
c
 
(%) 
MF
d 
Gallic acid derivatives 
5-galloylquinic acid 0.584 344.3 343.9918 (−) 11.17 C14H16O10 
Hydroxybenzoic acid 
Syringic acid 0.039 198.17 197.8067 (−) 100 C9H10O5  
Ellagic acid pentoside 1.116 434.0 433.2060 (−) 9.98 C19H14O12 
Methyl gallate 1.589 184.15 183.8496 (−) 5.42 C8H8O5 
Vanillic acid 57.427 168.15 169.0865 (+) 5.30 C8H8O4 
Protocatechuic acid/ 
3,4-Dihydroxybenzoic acid 
57.447 154.12 153.8703 (−) 5.93 C7H6O4 
Hydroxycinnamic acid 
trans-Cinnamic acid 0.393 148.16 149.9509 (+) 5.19 C9H8O2 
Sinapic acid 0.442 224.21 223.8542 (−) 5.05 C11H12O5 
Ferulic acid 0.584 194.18 193.8159 (−) 5.41 C10H10O4 
p-Coumaric acid 0.631 164.16 163.8459 (−) 11.23 C9H8O3 
Caftaric acid 18.828 312.23 311.1666 (−) 11.59 C13H12O9 
Caffeic acid 58.019 180.16 181.1657 (+) 5.7 C9H8O4 
Hydroxycinammate quinic esters 
Dicaffeoylquinic acid 1.069 516.45 515.1231 (−) 35.08 C25H24O12 
Caffeoylquinic acid 1.234 354.31 353.0885 (−) 20.17 C16H18O9 
Feruloylquinic acid 11.528 368.34 367.0509 (−) 28.31 C17H20O9 
Coumaroylquinic acid 60.953 338.31 339.3429 (+) 8.63 C16H18O8 
Flavan-3-ols 
(+)-Catechin/(−)-Epicatechin 1.115 290.27 291.1301 (+) 5.94  
(-)-Gallocatechin gallate 1.174 458.37 459.2540 (+) 11.29 C22H18O11 
(-)-Gallocatechin 59.214 306.27 307.1580 (+) 5.32 C15H14O7 
Flavonol and flavonol glycosides 
Quercetin 3-O-rhamnoside 1.104 448.38 447.0979 (−) 19.15 C21H20O11 
Rutin 1.115 610.52 611.3310 (+) 27.15 C27H30O16 
(±)-Taxifolin 1.115 304.25 305.1595 (+) 8.01 C15H12O7 
Isorhamnetin-3-O-glucoside 1.115 478.40 479.2425 (+) 9.72 C22H22O12 
Isorhamnetin-3-O-rutinoside  1.115 624.54 625.2916 (+) 25.14 C28H32O16 
Phloridzin 1.127 436.41 437.2339 (+) 52.84 C21H24O10 
Rhamnetin-O-rutinoside 1.174 624.54 625.2845 (+) 34.47 C28H32O16 
Cirsimaritin 1.174 314.29 315.1573 (+) 5.01 C17H14O6 
Apigenin-7-O-glucoside 1.175 432.38 431.1784 (−) 13.88 C21H20O10 
Chrysin 3.932 254.24 253.8765 (−) 6.68 C15H10O4 
Flavanone and flavanone glycosides 
Neohesperidin 1.115 610.56 611.8362 (+) 9.89 C28H34O15 
Naringin 1.115 580.54 581.2676 (+) 15.86 C27H32O14 
(±)-Naringenin 1.175 272.25 271.1044 (−) 17.48 C15H12O5 
Luteolin-7-O-glucoside 1.234 448.38 447.0985 (−) 14.45 C21H20O11 
Luteolin 8.759 286.24 285.0799 (−) 5.22 C15H10O6 
Hesperitin 58.681 302.28 303.1537 (+) 5.51 C16H14O6 
Resveratrols 
trans-Resveratrol/cis-Resveratrol 1.175 228.24 227.0768 (−) 23.56 C14H12O3 
Purine alkaloids 
Theobromine 59.545 180.16 181.1695 (+) 7.79 C7H8N4O2 
Phenolic terpenes and lignin 
Rosmadial 0.607 344.40 343.9953 (−) 18.7 C20H24O5 
Methyl carnosate 61.426 346.46 347.1727 (+) 6.62 C21H30O4 
Epirosmanol 62.455  346.42 347.1721 (+) 5.84 C20H26O5 
Table displays the phenolic compounds identified in the methanolic extract of V. amygdalina analysed by 
Liquid Chromatography-Mass Spectroscopy (LC-MS Q-TOF). The analysis was performed with an 
Electrospray Ionisation (ESI-MS) source in negative and positive mode. 
a
RT - Retention time; 
b
MW - 
Molecular weight; Abundance
c 
 - Relative abundance of the major ion; and 
d
MF - Molecular formula of the 
compounds identified. 
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Figure 4- 22: Total Ion Current (TIC) chromatogram of C. asiatica (A) and V. amygdalina (B) 
methanolic extract by LC-ESI-MS analysis 
Figure displays the TIC chromatogram of the phenolic compounds detected in the methanolic extract of C. 
asiatica and V. amygdalina by LC-MS Q-TOF with an Electrospray Ionisation (ESI-MS) source in the 
positive mode. Inset is the Electrospray ionization–mass spectra (ESI-MS) positive ionization for the major 
peak of each extract at retention time 1.138 and 1.115 respectively. 
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5.0 DISCUSSION 
5.1 Choice of Plant Used in the Study 
 
Based on traditional folklore medicine (Anbarashan et al., 2011), chemotaxonomic 
approach and by random selection (Jantan, 2004), six medicinal plants  Aloe vera (leaf and 
gel), Azadirachta indica (leaf), Carica papaya (leaf), Centella asiatica (whole plant), 
Hymenocallis speciosa (leaf, tuber and root) and Vernonia amygdalina (leaf and stem) were 
selected.  
These plants and their parts were chosen specifically because (i) A. vera leaf and gel 
were reported to possess wound healing properties (Anbarashan et al., 2011; Kumar et al., 
2010).  
(ii) A. indica leaf has antibacterial properties (Almas, 1999) and have been used to 
cure various skin disorders (Anbarashan et al., 2011).  
(iii) The leaf of Carica papaya was proven to treat dengue fever in the tropics 
(Ahmad et al., 2011).  
(iv) The whole plant of C. asiatica was widely used in folklore medicine and had a 
wide range of health benefits such as  improving memory, curing skin disorders and in the 
wound healing process (Duke, 2010; Hargono et al., 1999). It belongs to the Apiaceae 
family which comprises of important medicinal plants such as coriander and fennel (Gurib-
Fakim, 2006), thus the same active biological compounds may be present in C. asiatica 
(Eloff & McGaw, 2006). 
(v) H. speciosa was selected because it had been used to cure jaundice in Malaysian 
folklore medicine (Azliza et al., 2012). Furthermore it belongs to the Amaryllidaceae 
family which possess bioactive compounds such as amaryllidaceae alkaloids that display 
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antimalarial activity (Şener et al., 2003). The tuber and root were chosen because in 
general, underground plant parts were found to possess bioactive compounds with 
antimicrobial properties compared to other aerial parts of plants (Das et al., 2010). 
Furthermore, these plant parts have not been studied for H. speciosa to the best of our 
knowledge and the antimicrobial properties have not been evaluated.  
(vi) The leaf and stem of V. amygdalina were selected because it had been reported 
to possess high antidiabetic and antimicrobial properties (Akinpelu, 1999; Ekpenyong et 
al., 1999). The main purpose for selecting these plants was because of their antimicrobial 
trait due to the secondary metabolites in these plants which may be significant in 
therapeutic treatments. 
 
5.2 Extraction Yield and Antimicrobial Activity of the Medicinal Plants Screened 
 
The percentage yield was highest for ethanolic extract H. speciosa root because it 
was homogenized to a fine powder with the absence of fibre. This was followed by 
ethanolic extract of A. vera gel because it has high water content of 99.5% (Eshun & He, 
2004). The difference in extraction yield ascribes to the difference in extractable 
compounds based on the different bioactive compounds found in the plants and different 
types of solvent possess varying extraction capabilities.  
The antimicrobial susceptibility test is important to determine efficiency of novel 
antimicrobial agent isolated from biological samples against various microorganisms (Das 
et al., 2010). In this study, the screening of the selected plants was based on their 
antimicrobial property which was determined by well diffusion assay. Both Gram-negative 
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bacteria (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive bacteria 
(Bacillus cereus, Staphylococcus aureus, and Streptococcus mutans) were selected due to 
the following reasons:  
(i) Gram-negative bacteria were more resistant to antimicrobials due to the presence 
of an additional outer membrane layer (Alberts et al., 2002) and they make up most plant 
pathogens. In general, purified plant bioactive compounds display low antimicrobial 
activity towards Gram-negative bacteria (González-Lamothe et al., 2009). 
 (ii) E. coli was selected because it is easily cultured in the laboratory, well 
characterized, found in a wide range of hosts and acquires resistance to antimicrobial agents 
easily (Erb et al., 2007; Welch, 2006).  
(iii) P. aeruginosa is resistant to antibiotics due to the lipopolysaccharide layer and 
forms biofilm to colonize surfaces. It is a notorious pathogen that may be potentially 
inhibited by antimicrobial agents of plant origin (Kim et al., 1995; Iinuma et al., 1994).  
(iv) B. cereus is a soil bacterium and can be easily transmitted into food products, 
hence infecting the human intestine (Vilain et al., 2006). It is resistant to a wide array of 
antimicrobials including clindamycin, cefazolin, cefotaxime, cephalosporin and penicillin 
(Bottone, 2010).  
(v) S. aureus was chosen because it is a commensal in humans and develops 
resistance to antibiotics easily (Rasigade & Vandenesch, 2013).  
(vi) The oral bacterium S. mutans was chosen because it invades the oral cavity and 
is known to cause dental caries (Loesche, 1986). Some of the medicinal plants in this study 
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such as A. vera and A. indica, were known to inhibit oral bacteria that cause gum diseases 
(Kumar et al., 2010; Ajik, 1990).   
Well diffusion assay with the aqueous extract revealed that C. asiatica significantly 
inhibited all the five microbial strains while the other medicinal plants did not inhibit any of 
the test microorganisms. However ethanolic extracts displayed stronger antimicrobial 
activities. The ethanolic extracts of C. asiatica inhibited all the test microorganism and 
ethanolic extract of V. amygdalina leaf significantly inhibited B. cereus. Slight inhibition 
was recorded for the ethanolic extracts of A.vera gel against B. cereus and S. aureus; A.vera 
leaf against B. cereus and E. coli; and H. speciosa leaf against B. cereus and P. aeruginosa 
but the inhibition was insignificant.  
Previous studies have reported the inhibition of A. vera gel and leaf extracts against 
S. aureus, P. aeruginosa (Agarry et al., 2005), and E.coli (Kaithwas et al., 2008). However 
Alemdar and Agaoglu (2009) reported similar results to this study in A. vera juice which 
failed to inhibit these microorganism. A. indica extract was reported to inhibit S. mutans 
(Biswas et al., 2002), P. aeruginosa, S. aureus and E. coli (Abdullah Al et al., 2011). 
Ethanolic extract of Carica papaya leaf was reported to inhibit E. coli, B. cereus, P. 
aeruginosa and S. aureus (Baskaran et al., 2012). No antimicrobial activity has been 
reported for extracts of H. speciosa.  
 Dash et al. (2011) reported higher inhibition of C. asiatica ethanolic extract towards 
E. coli and S. aureus compared to aqueous extract which was in contrary with the results in 
this study and Kannabiran et al. (2009) reported slight inhibition of aqueous extract and no 
inhibition with ethanolic extract against P. aeruginosa. The leaf sap of V. amygdalina, was 
reported to inhibit S. aureus, E. coli, and P. aeroginosa (Ijeh et al., 1996), while the 
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methanolic leaf extract inhibited P. aeruginosa, and S. aureus (Akinpelu, 1999) Vernolide 
and vernodalol isolated from the plant was reported to inhibit Bacillus cereus and S. aureus 
(Erasto et al., 2006). 
 The difference in findings between this study and previous studies are difficult to be 
compared to because different methodologies such as extract, extraction technique, test 
microorganism and choice of antimicrobial test were employed (Weerakkody et al., 2010; 
Nostro et al., 2000; Hammer et al., 1999). However, the antimicrobial susceptibility test in 
this study followed all the standards of the Clinical and Laboratory Standards Institute 
2007). Screening of various plant species confirmed the therapeutic potency of C. asiatica 
and V. amygdalina as used in traditional medicine. These findings were the basis for 
choosing C. asiatica and V. amygdalina as candidate plant species for the determination of 
the bioactive constituents present.  
The type of solvent used could greatly affect the antimicrobial activity in the plants. 
Most plant antimicrobial are aromatic or saturated organic compounds, therefore the most 
effective solvents used for preliminary screening of plant antimicrobial activity are 
methanol, ethanol and water (Parekh et al., 2006; Rojas et al., 2006; Lourens et al., 2004; 
Bisignano et al., 1996; Salie et al., 1996). For C. asiatica and V. amygdalina, methanol 
extraction was also included and the results between extracts were compared. Aqueous 
extracts of C. asiatica possess greater zone of inhibition compared to ethanolic and 
methanolic extracts. Ethanolic and methanolic extracts exhibited similar inhibition at 
corresponding plant extract concentration. Aqueous extraction was chosen because most 
traditional medicines used water as solvent to dissolve the traditional preparations (Das et 
al., 2010) and this study revealed that aqueous extract of C. asiatica have strong 
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antimicrobial activity. This result proved the presence of water soluble bioactive 
compounds active against the tested microorganisms in C. asiatica.  
C. asiatica plant extracts displayed antimicrobial activity towards both Gram-
positive and Gram-negative bacteria that possess an outer layer making it a strong 
antibacterial plant. The most susceptible bacteria amongst the bacterial strains investigated 
in this study was S. mutans. Hence this plant may be useful as an oral antibacterial agent 
and can be incorporated into mouthwashes and toothpastes. C. asiatica extracts also had 
significantly greater levels of inhibition on P. aeruginosa compared to the positive control 
tetracycline. P. aeruginosa is a nosocomial pathogen that easily acquires resistance towards 
antibacterial agents (Morita et al., 2014). Thus C. asiatica may be an effective agent to 
control this nosocomial pathogen. The usage of this plant in wound healing and healing 
skin disorders in folklore was shown to be correct since this plant extract possess 
antimicrobial compounds which can inhibit pathogens.  
The aqueous extracts of V. amygdalina exhibited no antimicrobial activity, however 
strong inhibition was observed in ethanolic and methanolic leaf extracts. This finding was 
in agreement with previous study by Parekh et al. (2005), whereby organic solvent extracts 
provide better antimicrobial activity compared to water extracts. The antimicrobial 
compounds from V. amygdalina dissolved in polar solvents. Most plant antimicrobial 
compounds are aromatic or saturated organic compounds that are extracted by ethanol or 
methanol (Serkedjieva & Manolova, 1992). The methanolic and ethanolic extracts were 
more active against Gram-positive microorganisms compared to Gram-negative 
microorganisms in agreement with previous studies (González-Lamothe et al., 2009; 
Alberts et al., 2002). B. cereus, a foodborne pathogen was found to be most susceptible 
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towards methanolic leaf extract proving the folklore usage of this plant in treating 
gastrointestinal disorders (Aregheore et al., 1998). 
The yield of C. asiatica was slightly higher in aqueous extracts and almost similar 
between ethanolic and methanolic extracts in agreement with the antimicrobial results that 
aqueous extracts showed better inhibitory activity between the three extracts ethanolic and 
methanolic extracts display similar inhibition. Similar results were obtained in V. 
amygdalina, whereby the methanolic and ethanolic extracts displayed higher yield and 
aqueous extract displayed lowest yield in agreement with the antimicrobial results obtained. 
This indicated that the solvent used played a major role in extracting the bioactive 
compounds such as antimicrobial compounds present in the plant.  
 
5.3 Authentication of the Medicinal Plants in the Study 
 
When utilizing medicinal benefits from plants, it is important that the medicinal 
compound is prepared from the correct and authenticated plant species. A rapid and reliable 
method used to authenticate plant samples is by DNA barcoding method through sequence 
comparison of the ITS2 region (Chen et al., 2010; Shiba et al., 2006; Lau et al., 2001; Zhao 
et al., 2001). Variation between species can be distinguished with nucleotide sequencing of 
the ITS2 region whereby sequence identities between the unknown plant and the sequence 
from the Genbank is capable of identifying species.  
BLAST search of the unidentified medicinal plant CA and VA was determined as 
Centella asiatica and Vernonia amygdalina respectively when compared with sequences 
from the Genbank, each with at least 99% identity.    
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5.4 Antimicrobial Activity after Ammonium Sulphate Precipitation of Ethanolic 
Extracts 
 
Various studies have shown that plant defence mechanism against pathogen is by 
secondary metabolites or antimicrobial peptides (Feng et al., 2003). The antimicrobial 
activity reported in the whole plant extract of C. asiatica and leaf extract of V. amygdalina 
was tested to determine if it was due to the presence of secondary metabolites or 
antimicrobial peptides in the plant by performing 100% ammonium sulphate precipitation 
of the plant ethanolic extract. 
 Based on the result, the supernatant obtained after ammonium sulphate precipitation 
of C. asiatica ethanolic extract displayed high antimicrobial activity against B. cereus, E. 
coli, P. aeruginosa and S. aureus while no activity was displayed against S. mutans. The 
pellet of ammonium sulphate precipitate showed relative insignificant activity against E. 
coli and P. aeruginosa, while no activity was observed against B. cereus, S. aureus and S. 
mutans. 
 Similarly, the supernatant of V. amygdalina leaf ethanolic extract after ammonium 
sulphate precipitation exhibited antimicrobial activity against B. cereus while the pellet 
exhibited insignificant activity against B. cereus. No inhibitory activity was observed for 
both the pellet and supernatant against the other test microorganism. Thus this study found 
that the antimicrobial activity was prominent in the supernatant for both C. asiatica and V. 
amygdalina extracts. Hence, antimicrobial compounds present in the plant were due to 
secondary metabolites and not peptides.   
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5.5 Total phenolic content (TPC) 
 
 Phenolic compounds are secondary metabolites present in all plants. Structurally 
phenolic compound comprises of an aromatic ring with one or more hydroxyl groups 
(Michalak, 2006). Phenolic compounds contribute towards many biological effects such as 
antioxidant, antimicrobial and anti-haemolysis activity (Middleton et al., 2000; Osawa, 
1994). In this study, the antimicrobial activities of C. asiatica and V. amygdalina extracts 
were attributed to the phenolic compounds present in the plant as reported by Gurjar et al. 
(2012) when the supernatant of ammonium sulphate precipitation showed antimicrobial 
activity. 
Antioxidant activity of phenolic compounds is based on the redox properties that 
scavenge free radicals, decompose peroxides and quench singlet and triplet oxygen (Osawa, 
1994). The number and configuration of the hydroxyl functional group are the main 
features that determine the antioxidant capacity of phenolic compound in medicinal plants 
(Pannala et al., 2001; Cao et al., 1997). Therefore, it is crucial to study the TPC in plants as 
phenolics with natural antioxidant are potential therapeutic agents of various ailments such 
as cancer, neurodegenerative diseases, diabetes, cardiovascular dysfunctions, inflammatory 
diseases and aging.  
The Folin-Ciocalteu method was used to determine the TPC in the plants. TPC was 
expressed as milligram gallic acid equivalent per g dry weight (mg GAE/g d.w). The Folin 
reagent produced a blue coloured complex when reacted with phenols which can be 
quantified spectrophotometrically (Slinkard & Singleton, 1977). In this study, the highest 
amount of polyphenols (4.006 mg GAE/g d.w.) were found in the ethanolic extract of the 
whole plant of C. asiatica which was slightly lower than the amount earlier reported by 
Andarwulan et al. (2010) (5.82 mg GAE/g d.w.) and much lower than the amount reported 
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by Wongsa et al. (2012) (52.5 mg GAE/g d.w.). Previously, the TPC in the whole plant 
extracted using methanol reported by Guleria et al. (2013) (27.43 mg GAE/g d.w.) was 
much higher than found in the methanolic extracts in this study. However in another study, 
Wongsa et al. (2012) reported a much lower TPC (1.4 mg GAE/g d.w.) comparable to this 
study. A low amount of phenolic content had been recorded in the aqueous extract which 
was consistent with this study (Wongsa et al., 2012).  
The three extracts of the leaf of V. amygdalina displayed similar TPC with the 
highest of them being the methanolic extract. Previous studies showed similarly low TPC in 
ethanolic and aqueous extracts (3.97 and 2.71 mg GAE/g d.w.) respectively (Audu et al., 
2012). However higher TPC value was recorded by Fasakin et al. (2011) in ethanolic (8.2 
mg GAE/g d.w.) and methanolic (14.8 mg GAE/g d.w.) extracts contrasting with the results 
of this study.  
Generally the TPC of V. amygdalina was found to be lower than C. asiatica which 
may explain better antimicrobial activity displayed by C. asiatica. C. asiatica had higher 
phenolic content compared to methanolic extracts of medicinal plants such  as Alpinia 
oxyphylla, Asparagus cochinchinensis, Astragalus membranaceus, Atractylodes 
macrocephala,  Dendrobium nobile, Dioscorea opposite,  Lilium brownii, Morinda 
officinalis, Ophiopogon japonicas, Polygonatum odoratum and Tremella fuciformis (Wong, 
Li, et al., 2006) and ethanolic extracts of vegetables such as Apium graveolens (leaf celery), 
Justica gendarussa (willow-leaved justice), Kaempferia galanga (chinese ginger), 
Micromelum minutum (lime berry), Morinda elliptica (indian mulberry), Ocimum basilicum 
(basil), Vigna sinensis (long beans) and Vigna radiate (mung bean sprout) (Sulaiman et al., 
2011). 
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5.6 Antioxidant Activity in the Plant of Study 
 
 Antioxidant activity present in the plant must be determined to evaluate if it is 
related to the phenolic compounds present in the plant. More than one antioxidant assay 
was employed to measure the antioxidant activity present to take into account the different 
modes of actions of antioxidants present in the plant extracts related to difference in 
chemical structure and complexity of the antioxidants (Huang et al., 2005; Prior & Cao, 
1999). In this study DPPH (2, 2-diphenyl-1-picrylhydrazyl) radical scavenging activity 
assay, Ferric Reducing Antioxidant Power (FRAP) Assay and hydrogen peroxide (H2O2) 
induced haemolysis assay were performed to determine the antioxidant activity in C. 
asiatica and V. amygdalina. 
 
5.6.1 DPPH (2, 2-diphenyl-1-picrylhydrazyl) Radical Scavenging Activity Assay 
 
 DPPH radical scavenging assay is the most common method used to evaluate 
antioxidant activity because it is simple and rapid. The mechanism of radical scavenging 
activity employed in this assay is via the hydrogen atom donated by phenolic compounds 
with antioxidant activity which binds to the purple coloured DPPH thus reducing DPPH 
which turns yellow in colour (Gulcin et al., 2007). Antioxidant activity was measured by 
comparing the inhibition of phenols to Trolox and expressed as milimole Trolox equivalent 
per gram dry weight sample (mmol TE/g d.w.). The greater scavenging activity of the plant 
extracts, higher antioxidant capacity was displayed. 
 From the experimental data, all extracts of C. asiatica showed scavenging activity 
towards DPPH. The highest scavenging activity and antioxidant capacity was observed 
with the ethanolic extract which was comparable to ascorbic acid but was much higher than 
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with BHT. Ethanolic extract showed the lowest IC50. Antioxidant capacity of methanolic 
extract was comparable to ethanolic extract. Aqueous extract displayed the lowest 
scavenging activity with little antioxidant capacity. These results were in agreement with 
those of Hamid et al. (2002).  
However, ethanolic and methanolic extracts of V. amygdalina leaf displayed radical 
scavenging activity which was lower compared to that of C. asiatica. The aqueous extract 
showed apparently no antioxidant capacity. This result was in agreement with the findings 
of Anyasor et al. (2010). The IC50 was very high for all the extracts of V. amygdalina, 
displaying the weak antioxidant activity of this plant. 
Based on this assay, phenolic compounds with antioxidant activity was better 
extracted by ethanol/methanol compared to water for both the plants of study. This property 
was also observed by Hamid et al. (2002). A common pattern of inhibition towards DPPH 
was observed amongst all the extracts for both the plants where a steady increase in 
inhibition was followed by a much slower increase with a levelling off. This general pattern 
was found to be common in plant extracts (Razali et al., 2008; Kumaran & Karunakaran, 
2007). However, aqueous extracts of V. amygdalina did not follow the same pattern 
because it possessed weak radical scavenging activity and higher concentration of this 
extract is required to display significant results.   
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5.6.2 Ferric Reducing Antioxidant Power (FRAP) Assay 
 
 FRAP assay involves the reduction of the almost colourless ferric tripyridyl triazine 
(Fe(III)-TPTZ) complex to a blue coloured ferrous (Fe(II)-TPTZ) complex by antioxidants 
present in the plant extracts. The assay is by monitoring the change in absorbance at 593 
nm. This assay is used to evaluate the reducing power of samples where the greater the 
antioxidants present in the plant extract, the greater the intensity of the blue colour 
formation and hence higher the absorbance. 
 The reaction of the samples and standards were measured at an interval of 15 
seconds for 4 minutes. The antioxidant capacity of the extracts and standards were 
measured by comparison with a ferrous sulphate (FeSO4.7H2O) standard curve and 
expressed as milimole ferrous sulphate per gram of dry weight (mmole Fe
2+
/g dry weight). 
A linear pattern was observed for absorbance of the controls and extracts with 
regards to time. The absorbance of all the extracts of C. asiatica, V. amygdalina and 
standards reached a plateau by the fourth minute of incubation indicating there was no 
further increase in the reduction of ferric ions.  
 At 1.0 mg/ml concentration, methanolic and ethanolic extracts of C. asiatica 
showed rapid reaction with high absorbance within the 4 minute reaction time (0.466±0.012 
AU at 0 seconds to 0.555±0.012 AU at 4 minutes) and (0.421±0.011 AU at 0 seconds to 
0.502±0.014 AU at 4 minutes) respectively. Antioxidant capacity was highest in the 
methanolic extract. The antioxidant capacity was lower than previous reports by 
Malinowska (2013) who showed  high antioxidant capacity of C. asiatica extracted from 
commercial cosmetic (1.02 mg Fe
2+
/g d.w) and Guleria et al. (2013) who showed high 
antioxidant capacity in 80% methanolic extract (22.5 mg Fe
2+
/g d.w.). The aqueous extract 
in this study displayed low antioxidant activity in agreement with the findings of Wong et 
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al. (2006) and Reihani and Azhar (2012). The antioxidant capacities of all extracts were 
higher than ascorbic acid, but lower than BHT (Table 4-7).   
 The methanolic extract of V. amygdalina possesses the highest absorbance 
compared to other extracts (0.142±0.020 AU at 0 seconds to 0.222±0.012 AU at 4 minutes) 
at 1.0 mg/ml concentration. The highest antioxidant capacity was recorded for the 
methanolic extract while the lowest was for the aqueous extract. All extracts had higher 
antioxidant capacity than ascorbic acid but lower than BHT (Table 4-8). Oriakhi et al. 
(2014) reported FRAP antioxidant capacity value in the ethanolic extract of V. amygdalina 
to be two times higher than in this study. The difference in result could be due to the 
extraction technique used or the plant growth conditions met.  
Overall the extracts of C. asiatica showed higher FRAP antioxidant capacity 
compared to extracts of V. amygdalina suggesting that C. asiatica is a more potent 
antioxidant. This study shows methanol was a better extractant of phenolic compounds 
possessing antioxidant activity. 
The methanolic extract of C. asiatica was shown to possess good reducing 
capabilities such that it was able to donate electrons to free radicals. Hence in actual 
biological systems, this extract may be useful as a natural remedy in the treatment of free 
radical related diseases such as cancer, diabetes, arthritis, and acceleration of the ageing 
process (Shahidi, 1997). 
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5.6.3 Protective Effects of the Plant of Study against Hydrogen Peroxide Induced 
Red Blood Cell Lysis  
 
 Hydrogen peroxide (H2O2) a reactive compound formed from superoxide, can 
inactivate enzymes in the body. It easily diffuses across the cell membrane and reacts with 
Fe
2+
 or Cu
2+
 forming the hydroxyl radicals which reacts with macromolecules in the body 
resulting in cellular stress which is the root cause of many diseases (Bhatia et al., 2011; 
Sebastia et al., 2006). Therefore, it is important to evaluate compounds that can scavenge 
the H2O2 and control their accumulation in the cell for the benefit of health and wellbeing.  
In this study the erythrocytes cell membranes were used to determine oxidative 
damage because they are susceptible to oxidation and are targets of oxidizing agents. 
Erythrocytes generate reactive oxygen species because its membrane has a high 
concentration of polyunsaturated fatty acids. Furthermore, it contains redox active 
haemoglobin molecules involved in the transport of oxygen (Shalini et al., 2009). 
Haemoglobin exposed to H2O2 causes degradation of haem, which results in the release of 
iron ions forming light yellow colour that can be measured at 540 nm. The greater the 
protective effect of the plant extracts, the lower the absorbance measured. Antioxidant 
capacity was determined in comparison with ascorbic acid and expressed as milimole 
ascorbic acid equivalent per gram dry weight plant sample (mmol AAE/g d.w.). 
Firstly it was discovered that extracts of both C. asiatica and V. amygdalina pre-
incubated with erythrocytes did not exhibit any lytic effect on the red blood cells. In fact, it 
was discovered that both the plants showed protective effect against H2O2 induced 
haemolysis. Maximal protective effect and antioxidant capacity in both C. asiatica and V. 
amygdalina was found in methanolic extract which was higher than that of ascorbic acid 
indicating that the compounds extracted with methanolic extract are potent anti-haemolytic 
agent(s). The protective effect against haemolysis was in a dose dependent pattern for 
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methanolic and ethanolic extracts. Aqueous extracts did not follow a dose dependent 
pattern and displayed varying protective effects against extract concentration showing it to 
be a weak extractant of anti-haemolytic agents in both the plants.    
In this study, different concentrations of H2O2 (10 mM and 50 mM) were tested and 
in both C. asiatica and V. amygdalina, aqueous extracts against 50 mM H2O2 displayed 
lower protective effects than against 10 mM H2O2 and ethanolic extracts showed similar 
protective effect against both the concentration of H2O2. However, methanolic extract 
displayed higher protective effect against 50 mM H2O2 compared to 10 mM H2O2. Aqueous 
extracts were weak antioxidants and displayed lower protective effect. The strongest 
antioxidant activity was in the methanolic extract that displayed stronger protective effect 
against higher concentration of H2O2.  
Previous studies such as on red wine and mango peel showed protective properties 
against H2O2 induced erythrocyte haemolysis (Ajila & Rao, 2008; Tedesco et al., 2001). 
However some plants such as Allium stracheyi promote haemolysis of erythrocyte due to 
the oxidative reaction of phenols (Mukherjee & Rajasekaran, 2010; Bukowska & 
Kowalska, 2004). Thus measuring haemolytic activity in plant extracts is important in 
toxicological evaluation (Gandhi & Cherian, 2000). From this study, phenolic compound in 
both the plants were shown not to cause harmful effects on haemoglobin. C. asiatica and V. 
amygdalina possessed compound to effectively scavenge H2O2 before it could affect the 
erythrocytes and thus are safe to be utilized as pharmacological applicants. This study is 
also the first to report protective effect of C. asiatica whole plant extracts and V. 
amygdalina leaf extracts against H2O2 induced haemolysis.  
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5.7 Relationship between Phenolic Compounds and Bioactivity 
5.7.1 Relationship between Phenolic Compounds and Antimicrobial Activity 
 
 Antimicrobial activity in medicinal plants has been attributed to the phenolic 
compounds present (Das et al., 2010; Urs & Dunleavy, 1975). Interestingly, this study 
revealed that the relationship between the antimicrobial activity and phenolic content of C. 
asiatica was generally low for each test microorganisms when compared using the aqueous, 
ethanolic and methanolic extracts for each plant. The high negative correlation in C. 
asiatica towards B. cereus and S. mutans indicated that the aqueous extract displayed high 
antimicrobial activity but low phenolic content and the ethanolic extract possessed high 
phenolic content but low antimicrobial activity. This result indicated that water extracted 
certain bioactive compounds believed to inhibit B. cereus and S. aureus effectively. This 
suggests the presence of other compounds such as organic acids or aldehydes in addition to 
the phenolic compounds that may be responsible for the antimicrobial activity. The results 
also indicated that phenolic compounds were extracted better in ethanol.  
 Extracts of V. amygdalina displayed significantly relationship between the 
antimicrobial activity and phenolic content towards B. cereus and S. mutans with the later 
showing about 0.60 coefficient of determination (R
2
). This result indicated that phenolic 
compounds present in V. amygdalina were responsible for the antimicrobial activity 
displayed by the plant extracts.  
When comparison was made between both plants using one of the extract (ethanol) 
the relationship between antimicrobial activity and total phenolic content was significantly 
high in agreement with the findings by Shan et al. (2007) who discovered high correlation 
between the antimicrobial activity and total phenolic content of 46 spice and herb extracts. 
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This finding suggests that the phenolic compounds significantly contributed to the 
antimicrobial activity of many plant extracts including those of C. asiatica and V. 
amygdalina.  
 
5.7.2 Relationship between Phenolic Compounds and Antioxidant Activity  
 
 Correlation between total phenolic content (TPC) and antioxidant capacity was 
determined to evaluate if antioxidant capacity may be attributed to the phenolic compounds 
present in C. asiatica and V. amygdalina as reported by previous studies on other plants 
(Jahan, 2011; Šetkoviš et al., 2007; Pietta, Simonetti, Gardana, et al., 1998; Shahidi et al., 
1992). Phenolic compounds in plants are composed of one or more aromatic rings which 
are bound to hydroxyl group(s) that forms resonance-stabilized phenoxyl radicals by 
quenching free radicals giving them their antioxidant properties (Bors & Michel, 2002; 
Rice-Evans et al., 1997). 
The correlation between TPC with DPPH, FRAP and anti-haemolysis activity of C. 
asiatica extracts were significantly high indicating that the phenolic hydroxyl groups were 
the major contributors of the free radical scavenging activity, ferric reducing capacities and 
protective effect against hydrogen peroxide shown by the plant extracts. Strong correlation 
was also observed between the antioxidant capacities determined by DPPH, FRAP and 
anti-haemolysis assays indicating that the antioxidants present in the plant extracts possess 
strong antioxidant capacities, although they might act through different modes of action 
(Huang et al., 2005; Prior & Cao, 1999). Based on the phenolic compounds present in the 
plant C. asiatica is a good source of antioxidant. 
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 The correlation between TPC and antioxidant capacity for V. amygdalina extracts 
was generally low for all the antioxidant assays suggesting that the phenolic compounds in 
the plant did not display antioxidant potential. Interestingly, the results revealed 
significantly high correlation between DPPH and anti-haemolysis assay while the other 
antioxidant assays showed non-significant correlations. This is probably because the 
phenolic compounds with strong radical scavenging potential also showed strong protective 
effect towards hydrogen peroxide, but did not efficiently reduce ferric ions. In general, the 
difference in antioxidant capacities between assays may be due to (i) the difference in 
stoichiometry between the antioxidants and free radicals; (ii) the different solubility of the 
antioxidant compounds in aqueous, ethanol or methanol solvents and (iii) stereo selectivity 
of the free radical ions (Khan et al., 2012). V. amygdalina was found to be a weak source of 
antioxidant.  
 Correlation between TPC and antioxidant capacities were significantly higher 
between C. asiatica and V. amygdalina (ethanolic extract) compared to the correlation 
between the aqueous, ethanolic and methanolic extracts of each plant. These findings 
revealed that the presence of phenolic compounds in each plant contributes significantly to 
their antioxidant capacity as previously reported (Wong, Leong, et al., 2006; Cai et al., 
2004). A clear correlation was established in C. asiatica but not in V. amygdalina. Thus the 
phenolic compounds of C. asiatica possessed stronger antioxidant capacities compared to 
V. amygdalina. 
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5.8 Bioactivity of Aqueous, Ethanolic and Methanolic extracts of C. asiatica and V. 
amygdalina. 
 
 When the overall comparison of the bioactivity present in the aqueous, ethanolic 
and methanolic extracts of C. asiatica and V. amygdalina were made, it was revealed that 
aqueous extract of C. asiatica showed strongest antimicrobial activity. However methanolic 
extraction was effective in the isolation of bioactive compounds and the methanolic extract 
of V. amygdalina showed higher antimicrobial activity in agreement with Parekh et al. 
(2005). The ethanolic and methanolic extracts showed highest TPC compared to aqueous 
extract in both plants. This indicates that phenolic compounds are extracted effectively by 
ethanol or methanol.  
 Amongst all the extracts tested, methanolic extract displayed the highest ferric 
reducing capabilities and anti-haemolysis activity while ethanolic extract displayed highest 
DPPH radical scavenging capacity in both C. asiatica and V. amygdalina. It may be 
assumed that methanol extracted most phenolic compounds possessing ferric reducing 
capacities and protective effect against hydrogen peroxide and ethanol effectively extracted 
phenolic compounds possessing DPPH radical scavenging activity.  
Ethanolic extract of C. asiatica displayed significantly higher DPPH radical 
scavenging capacity compared to the standard BHT. Synthetic antioxidants such as BHT 
have been added in to food product to prolong shelf life by controlling lipid oxidation in 
food. However synthetic antioxidants may be hazardous to health (Kahl & Kappus, 1993).  
Therefore natural antioxidants especially from medicinal plants are suitable 
replacement for the synthetic ones in the food industry. In this study, ethanolic extract of C. 
asiatica may be the best replacement for BHT in the food industry as it possessed high 
phenolic content and strong antioxidant activity.  
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The methanolic extract of both C. asiatica and V. amygdalina displayed 
significantly higher ferric reducing capacity and anti-haemolysis capacity compared to 
ascorbic acid. Therefore antioxidant agent from methanolic extracts of these plants may be 
developed for the management of disorders linked to free radicals such as ageing, cancer, 
cardiovascular disease, diabetes, rheumatoid arthritis, epilepsy & degradation of essential 
fatty acids (Subedi et al., 2012; Barros et al., 2007; Singh et al., 2007).   
  
5.9 Identification of Phenolic Compounds through Reverse Phase High 
Performance Liquid Chromatography (RP-HPLC) and Fourier Transform 
Infrared Spectroscopy (FT-IR) 
 
Based on the findings of the current study, it was concluded that phenolic 
compounds were present in both the medicinal plants and the antioxidant and antimicrobial 
properties displayed in both the plants were attributed to phenolic compounds. RP-HPLC 
used for the separation, identification and quantification of phenolic compounds present in 
C. asiatica and V. amygdalina same as others, has shown to be a reliable method (Molnar-
Perl & Fuzfai, 2005). 
 The ethanolic and methanolic extracts of C. asiatica and V. amygdalina showed 
high TPC as determined by the Folin-Coicalteu method. Purification of plant extracts was 
required prior to injection into HPLC to remove compounds such as chlorophyll, waxes 
sterols, etc. which may damage the HPLC column and interfere with the elution of 
compounds (Głowniak et al., 1996). SPE (solid phase extraction) method was chosen as the 
pretreatment method over the hydrolysis method because pretreatment with SPE columns is 
known to give higher recovery of phenolic compounds whereas, pretreatment by hydrolysis 
caused decomposition of polyphenols which often led to the loss in recovery of phenolic 
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compounds (Kermasha et al., 1995; Hertog et al., 1992). Furthermore the SPE pretreatment 
method is highly reproducible and a low volume of sample is required (Głowniak et al., 
1996).  
 The identity of the phenolic compounds were determined by comparing with the 
retention time of standards as established by Bartolomé et al. (1993). In this study, the RP-
HPLC analysis of C. asiatica extracts revealed the presence of chloramphenicol and 
benzoic acid whereby both ethanolic and methanolic extracts displayed similar 
chromatographic patterns. The peaks for chloramphenicol and benzoic acid obtained were 
confirmed firstly by spiking with authentic chloramphenicol and benzoic acid standards and 
then by FT-IR. Interestingly, this study is the first to report the presence of chloramphenicol 
and benzoic acid in C. asiatica which may contribute to the plant‘s antioxidant and 
antimicrobial activities.   
 In this study, chloramphenicol is the major compound in extracts of C. asiatica 
whole plant. It is a broad spectrum antibiotic which was first isolated from Streptomyces 
venezuelae in 1947. Chloramphenicol inhibits both gram positive and negative bacteria and 
is effectively used in the treatment of meningitis, typhoid fever, and cystic fibrosis (Baselt 
& Cravey, 1995). This may explain the antimicrobial activity displayed by the plant 
extracts. Chloramphenicol was discovered to exist naturally in herbs, grass and in plants 
from the Artemisia family (Berendsen et al., 2013; Berendsen et al., 2010). 
 The other major compound present, benzoic acid is the most widely used 
preservative in the food, drug and cosmetic industries (Davidson, 2001). It exists as a white 
powder in pure form and is slightly soluble in water. It was found to occur naturally in 
blackberries, mushrooms and tomatoes (Abdullah et al., 1994; Marlatt et al., 1992; Humpf 
& Schreier, 1991). 
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Previous studies reported the presence of triterpenes such as asiatic acid, madecassic 
acid, asiaticosside, madecassoside, terminolic acid, 11,12-dehydroursolic acid lactone, 
ursolic acid, pomolic acid, 2a ,3a -dihydroxyurs-12-en-28-oic acid, 3-epimaslinic acid, 
corosolic acid, 8-acetoxy-1,9-pentadecadiene-4,6-diyn-3-ol, β-sitosterol 3-O-β-
glucopyranoside and asiaticoside-B; and rosmaric acid in the plant (Bonfill et al., 2006; 
Yoshida et al., 2005; Schaneberg et al., 2003; Verma et al., 1999; Inamdar et al., 1996).  
Quantification of the total phenolic content (TPC) of the two major peaks obtained 
was done by (i) Folin-Coicalteu assay; and (ii) comparison with the peak profiles of 
commercial standards chloramphenicol and benzoic acid. The TPC of the peaks obtained 
by Folin-Coicalteu method was much higher than by comparison of peak profiles to 
standards. The difference in the phenolic content obtained by both methods may be due to 
the lack of accuracy of the Folin-Coicalteu method, which may be affected by interference 
such as sulphur dioxide, ascorbic acid, sugar, aromatic amines, organic acids and other non-
phenolic substances that may react with the assay (Singleton et al., 1999). 
The RP-HPLC analysis of V. amygdalina detected six major unknown peaks. 
Further analysis by LC-MS and GC-MS was done to identify the phenolic compounds 
present. Previous studies of V. amygdalina extracts revealed the presence of caffeoylquinic 
acid (Johnson et al., 2011) flavonoids (Igile et al., 1994), steroidal alcohol (Arene, 1972), 
steroid glucosides (Igile et al., 1994; Jisaka et al., 1993), fatty acids (Erasto et al., 2007) 
and sesquiterpene lactones (vernodalin and vernoamygdalin) (Luo et al., 2011; Erasto et al., 
2006).  
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5.10 Liquid Chromatography-Mass Spectroscopy Analysis of the Plant extracts  
 
 Currently LC-MS is considered as the best analytical method for identifying 
phenolic compounds present in plant extracts (Motilva et al., 2013; Savarese et al., 2007). 
Previous studies indicated that the negative ionization mode of the ESI-MS provides better 
identification of phenolic compounds with low molecular weight and low concentration 
(Abad-García et al., 2012; Sun et al., 2007; Charrouf et al., 2007). However in this study, 
both the ionization modes (positive and negative) were used to provide certainty of the 
molecular mass determination. Identification of phenolic compounds was based on the 
accurate molecular mass by search of the literature. 
 In this study, thirty eight phenolic compounds were identified in the methanolic 
extract of C. asiatica. The phenolic compounds were classified into the following groups: 
gallic acid derivatives, hydroxybenzoic acid, hydroxycinnamic acid, flavonoids (flavan-3-
ols, flavonol and flavonol glycosides, flavanone and flavanone glycosides), purine alkaloids 
and phenolic terpenes and lignin. Other compounds such as chloramphenicol and benzoic 
acid which were previously identified by RP-HPLC and FT-IR were also detected by LC-
MS confirming the presence of these compounds in C. asiatica extracts.  
 The LC-MS analysis showed that the methanolic extract of V. amygdalina contained 
forty phenolic compounds ranging from gallic acid derivatives, hydroxybenzoic acid, 
hydroxycinnamic acid, flavonoids (flavan-3-ols, flavonol and flavonol glycosides, 
flavanone and flavanone glycosides), resveratrols, purine alkaloids and phenolic terpenes 
and lignin.  
Interestingly, this study is the first to report the presence of the phenolic compound 
phloridzin. Phloridzin is characterized as a dihydrochalcone, which is present as a major 
phenolic compound in Malus domestica (Gosch et al., 2009). In a recent study conducted 
Discussion 
162 
 
by Najafian et al. (2012), this compound significantly reduced the blood glucose levels and 
improved dyslipidemia in streptozotocin-induced diabetic rats. Phloridzin was discovered 
to help reduce diabetes, obesity, stress and hyperglycaemia and is a strong antioxidant 
agent (Kobori et al., 2012; Gosch et al., 2010). The leaf extracts of V. amygdalina is known 
to possess antidiabetic activity (Osinubi, 2008; Ekpenyong et al., 1999) and this may be 
related to the presence of phloridzin. 
The combination of phenolic compounds detected in both C. asiatica and V. 
amygdalina may work in synergy to exhibit the antimicrobial, antioxidant and anti-
haemolyis properties. Synergy between different constituents of plant extracts has been 
shown in Cinchona bark, whereby thirty alkaloids have been detected and the mixtures of 
alkaloids have a greater inhibition against Plasmodium falciparumin than any of the 
alkaloids used separately (Druilhe et al., 1988). This study is also the first to identify 
various phenolic compounds present in C. asiatica and V. amygdalina. 
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6.0 CONCLUSION 
 
 Six medicinal plants: Aloe vera (leaf and gel), Azadirachta indica (leaf), Carica 
papaya (leaf), Centella asiatica (whole plant), Hymenocallis speciosa (leaf, tuber and root) 
and Vernonia amygdalina (leaf and stem) were screened for antimicrobial activity. On the 
basis of antimicrobial activity, C. asiatica (whole plant) and V. amygdalina (leaf) were 
chosen as candidate plant species for the determination of bioactive constituents present. 
The aqueous, ethanolic and methanolic extracts of C. asiatica inhibited B. cereus, E. coli, 
P. aeruginosa, S. mutans and S. aureus. Ethanolic extracts of V. amygdalina inhibited B. 
cereus while the methanolic extract inhibited B. cereus and S. mutans.   
 The supernatant obtained from the ammonium sulphate precipitation of the 
ethanolic extracts of C. asiatica displayed high antimicrobial activity against B. cereus, E. 
coli, P. aeruginosa and S. aureus. The supernatant of the ethanolic extract of V. amygdalina 
exhibited antimicrobial activity against B. cereus. Insignificant inhibition was observed for 
the ammonium sulphate pellet against the test microorganisms. Hence the antimicrobial 
activity of the plant extracts was not attributed to peptides but may be due to phenolic 
compounds. 
 Total phenolic content (TPC) of the extracts were determined. The ethanolic extract 
of C. asiatica showed high TPC whereas the TPC in V. amygdalina was similar in the 
aqueous, ethanolic and methanolic extracts but lower in amount compared to C. asiatica. 
Phenolic compounds have been known to be major contributors of antioxidant activity in 
plants. The antioxidant potential of both the plants were evaluated based on DPPH free 
radical scavenging activity, FRAP assay and anti-haemolysis activity.  
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The ethanolic extract of C. asiatica showed high scavenging activity towards 
DPPH, which was stronger than that of BHT. The methanolic extract displayed high FRAP 
antioxidant capacity, which was stronger than that of ascorbic acid. Hence the extracts of 
this plant may be useful as a natural antioxidant agent for the management of health 
disorders associated with free radicals.  
 The methanolic and ethanolic extracts of V. amygdalina displayed high scavenging 
activity towards the DPPH radical, and the methanolic extract displayed high FRAP 
antioxidant capacity. However it was lower than C. asiatica and higher concentrations of 
the extract was required to display significant antioxidant activity.  
This study also demonstrated for the first time the protective effect of C. asiatica 
and V. amygdalina extracts against hydrogen peroxide induced red blood cell lysis. The 
protective effect against haemolysis was higher than that of ascorbic acid.  
Biologically active phenolic compounds in C. asiatica and V. amygdalina were 
identified by RP-HPLC, LC-MS, and FT-IR. RP-HPLC analysis of the methanolic extract 
of C. asiatica identified the presence of chloramphenicol and benzoic acid as the major 
phenolic compounds in the plant. The identification of these compounds was confirmed by 
FT-IR analysis. However RP-HPLC analysis of V. amygdalina extracts detected six major 
phenolic compounds which were not identified. Analysis by LC-MS was done to identify 
the phenolic compounds present in the plant extracts. 
Analysis by LC-MS identified thirty eight and forty different phenolic compounds 
in C. asiatica and V. amygdalina respectively including gallic acid derivatives, 
hydroxybenzoic acid, hydroxycinnamic acid, flavonoids, purine alkaloids and phenolic 
terpenes and lignins. Amongst them, the presence of phloridzin was detected in the 
methanolic extract of V. amygdalina. Phloridzin is known to have antidiabetic properties. 
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The results from this study suggests that extracts of the selected medicinal plants C. 
asiatica and V. amygdalina possesses phenolic compounds with antimicrobial and 
antioxidant properties that can be used as antimicrobial and antioxidant agents in the search 
for new drugs. Furthermore the natural plant pheolics could serve as a natural preservative 
in the food industry to replace synthetic antioxidant agents.  
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APPENDICES 
 
Appendix A. Plants Selected in the Study 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Medicinal plants collected for the study 
The medicinal plants Azadirachta indica (A), Aloe vera (B), Carica papaya (C), Centella asiatica  (D), 
Hymenocallis speciosa (E) and  Vernonia amygdalina (F) were collected from Seksyen 4, Petaling Jaya, 
Selangor 
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Appendix B. Voucher Deposit of Selected Plants  
  
  
Figure 2a: Voucher deposited at the Herbarium of the Institute of Biological Sciences, Faculty of 
Science, University of Malaya, Kuala Lumpur, Malaysia. 
The voucher was deposited for the six medicinal plants as follows Aloe vera (A), Azadirachta  indica (B), 
Carica papaya (C), and Centella asiatica (D). 
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Appendix B continued. 
 
  
Figure 2b: Voucher deposited at the Herbarium of the Institute of Biological Sciences, Faculty of 
Science, University of Malaya, Kuala Lumpur, Malaysia. 
Hymenocallis speciosa (E) and Vernonia amygdalina (F). 
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Appendix C. Well Diffusion Assay  
 
 
 
 
 
 
 
 
 
 
                          
Figure 3a: Template for six wells on a 90 x 15mm petri plate 
Template was used as a guide to bore six wells onto agar medium of petri plate in a 
well diffusion assay. 
 
 
  
 
Figure 3b: Measuring zones of inhibition.   
Grey shading represents a confluent lawn of bacterial growth. Black circle represents the well 
bored on the agar. The white circle represents no growth of the test organism (zone of inhibition). 
 
 
 
 
 
 
Measure centre of 
antibiotic well to a point 
on the circumference of 
the zone where a 
distinct edge is present 
and multiply by 2 
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inhibition over the centre 
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Appendix D. Antimicrobial Activity of Plant Extracts by Well Diffusion Assay  
 
 
 
Figure 4a: Well diffusion assay for C. asiatica ethanolic and aqueous extracts against test microorganisms 
+ve – Positive control; CE – C. asiatica ethanolic extract; CA – C. asiatica aqueous extract; at 25, 50 and 100 mg/ml 
concentration respectively   
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Appendix D continued         
 
   
 
 
 
      
 
Figure 4b: Well diffusion assay for A. vera leaf, V. amaygdalina leaf and H. speciosa leaf ethanolic extract 
against test microorganisms 
+ve – Positive control; AVL – A. vera leaf; VL – V. amygdalina leaf and HL – H. speciosa leaf extract; at 25, 50 and 
100 mg/ml concentration respectively   
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Appendix D continued           
 
 
 
 
Figure 4c: Well diffusion assay for C. asiatica methanolic extract against test microorganisms 
+ve – Positive control; CM 25 - C. asiatica 25 mg/ml; CM 50 - C. asiatica 50 mg/ml and CM 100 - C. asiatica 100 
mg/ml of methanol extract. 
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Appendix D continued  
 
 
 
 
Figure 4d: Well diffusion assay for C. asiatica and V. amaygdalina methanolic extract against test 
microorganisms 
+ve – Positive control; CM 25 - C. asiatica 25 mg/ml; CM 50 - C. asiatica 50 mg/ml; CM 100 - C. asiatica 100 
mg/ml VM 25 – V. amygdalina 25 mg/ml; VM 50 - V. amygdalina 50 mg/ml and VM 100 - V. amygdalina 100 
mg/ml of methanol extract. 
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Appendix E. BLAST Query Search from the NCBI Database for the DNA 
Sequence of the Selected Medicinal Plants 
 
 
Figure 5a: BLAST query search from NCBI database of the 414 nucleotide of the PCR product. 
The query results list different sequences. Sequence homology of 99% was obtained for Centella asiatica   
(            ). 
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Appendix E continued 
 
 
Figure 5b: Detailed information of Centella asiatica (AF272352). 
The BLAST query of the ITS2 region with the 99% homology showed Centella asiatica. 
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Appendix E continued 
 
 
 
 
Figure 5c: BLAST query search from NCBI database of the 390 nucleotide of the PCR product. 
The query results list different sequences. Sequence homology of 99% was obtained for Gymnanthemum 
amygdalinnum/Vernonia amygdalina (         ).   
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Appendix E continued 
 
 
Figure 5d: Detailed information of Gymnanthemum amygdalinum (AY504695). 
The BLAST query of the ITS2 region with the 99% homology showed Gymnanthemum amygdalinum. 
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Appendix F. Total Phenolic Content (TPC) Determination by Folin-Ciocalteu 
Assay  
 
 
Figure 6: Gallic acid standard curve in Folin-Ciocalteu Assay 
Graph shows the gallic acid standard curve in Folin-Ciocalteu assay whereby absorbance at 765nm was 
plot against concentration of gallic acid in mg/litre for (50-500 mg/l) concentration of gallic acid. Gallic 
acid standard was used to estimate the total phenolic content in plant extracts by the Folin-Ciocalteu 
colorimetric method. The assay was performed in trplicate and results were presented as mean ± SD. 
  
 
 
 
 
 
Table 1: Total phenolic content of Centella asiatica and Vernonia amygdalina 
Medicinal plant of study Total phenolic content (mg GAE/g d.w.) 
Aqueous Ethanol Methanol 
Centella asiatica 1.120±0.063a 4.006±0.032b 3.346±0.029c 
Vernonia amygdalina 1.031±0.058de 0.974±0.049d 1.168±0.101e 
Total phenolic content was determined based on Folin-Ciocalteu‘s method for C. asiatica and V. 
amygdalina expressed as milligram gallic acid equivalent per gram dry weight (mg GAE/g d.w.). Results 
were presented as mean ± SD; n = 3. The mean changes between the samples were analysed by one-way 
ANOVA followed by Tukey‘s Multiple Comparison Test. Samples represented by different alphabets are 
significantly different (p < .05) from each other.       
 
 
 
 
 
 
Appendices 
219 
 
Appendix G. Results of DPPH Radical Scavenging Activity 
 
 
Table 2: Percentage inhibition of DPPH radicals by sample/positive control/standard at varying    
               concentrations (µg/ml). 
Samplea 
Concentration (µg/ml)b 
25 50 75 100 200 300 400 
C. asiatica 
aqueous 
-0.30±1.89 3.52±0.50 1.85±1.61 3.49±0.27 4.64±2.17 7.15±1.26 8.28±0.74 
C. asiatica 
ethanol 
11.39±0.94 25.28±1.62 27.50±1.08 36.72±0.43 64.58±0.28 86.44±0.13 88.83±0.23 
C. asiatica 
methanol 
7.33±3.63 16.35±3.19 21.82±2.03 26.56±0.87 46.49±0.63 65.59±0.56 73.17±0.71 
V.amygdalina 
aqueous 
4.93±7.56 6.56±5.43 2.21±1.19 1.48±0.27 8.17±8.76 7.72±4.74 5.95±1.37 
V.amygdalina 
ethanol 
5.36±6.85 8.30±6.28 9.74±6.10 10.72±5.12 15.62±5.37 21.03±6.58 26.07±5.32 
V.amygdalina 
methanol 
7.60±10.81 8.53±8.29 8.58±8.18 10.76±7.38 15.94±7.69 20.88±6.09 25.97±4.39 
Ascorbic acid 13.90±1.97 29.29±1.02 46.41±0.71 90.73±0.30 90.56±0.29 90.57±0.32 90.49±0.69 
BHT -7.38±1.40 -3.58±1.05 0.19±0.72 5.43±2.95 13.10±1.44 21.38±0.92 26.34±1.47 
Trolox 23.28±3.25 39.38±1.43 49.31±0.85 60.13±1.51 90.51±0.21 90.68±0.19 90.80±0.28 
Table presents the percentage inhibition of DPPH radicals by samples C. asiatica and V. amygdalina 
aqueous, ethanolic and methanolic extracts; positive controls ascorbic acid and BHT; and standard 
Trolox. 
a
Results were presented as mean ± SD, where n = 3. 
b
Concentration of sample/positive control and standard was (25-400 µg/ml) 
 
 
 
Figure 7a: Trolox standard curve with DPPH assay  
Graph depicts the trolox standard curve in DPPH assay whereby the percentage inhibition of DPPH 
radical was plot against concentration (25-200µg/ml) of trolox. Trolox standard curve was used to 
determine the antioxidant activity of samples, expressed as milimole Trolox equivalent antioxidant 
capacity per gram dried weight of plant sample (mmol TE/g d.w.). Results were presented as mean ± SD, 
where n = 3.      
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Appendix G continued 
 
  
Figure 7b: Non-linear regression analysis of C. asiatica (A), V. amygdalina (B) 
extracts and positive control (C) used to determine IC50 of DPPH assay  
Graph depicts the non-linear regression curve of C. asiatica and V. amygdalina 
aqueous ( ), ethanolic ( ) and methanolic ( ) extracts and positive control 
ascorbic acid ( ) and BHT ( ) used to determine IC50. The percentage 
inhibition of DPPH radical was plot against log concentration (1.3 – 2.6 µg/ml). 
Results were presented as mean ± SD, where n = 3. 
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Appendix H. Results of FRAP Assay for the Extracts of C. asiatica and V. 
amygdalina 
 
 
 
Table 3a: Ferric Reducing Antioxidant Power (FRAP) activity in 1 mg/ml of sample and positive 
control 
Time 
(s) 
Absorbance 595nma 
Centella asiatica Vernonia amygdalina Ascorbic 
acid 
BHT 
aqueous ethanolic methanolic aqueous ethanolic methanolic 
0 0.037±0.004 0.421±0.011 0.466±0.012 0.041±0.003 0.093±0.006 0.142±0.020 3.224±0.103 0.048±0.017 
15 0.050±0.003 0.447±0.014 0.496±0.009 0.058±0.001 0.104±0.006 0.170±0.007 3.290±0.036 0.051±0.014 
30 0.057±0.005 0.460±0.014 0.512±0.009 0.067±0.001 0.111±0.006 0.183±0.007 3.310±0.037 0.064±0.011 
45 0.062±0.005 0.468±0.013 0.521±0.009 0.073±0.002 0.116±0.006 0.192±0.008 3.301±0.021 0.079±0.011 
60 0.066±0.005 0.477±0.013 0.527±0.010 0.079±0.004 0.121±0.009 0.198±0.009 3.315±0.011 0.095±0.012 
90 0.068±0.005 0.482±0.012 0.532±0.010 0.082±0.005 0.124±0.010 0.202±0.011 3.316±0.014 0.109±0.013 
120 0.071±0.006 0.487±0.011 0.538±0.012 0.086±0.005 0.127±0.010 0.207±0.012 3.326±0.009 0.124±0.016 
150 0.074±0.006 0.490±0.013 0.542±0.013 0.089±0.006 0.130±0.011 0.211±0.012 3.334±0.014 0.138±0.017 
180 0.079±0.005 0.494±0.012 0.547±0.013 0.092±0.275 0.132±0.011 0.215±0.012 3.302±0.033 0.152±0.017 
210 0.081±0.005 0.498±0.013 0.550±0.013 0.094±0.006 0.134±0.011 0.218±0.012 3.304±0.011 0.166±0.018 
240 0.084±0.005 0.502±0.014 0.555±0.012 0.096±0.006 0.137±0.011 0.222±0.012 3.318±0.021 0.179±0.017 
Table depicts Ferric Reducing Antioxidant Power (FRAP) assay of C. asiatica and V. amygdalina 
aqueous, ethanolic and methanolic extracts and positive controls ascorbic acid and BHT at 1 mg/ml 
concentration. Absorbance was recorded at 595 nm. 
a
Assay was performed in trplicate and results presented as mean ± SD. 
 
 
 
 
 
Table 3b: Ferric Reducing Antioxidant Power (FRAP) activity in 0.5 mg/ml of sample and positive 
control  
T
Time 
(s) 
Absorbance 595nma 
Centella asiatica Vernonia amygdalina Ascorbic 
acid 
BHT 
aqueous ethanolic methanolic aqueous ethanolic methanolic 
0 0.025±0.003 0.211±0.003 0.258±0.012 0.025±0.002 0.045±0.003 0.084±0.008 2.192±0.090 0.007±0.007 
15 0.034±0.001 0.220±0.002 0.265±0.006 0.035±0.004 0.051±0.001 0.087±0.003 2.242±0.086 0.006±0.004 
30 0.037±0.003 0.225±0.002 0.272±0.004 0.039±0.005 0.055±0.003 0.092±0.002 2.246±0.086 0.010±0.005 
45 0.039±0.004 0.228±0.003 0.275±0.005 0.043±0.007 0.056±0.003 0.095±0.001 2.253±0.087 0.016±0.008 
60 0.041±0.004 0.231±0.003 0.277±0.006 0.044±0.006 0.057±0.003 0.098±0.002 2.251±0.087 0.025±0.010 
90 0.044±0.003 0.238±0.006 0.284±0.008 0.047±0.001 0.060±0.004 0.103±0.009 2.261±0.095 0.053±0.038 
120 0.045±0.004 0.240±0.006 0.286±0.007 0.048±0.001 0.061±0.005 0.105±0.009 2.268±0.104 0.062±0.039 
150 0.046±0.003 0.242±0.006 0.287±0.008 0.049±0.001 0.061±0.005 0.106±0.009 2.274±0.102 0.070±0.039 
180 0.046±0.003 0.244±0.005 0.288±0.007 0.049±0.002 0.061±0.005 0.108±0.009 2.284±0.099 0.077±0.039 
210 0.048±0.003 0.246±0.005 0.291±0.007 0.051±0.001 0.062±0.005 0.109±0.009 2.287±0.104 0.084±0.040 
240 0.049±0.004 0.250±0.005 0.295±0.007 0.053±0.001 0.064±0.006 0.112±0.010 2.295±0.104 0.094±0.044 
Table depicts Ferric Reducing Antioxidant Power (FRAP) assay of C. asiatica and V. amygdalina 
aqueous, ethanolic and methanolic extracts and positive controls ascorbic acid and BHT at 0.5mg/ml 
concentration. Absorbance was recorded at 595 nm. 
a
Assay was performed in trplicate and results presented as mean ± SD. 
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Appendix H continued 
 
 
Table 3c: Ferric Reducing Antioxidant Power (FRAP) activity of standard ferrous sulphate  
                 (FeSO4.7H2O) at varying concentrations 
Concentration 
(µmol/L) 
100 200 400 600 800 1000 
Absorbance 
595nm 
0.015±0.023 0.055±0.012 0.119±0.036 0.208±0.012 0.089±0.049 0.044±0.025 
Table depicts Ferric Reducing Antioxidant Power (FRAP) activity of standard ferrous sulphate (100-1000 
µmol/L) at absorbance 595 nm which was used to plot the FeSO4.7H2O standard curve. Results were 
presented as mean ± SD, where n = 3.  
 
 
 
 
Figure 8: Ferrous sulphate (FeSO4.7H2O) standard curve with FRAP assay  
Graph depicts the ferrous sulphate (FeSO4.7H2O) standard curve in FRAP assay whereby the absorbance 
at 595 nm was plot against concentration (100-600 µmol/L) of FeSO4.7H2O. Standard curve was used to 
determine the antioxidant activity of samples, expressed as milimole ferrous sulphate per gram dried 
weight (mmol Fe
2+
 /g d.w.). Results were presented as mean ± SD, where n = 3. 
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Appendix I. Results for the Protective Effect of C. asiatica and V. amygdalina 
Extracts against Hydrogen Peroxide Induced Haemolysis of Rabbit 
Erythrocytes 
 
 
Table 4a: Percentages of the in vitro protective effect of C. asiatica and V. amygdalina against 10  
mM H2O2 induced haemolysis of rabbit erythrocytes.  
Sample
a
 
Concentration (mg/ml) 
0.1 0.25 0.5 0.75 1.0 
C.asiatica aqueous 77.44±2.28 74.16±2.01 75.83±6.76 74.16±2.01 76.47±0.79 
C.asiatica ethanol 73.22±2.37 74.30±1.64 81.03±1.00 81.19±1.94 85.12±1.69 
C.asiatica methanol 73.60±1.27 74.27±1.36 80.21±2.05 82.95±1.14 88.14±0.83 
V. amygdalina aqueous 75.73±1.23 72.29±0.54 70.38±1.06 71.02±0.52 72.92±0.77 
V. amygdalina ethanol 73.74±1.82 74.46±0.61 75.88±0.52 78.75±0.41 78.46±0.35 
V. amygdalina methanol 70.23±0.71 73.30±0.20 73.39±1.45 74.27±0.06 79.25±0.64 
Ascorbic acid 71.40±0.51 76.69±0.20 79.69±0.75 82.69±0.21 86.05±0.66 
Phosphate buffer 72.44±1.04 
Distilled water 0.00±0.00 
Table depicts in vitro anti-haemolysis assay of C. asiatica and V. amygdalina aqueous, ethanolic and 
methanolic extracts and positive control ascorbic acid at (0.1 – 1.0 mg/ml) concentrations whereby10 mM 
H2O2 was used to induce haemolysis. Isotonic phosphate buffer was the standard used. Distilled water 
showed 100% haemolysis.  
a
Assay was performed in trplicate and results were presented as mean ± SD. 
 
 
 
Table 4b: Percentages of the in vitro protective effect of C. asiatica and V. amygdalina against 50 
mM H2O2 induced haemolysis of rabbit erythrocytes.  
Sample
a 
Concentration (mg/ml) 
0.1 0.25 0.5 0.75 1.0 
C.asiatica aqueous 67.79±1.11 72.54±0.88 69.35±2.03 69.85±0.40 71.61±0.53 
C.asiatica ethanol 54.93±1.34 74.53±1.64 75.69±0.42 83.27±0.54 84.73±0.65 
C.asiatica methanol 60.34±0.98 66.32±0.62 78.06±2.23 85.87±0.40 91.81±0.55 
V. amygdalina aqueous 55.73±0.34 51.76±0.80 59.69±1.62 63.73±0.51 57.55±1.46 
V. amygdalina ethanol 62.59±1.16 68.21±0.39 71.84±1.90 75.41±0.63 78.10±0.26 
V. amygdalina methanol 60.85±0.86 61.28±0.31 67.22±0.83 70.51±0.37 81.77±0.23 
Ascorbic acid 52.70±1.32 64.63±0.65 61.71±1.83 62.74±0.15 71.97±0.76 
Phosphate buffer 57.13±0.80 
Distilled water 0.00±0.00 
Table depicts in vitro anti-haemolysis assay of C. asiatica and V. amygdalina aqueous, ethanolic and 
methanolic extracts and positive control ascorbic acid at (0.1 – 1.0 mg/ml) concentrations whereby 50 
mM H2O2 was used to induce haemolysis. Isotonic phosphate buffer was the standard used. Distilled 
water showed 100% haemolysis. 
a
Assay was performed in trplicate and results were presented as mean ± SD. 
 
 
Appendices 
224 
 
Appendix I continued 
 
 
Figure 9a: Non-linear regression analysis of C. asiatica (A) V. amygdalina (B) 
extracts and positive control (C) against 10 mM H2O2 used to determine IC50 of 
in vitro haemolysis assay  
Graph depicts the non-linear regression curve of C. asiatica and V. amygdalina 
aqueous ( ), ethanolic ( ) and methanolic ( ) extracts and positive control 
ascorbic acid ( ) used to determine IC50. The percentage inhibition of haemolysis 
was plot against log concentration (-1 - 0 mg/ml). Results were presented as mean ± 
SD, where n = 3. 
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Appendix I continued 
 
 
 
 
 
 
Figure 9b: Non-linear regression analysis of C. asiatica (A) and V. amygdalina 
(B) extracts and positive control (C) against 50 mM H2O2 used to determine 
IC50 of in vitro haemolysis assay  
Graph depicts the non-linear regression curve of C. asiatica and V. amygdalina 
aqueous ( ), ethanolic ( ) and methanolic ( ) extracts and positive control 
ascorbic acid ( ) used to determine IC50. The percentage inhibition of 
haemolysis was plot against log concentration (-1-0 mg/ml). Results were 
presented as mean ± SD, where n = 3. 
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Appendix I continued 
 
 
 
Table 4c: In vitro anti-haemolysis effect of standard ascorbic acid at varying concentrations  
Concentration 
(mg/ml) 
0.1 0.25 0.5 0.75 1.0 
Anti-haemolysis 
(%) 
52.70±1.32 64.63±0.65 61.71±1.83 62.74±0.15 71.97±0.76 
Table depicts anti-haemolysis effect of standard ascorbic acid (0.1-1.0 mg/ml) at absorbance 540 nm 
which was used to plot the standard curve. Results were presented as mean ± SD, where n = 3.  
 
 
 
 
 
 
 
Figure 9c: Ascorbic acid standard curve with anti-haemolysis assay  
Graph depicts the ascorbic acid standard curve in anti-haemolysis assay whereby the percentage inhibition of 
haemolysis was plot against concentration (0.1-1.0 mg/ml) of ascorbic acid. Standard curve was used to 
determine the antioxidant activity of samples, expressed as milimole ascorbic acid equivalent per gram of 
dried weight (mmole AAE/g dried weight). Results were presented as mean ± SD, where n = 3. 
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Appendix J. Homogenous Peak Test of the Methanolic Extract of C. asiatica 
 
 
Figure 10a: Homogenous peak test of C. asiatica methanolic extract with chloramphenicol 
standard. 
Chromatogram displays peak obtained by spiking the plant sample with chloramphenicol standard at 280 
nm wavelength.  
 
 
Figure 10b: Homogenous peak test of C.asiatica methanolic extract with chloramphenicol 
standard.  
Chromatogram displays peak obtained by spiking the plant sample with benzoic acid standard at 280 nm 
wavelength.  
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Appendix K.  LC-MS Mass Spectrum of the Extracts of C. asiatica V. 
amygdalina 
 
  
  
  
Figure 11a: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of 5-galloylquinic acid (A); syringic acid 
(B); ellagic acid pentoside (C); hydroxybenzoic acid-O-hexoside (D); protocatechuic acid (E); and methyl gallate (F) 
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Appendix K continued  
 
  
  
  
Figure 11b: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of caftaric acid (A); sinapic acid (B); ferulic 
acid (C); dicaffeoylquinic acid (D); caffeoylquinic acid (E); and coumaroylquinic acid (F)  
 
 
 
 
 
m/z m/z 
m/z m/z 
517.9 195.1 
313.1 
223.8 
353.1 
m/z 
339.3 
m/z 
A B 
D 
F 
C 
E 
Appendices 
230 
 
Appendix K continued  
 
  
  
  
Figure 11c: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of feruloylquinic acid (A); (-)-gallocatechin 
(B); (-)-gallocatechin gallate (C); rutin (D); isorhamnetin-3-O-glucoside (E); and isorhamnetin-3-O-rutinoside (F)  
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Appendix K continued  
 
  
  
  
Figure 11d: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of quercetin-3-O-glucuronide (A); rhamnetin-
O-rutinoside (B); cirsimaritin (C); (±)-taxifolin (D); phloridzin (E); and myricetin (F)  
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Appendix L continued  
 
  
  
  
Figure 11e: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of acacetin (A); chrysin (B); kaempferol (C); 
apigenin-7-O-glucoside (D); quercetin 3-O-rhamnoside (E); and quercetin-3-O-glucoside (F)  
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Appendix k continued  
 
  
  
  
Figure 11f: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of isorhamnetin (A); naringin (B); luteolin-7-O-
glucoside (C); theobromine (D) rosmadial (E); and medioresinol (F)  
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Appendix k continued 
 
 
  
Figure 11g: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of C.asiatica methanolic extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of chloramphenicol (A); and benzoic acid (B)
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Appendix k continued 
 
  
  
  
Figure 12a: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of 5-galloylquinic acid (A); syringic acid 
(B); ellagic acid pentoside (C); methyl gallate (D); vanillic acid (E); and protocatechuic acid (F)  
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Appendix k continued  
 
  
  
  
Figure 12b: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of trans-cinnamic acid (A); sinapic acid (B); 
ferulic acid (C); p-coumaric acid (D); caftaric acid (E); and caffeic acid (F)  
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Appendix k continued  
 
  
  
  
Figure 12c: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of dicaffeoylquinic acid (A); caffeoylquinic 
acid (B); feruloylquinic acid (C); coumaroylquinic acid (D); (+)-catechin/(−)-epicatechin (E); and (-)-gallocatechin gallate 
(F)  
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Appendix k continued  
 
  
  
  
Figure 12d: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of (-)-gallocatechin (A); quercetin 3-O-
rhamnoside (B); rutin (C); taxifolin (D); isorhamnetin-3-O-glucoside (E); and isorhamnetin-3-O-rutinoside (F) 
 
 
 
 
 
m/z m/z 
m/z m/z 
m/z m/z 
447.1 
B A 307.2 
C 611.3 D 305.2 
E 
479.2 
F 625.3 
Appendices 
239 
 
Appendix k continued  
 
  
  
  
Figure 12e: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of phloridzin (A); rhamnetin-O-rutinoside (B); 
cirsimaritin (C); apigenin-7-O-glucoside (D); chrysin (E); and neohesperidin (F) 
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Appendix k continued  
 
  
  
  
Figure 12f: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of naringin (A); (±)-naringenin (B); luteolin-7-
O-glucoside (C); luteolin (D);hesperitin (E); and trans-resveratrol/cis-resveratrol (F) 
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Appendix k continued  
 
 
 
  
  
Figure 12g: Liquid Chromatography Mass Spectroscopy (LC-MS) mass spectrum of V. amygdalina methanolic 
extract.  
Mass spectra from full scan analysis by LC-MS and their molecular structure of theobromine (A); rosmadial (B); methyl 
carnosate (C); and epirosmanol (D) 
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Appendix L. Protocol and Data Sheet in the Study 
 
1. Protocol used for the plant DNA extraction kit 
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2. Manual for DNA Purification Kit. 
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